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Abstract
Inferior vena cava (IVC) filters are used to prevent a blood clot from blocking
the pulmonary vein causing a pulmonary embolism (PE). The filter is placed in
the large vein, vena cava, through a minimally invasive procedure. The filter
today are made from various metal alloys. Due to their long-term complica-
tions, such as filter fracture, filter migration, caval wall perforation, recurring
deep vein thrombosis (DVT) and post-thrombotic syndrome, there is currently
a need for an alternative to these IVC filters. A way to overcome the complica-
tions is to create a bioabsorbable IVC filter which is the main objective in this
project. The aim was to investigate potential bioabsorbable materials for use
in a bioabsorbable IVC filter. Certain requirements for the filter were identi-
fied, and the aim was to choose and optimize a material which could function
in a filter, exhibit adequate radial force to avoid migration while withstanding
the constant external force on the vena cava causing it to collapse continuously.
Through investigation of the literature and performance of initial experiments
on different bioabsorbable polymers, poly(L-lactide) (PLLA) was chosen as a
possible material candidate and further investigated. It was hypothesized that
PLLA could be optimized through strain-induced crystallization and was ex-
truded into small tubes, which underwent a biaxial strain during an expansion
process. The mechanical properties, such as stiffness and strength, were im-
proved through the processing. Several optimal processing parameters, such
as high straining temperature, fast axial processing strain and a large degree
of strain in the radial direction proved to improve the properties further. The
mechanical properties were shown not to be related to the crystal orientation
obtained during straining but related to the alignment of amorphous chains.
The biaxially strained tubes were laser cut into either appropriate filter designs
or the body part of the filter (stent-base) and expanded to 27 mm during a heat
treatment. The effect of processing, heat treatment and sterilization were eval-
uated under in vitro conditions. The radial force of the stent-base proved to
correlate with the circumferential stiffness of the biaxially strained tubes. The
fatigue properties of the stent-base were improved when tested under in vitro
conditions. Based on these results the stent-bases were implanted in vivo in an
ovine model for 2 and 31⁄2 weeks using three sheep. Two stent-bases were im-
planted per sheep, one cranially and one caudually. After merely 2 weeks the
stent-bases showed multiple fractures in the circumferential direction caused
by the continuous cyclic compression. The fragments from the caudal device
remained in the caval wall, whereas little remained of the cranial device. Histol-
ogy showed that the PLLA fragments were embedded in neointima to a degree
that fragmented pieces did not migrate. It also showedmild fibrosis around the
struts caused by the radial force of the stent. It was concluded that PLLA did
not exhibit the adequate flexibility in such a filter design to withstand the cyclic
compression of the vein over the course of 2 weeks. To achieve the goal of cre-
ating a bioabsorbable IVC filter, the stent-base must be made from a different
polymer.
Abstract
BioabsorbabareMaterialer til Brug i Vena Cava Filters
Inferior vena cava (IVC) filtre bruges til at forhindre en blodprop i at blokere
lungevenen, der forårsage en lungeemboli (PE). Filtrene fremstilles i dag af forskel-
lige metallegeringer og anbringes i den store vene, vena cava, gennem enmini-
mal invasiv procedure. På grund af komplikationer på længere sigt, såsom som
filter fraktur, filter migration, perforering af cava væggen, tilbagevendende dyb
venetrombose (DVT) og post-thrombotisk syndrom, er der i dag et behov for et
alternativ til disse IVC filtre. Dette alternativ kan findes ved at skabe et bioab-
sorberbart IVC filter, hvilket var det vigtigste formål i dette projekt. Formålet var
at undersøge potentielle bioabsorberbare materialer til brug i et bioabsorber-
bart IVC filter. Visse krav til filteret blev identificeret, og målet var at udvælge
og optimere et materiale, som kunne fungere i et filter, udvise tilstrækkelig ra-
dial kraft og derved undgå migration, og samtidig modstå den konstante ydre
kraft på vena cava, der forårsager venen i at kollapse kontinuerligt. Gennem
undersøgelse af litteraturen og resultater fra indledende forsøg på forskellige
bioabsorberbare polymerer, blev poly (L-lactid) (PLLA) valgt som enmulig ma-
terialekandidat og undersøgt yderligere. Det blev antaget, at PLLA kunne op-
timeres gennem træk-induceret krystallisation, og PLLA blev ekstruderet i små
rør, som undergik et biaksial træk under en ekspansionsproces. De mekaniske
egenskaber, såsom stivhed og styrke, blev forbedret ved behandlingen. Flere
procesoptimeringsparametre, såsom en høj træktemperatur, et hurtigt proc-
cesseringstræk aksialt og en stor grad af træk i den radiale retning viste sig at
forbedre egenskaberne yderligere. De mekaniske egenskaber viste sig ikke at
være relateret til krystalorientering opnået under træk, men at være relateret til
udstrækning af amorfe kæder. De biaksialt trukkede rør blev laserskåret i en-
ten et passende filterdesign eller basedelen af filteret (stentbasen) og udvidet
til 27 mm under varmebehandling. Effekten af processeringen, varmebehan-
dlingen og sterilisation blev evalueret under in vitro betingelser. Den radiale
kraft af stentbasen viste sig at korreleremed stivheden af biaksialt trukkede rør i
omkredsen. Udmattelse af stentbasen blev ligeledes forbedret og evalueret un-
der in vitro betingelser. Baseret på disse resultater blev stentbaser implanteret
in vivo i en fåremodel i 2 og 31⁄2 uge ved brug af tre får. To stentbaser blev
implanteret per får, én kranialt og én kaudualt. Efter blot 2 uger havde stent-
baserne multiple brud i omløbsretningen som følge af den kontinuerlige cyk-
liske kompression på venen. Fragmenterne fra det kaudale implantat forblev i
cava væggen, mens der var lidt tilbage af den kraniale implantat. Histologien
viste, at PLLA fragmenter var blevet dækket af neointima i en sådan grad, at
de fragmenterede stykker ikke migrerede. Den viste også mild grad af fibrose
omkring stentdelene forårsaget af radialkraft påvirkningen fra stenten. Det blev
konkluderet, at PLLA ikke udviste den passende fleksibilitet i det konkrete fil-
terdesign til at modstå den cykliske kompression på venen i løbet af de 2 uger.
For at imødekommemåletmed at skabe et bioabsorberbart IVC filter, bør stent-
basen være fremstillet af en anden polymer.
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PPHO Polyphosphazenes
PRESERVE Predicting the safety and effectiveness
of inferior vena cava filters
PTFE Polytetrafluoroethylene
PTMC Poly(trimethylene carbonate)
PU Polypropylene
RALLS Right angle laser light scattering
ROP Ring-opening polymerization
SAXS Small angle X-ray scattering
SEQ Sequential
SIC Strain-induced crystallization
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SIM Simultaneous
THF Tetrahydrofuran
TIB Triiodobenzoic acid
VTE Venous thromboembolism
WAXS Wide angle X-ray scattering
WGA Heat germ agglutinin
wt/vol Weight/volume
wt% Weight percentage
XRD X-ray diffraction
Greek Symbols
≤˙p Processing strain rate 1/s
≤˙ Strain rate during tensile testing 1/s
≤ Strain
≤a Axial processing strain
≤b Elongation at break
≤r Radial processing strain
™ The angle of the lamella normal to the
lamella interface
æ Stress Pa
æy Yield stress Pa
µ Bragg’s angle ±
(≤a ,≤r ) Axial to radial strain ratio
© Azimuthal angle ±
Roman Symbols
¢H0m Enthalpy of fusion of a 100% crystalline
material J/g
¢Hc Crystallization enthalpy J/g
¢Hm Melting enthalpy J/g
¢L Change in length
¢R Change in radius
A0 Initial cross-sectional area m2
A1 Cross-sectional area after axial strain m2
Aexp Degree of total area expansion %
AP Anterior-posterior
Cp Heat capacity J/±C
CA Caudal
CR Cranial
E Elastic modulus Pa
Fr French
L Lumbar
L0 Initial length m
L1 Length after axial strain m
LAO Left anterior oblique
Mn Number average molecular weight g/mol
Mw Weight average molecular weight g/mol
q Scattering vector Å°1
R0 Initial radius m
R1 Radius after axial strain m
R2 Radius after radial strain m
RAO Right anterior oblique
T Thoracic
ta Wall thickness after axial strain m
Tcc Cold crystallization temperature ±C
Tc Crystallization temperature ±C
Tg Glass transition temperature ±C
Tm Melting temperature ±C
Tp Processing temperature ±C
UTS Ultimate tensile strength Pa
V0 Initial volume m3
V1 Volume after axial strain m3
Xc Degree of crystallinity %
Other
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Nomenclature
Embolism Anymaterial including blood clotswhich
are dislodged, from its original site as a
thrombus, into the blood stream and blocks
the vessel it has traveled to
Embolus Blood clot circulating in the vascular sys-
tem
Hyperplasia Increase in tissue cells in response to
stimulus[1]
Intima Outermost layer facing the lumen[2]
Media Middle layer of the vein [2]
Nitinol Nickel titanium
Percutaneous Performed through the skin
Pulmonary embolism Embolus, which has traveled
to the lung and blocked the passage of flow
prohibiting oxygenation
Stenosis Occlusion of the vessel
Stent Circumferential scaffold. Primarily used in
the vessel to treat stenosis
Thrombosis Formation of a blood clot in a vessel,
obstructing blood flow
Thrombus Blood clot
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1Introduction
1.1 Introduction to the project
This thesis describes the research efforts done in the investigation of a bioabsorbable mate-
rial for use in a bioabsorbable inferior vena cava (IVC) filter. IVC filters are used to prevent
blockage of the pulmonary vein caused by free floating blood clots.
Rationale of theproject Blood clots formed in the lower extremities (thrombosis) are called
deep vein thrombosis (DVT) (Figure 1.1 step 1). When fragmented, it travels upstream
through the large vein (vena cava) (Figure 1.1 step 2) to the lungs and creates a blockage,
known as a pulmonary embolism (PE)(Figure 1.1 step 3). During the blockage, the oxygena-
tion of blood is prevented, and can bemortal if not treated. It is believed that DVT and PE af-
fect 422 out of a 100,000 people in the United States alone[3]. DVT and the subsequent PE is
often prevented by anticoagulants such as heparin and vitamin K antagonists[4]. Addition-
ally 100,000-300,000 Americans die from PE annually[5]. The treatment is often successful,
but not suitable for certain patient groups with for example bleeding complications and re-
occurring DVTs. As an alternative to anticoagulants, a filtration device is inserted in the IVC,
when the need for filtration is short, and anticoagulants are contraindicated [6][3][7]. The
mechanism of trapping a blood clot before reaching the lungs is portrayed in Figure 1.2.
Before the filters were invented caval ligation using sutures in the vena cava were per-
formed. It showed a high mortality of 14% and PE still occurred in 6% of patients despite
treatment. The mortality was reduced to 2% with the introduction of the Greenfield filter in
1992[4]. It is inserted percutaneously through a small incision in the skin and access to the
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Figure 1.1: Formation of a pulmonary embolism. Used from [8]
Figure 1.2: Inferior vena cava with filter, which has tapped a blood clot. Used from [9]
vein is obtained and thereby minimally invasive[10]. The filter is usually placed below the
renals andmechanically traps the embolus before reaching the lungs.
Several complications are associated with permanent placement of IVC filters in gen-
eral. Complications include short-term complications during insertion such as insertion
site thrombosis (∏28%)[7] and the long-term complications such as filter fracture (∏10%)[3]
filter migration (∏69%), dislocation, caval wall perforation (∏29%), rupture, recurring DVT
(∏46%) and post-thrombotic syndrome (venous stasis syndrome occurring after a DVT)
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(∏59%)[4]. Despite the long-term complications, the vast majority of the placed filters are
or become permanent[7] and never retrieved from the body. To reduce the risk of compli-
cations the Food and Drug Administration (FDA) issued a statement in both 2010 and 2014,
saying that all filters should be retrieved from the patient when the risk of PE has passed.
They also require manufacturers to collect clinical data for currently marketed IVC filters
in the United States, by either conducting post-market surveillance or participating in the
PRESERVE study (Predicting the Safety and Effectiveness of Inferior Vena Cava Filters). The
latter examines the use of IVC filters in the prevention of pulmonary embolism. The col-
lected data from both studies will provide safety assessment of the retrievable filters[11].
Whether or not patients benefit from an IVC filter is not conclusive. Patients where anti-
coagulants are contraindicated, would benefit from the placement of an IVC filter. However
reoccurring PE (2-5% with fatal outcome in 0.7%) is seen both with and without placement
of a filter. Anticoagulants will in many cases be used in combination with an IVC filter and
have a different outcome than just using anticoagulants (in favor of a filter present)[4].
The filter can be permanent or optional with various drawbacks, where the successful
prevention of PE is counterbalanced by the excess rate of DVT formation[7] due to the pres-
ence of the filter. There is also a difference in the different brands of filters and their benefits
and drawbacks [4], which will not be described further in detail in this thesis. A range of
filters is portrayed in Chapter 3.
Retrieval of the filter is often done percutaneously by using a snare to ’catch’ a part of
the filter, for example, a hook as seen for the CookMedical Celect and Tulip filters. The hook
is portrayed in Figure 1.2 at the top of the filter. Low retrieval rate is often due to physician
oversight [3] or difficult retrieval of the filter upon retrieval surgery. Over the last 30 years the
number of placed IVC filter in the US has increased by a 25-fold. An increase which is partly
due to better diagnostic techniques such as computed tomographic pulmonary angiogra-
phy for PE detection as well as an increase in filter placement for ’prophylactic indication’.
The prophylactic indication is based on the risk of thrombosis and PE occurring due to a
certain trauma, treatment or procedure. In 2009 the number of placed IVC filter in the US
alone was significantly higher than for Europe and the market is today dominated by the
US. The higher number is not only due to the large population (309 million) because Eu-
rope ’Big 5’ countries (France, Germany, Italy, Spain and the United Kingdom) holds just as
many (313 millions). The US places 224,700 filters versus the 9,070 filters placed in Europe’s
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’Big 5’. The number of annual venous thromboembolism (VTE)-related deaths in percent-
age are the same for the US and the ’Big 5’ but it is hard to determine, why the number of
filters placed in the US is significantly higher. A few reasons could be the insurance payer
status, medico-legal regions and intercontinental differences in financial reimbursement
[12]. Additionally, medical tradition can have an impact in the sense that ’we do or op-
erate as we normally do’. Given these substantial numbers, the IVC filter market is large.
If filters are banned or advised against in the future, due to long-term complications, the
manufacturer, including Cook Medical must act upon this and come up with an alterna-
tive treatment strategy. Therefore the next idea on how to eliminate both short-term and
long-term complications and eliminate the need for a scheduled filter retrieval surgery lies
in the ’true’ temporary filter. A filter which consists solely of bioabsorbablematerials, which
degrade over time, and the waste products are removed by the body when the risk of PE
has passed. If a bioabsorbable filter is not marketed, the trend in procedures might switch
solely towards the pharmaceutical treatments, which is not suitable for all patients and a
poor business case for the IVC filter manufacturers.
1.2 Readers guide on thesis content
This thesis is comprised of 10 parts: Chapter 2 describes the aims and objective of this Ph.D.
project. Chapter 3 gives an overview of current IVC filters and the rationale for creating a
bioabsorbable IVC filter. Chapter 4 highlights the experimentalmethods used in this project
and the rationale for choosing such. Chapter 5 summarizes the ideas and initial work on the
selection of an appropriate material and includes literature findings on the best material
candidate applicable. Through this investigation, poly(L-lactide) acid (PLLA) was chosen
as a good candidate for such application due to its stiffness and strength. Additionally, it
has a slow molecular degradation profile and maintains its strength up to 6 months. Chap-
ter and 5 and 6 both contain the necessary theoretical background shown at the beginning
of each chapter followed by the experimental findings of this project. Section 5.2 and 6.2
summarize the work performed with the intent of understanding the mechanical and ther-
mal properties, for identification of how amaterial could be processed into a bioabsorbable
filter. PLLA was investigated as both monofilament in a braided filter, and as a hollow ex-
truded tube, which underwent an expansion process similar to blow molding and subse-
quently laser cut into a suitable design. More specifically the influence of such process on
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the mechanical properties was investigated. The degree of strain, processing temperature
and processing strain rate were also studied and discussed in two separate articles 6.2.4.1
and 6.2.7. The first was published in Polymer International, and the latter is under review
in the same journal. The expanded tubes were laser cut into a different filter, or partial filter
(stent-base) designs portrayed in Chapter 7. They were tested under physiological condi-
tions (in vitro). The results are summarized in Chapter 8. From the in vitro findings, the
best design candidate processed at certain parameters was chosen. It was evaluated in vivo
in an ovine animal model for determination of the device integrity and tissue response and
discussed in Chapter 9 in which the results are summarized in article 9.2, which is currently
under revision. Chapter 10 discusses the overall findings in this project and what the future
might hold for bioabsorbable filters. A brief conclusion in Chapter 11 sums up the work
done during the project period.
Short explanations of less common technical terms can be found under abbreviations
and nomenclature.
During the project, I have been co-supervisor on the following three different master
projects. With the supervision, their work became beneficial to the overall goal of the this
project. For this reason, experimental data and results obtained through their theses are
referenced as such
• Maja Madsen ’Thermal and Mechanical Characterization of Bioabsobable Polymers
for Implantation use’[13]
• Marco Iwersen ’Investigation of Biosorbable Polymers under Static andCyclic Stress’[14]
• ToobaNoorzae ’TimeDependent Properties ofMedical ImplantsMade of Poly(L-lactic
acid)’[15]
1.2.1 Publications
Within the thesis, there are three publications. Additionally, one US patent application has
been submitted.
• Research paper in Polymer International ’Characterization of Biaxial Strain of Poly(L-
lactide) Tubes’ 15 October 2015
• United States Patent Application 20150367554 ’Sequential Biaxial Strain of Semi-crystalline
Tubes’ December 24, 2015
Under review
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• Research paper in Polymer International ’Mechanical Properties of Biaxially Strained
of Poly(L-Lactide) Tubes: Strain Rate and Temperature Dependence’ version 20 June
2016
Under revision
• Researchpaper inCardioVascular and Interventional Radiology ’Evaluation of a Bioab-
sorbable Self-expandable Vein Stent-base Made of Poly(L-lactide) in vitro and in vivo’
version 17 June 2016. Currently under revision for resubmissionbefore 15th of Septem-
ber 2016
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The main research objective was to identify the best possible material for creating a bioab-
sorbable inferior vena cava (IVC) filter. Firstly the material characteristics and properties
before and after processing into a filter design were evaluated. Secondly, the mechanical
performance upon implantation and over time was identified. The findings in vitro were
evaluated in vivo in a suitable animal model. Simultaneously commercial aspects were
taken into consideration when choosing material and processing pathways.
2.1 Research objectives: Material
The objective was to obtain the material knowledge needed to design a bioabsorbable IVC
filter. Below are the goals for identification of suitable materials
• Conduct a literature review of existing, commercial available bioabsorbable polymer
for medical use and choose the best candidate(s)
• Obtain knowledge ofmechanical properties initially and the properties of thematerial
over time
• Identify and characterize the parameters within processing and shaping of the device
which affect the mechanical behavior of the final device
2.2 Research objective: Validation ofmaterial, processing, and de-
sign
Prototypes used in this project were based on a convertible temporary filter (explained fur-
ther in detail in section 3.3.1). From the literature and subsequently experimental material
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characterization, the appropriate material was selected and tested under more physiologi-
cal conditions, in the prediction of its behavior in vivo. Below are the most important con-
siderations and steps during validation of the device in vitro listed.
• Create an in vitro test set-up predicting the outcome in vivo testing
• From the in vitro testing identify the best prototype for an in vivo study. Herein both
processing and design are taken into account
• Validate in vitro findings in vivo
• Identify the ingrowth rate of the bioabsorbable material in the vessel wall and the na-
ture of which the tissue will cover the bioabsorbable material with respect to surface
of the implant
2.3 Commercial objectives
The material and processing knowledge achieved during the Ph.D. project contributed to
the overall end goal; developing a final concept of how a bioabsorbable IVC filter can be
created. This includes the following sub-objectives:
• Identify design and materials which provide less late complications than the present
design
• Identify certain regulatory setbacks
• Identify processing pathway, which can be held in-house.
• Choice of material(s) must be based on the goal that complete absorption occurs
within 2 years
• The filter shall maintain its function as a filter for a period of 60 to 90 days, after which
it converts into a non-functional filter and all parts of the filter becomes embedded in
tissue to avoid risk of free-floating fragments
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This chapter includes the indications for placing an inferior vena cava (IVC) Filter and the
need for creating a bioabsorbable IVC filter. Furthermore, the requirements of such and the
underlying challenges are described. The chapter includes state of the art on bioabsorbable
IVC filters and how to proceed from there.
3.1 Indications
In general patients in need of a filter, are people with or in the risk of developing a pul-
monary embolism (PE), venous thromboembolism (VTE) and/or deep vein thrombosis (DVT).
Below is a list of additional indications where patients could benefit from placement of an
IVC filter [4] [16].
• patients with extensive trauma at risk of having VTE
• patients with calf vein thrombosis and upper extremity DVT
• patients with acute and/or reoccurring or chronic symptomatic PE regardless of anti-
coagulation treatment
• patients with a high risk of PE
• patients with any confirmed VTE with contraindications to anticoagulation or active
bleeding
• patientswithmassive free-floating iliofemoral thrombosiswho cannot be treatedwith
anticoagulants
• patients treated with estrogen
• patients with cancer and existing VTE
• patients with limited cardiopulmonary reserve and thereby formation of VTE
• pregnant women with established VTE
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3.2 Types of IVC filters
3.2.1 Permanent and optional filters
The filters today as seen in Figure 3.1 and 3.2 aremade ofmetal alloys such as nitinol, strain-
less steel or conichrome and can be delivery percutaneously either through the jugular or
femoral vein through 6-10Fr introducers[10].
A permanent filter is placed with the intention of never being retrieved. It becomes
endothelialized and incorporated into the caval wall and for that reason, retrieval is not
possible[4]. A new generation of filters, the optional filter later emerged and had the option
of being placed permanently or being retrieved, once the risk of PE has passed. Depending
on the design they are not significantly incorporated into the caval wall, which makes re-
trieval possible[17]. Retrieval is usually done after 12 weeks if the filter is no longer needed.
A convertible filter on the other hand only allows the filtration component to be removed,
while the remaining filter-base remains in the caval wall[17].
Figure 3.1: Permanent filters. From left to right: Greenfield (Boston Scientific; Natick, MA);
Bird’s Nest (Cook Medical; Bloomington, IL); Vena Tech LP (B Braun; Bethlehem, PA); Trapease
(Cordis Endovascular; Piscataway, NJ); Simon Nitinol (CR Bard; Tempe, AZ.) Used from [17]
Figure 3.2: Optional filters. From left to right: ALN filter (ALN Implants Chirurgicaux Ghisonac-
cia, France); Günther-Tulip (Cook Medical; Bloomington, IL); Celect (Cook Medical; Blooming-
ton, IL); Option ELITE (ArgonMedical; Athens, TX); Denali (CR Bard; Tempe, AZ); Crux (Volcano
Medical Corp; San Diego, CA); OptEase (Cordis Endovascular; Piscataway, NJ) Used from [17]
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The first filters were placed in the 1960’s and were permanent filters. The first was a
Mobin-Uddin umbrella, which filtrated the blood in the IVC, without open surgery. The
drawback was disruption of the flow dynamics and caval thrombosis. It was later replaced
by a cone filter, the Greenfield IVC filter by Boston Scientific Corporation (Marlborough,
MA, USA), which did not disrupt the flow and could hold a large thrombus while autolysis
of such occurred. Most of the following filters were then designed as a single cone or a bi-
conical filter[17]. Today both permanent (Figure 3.1) and optional filters (Figure 3.2) exist.
Long-term studies have been done to evaluate the drawbacks of both permanent and op-
tional filters. The permanent filter reduces the incidence of a PE, but over time there is an
increased risk of DVT formation and long-term filter placement is therefore not beneficial.
The optional filters eliminate the long-term complication of DVTs and caval stenosis, but re-
trieval rate is as low as 21% (>5000 patients)[18]. For both filter types, the risk of fracture and
perforation still exists. The existing filters still undergo changes to reduce the complications.
3.2.2 Convertible filters
There are currently convertible filters, which transform from a filter into a permanent stent.
This hybrid does not solve the late complication as seen with permanent vascular devices,
such as metal stents[19][20]. The Sentry filter (Novate Medical, Galway, Ireland) (Figure 3.3)
and VenaTech (B. Braun Interventional Systems, Inc, Bethlehem, PA) (Figure 3.4) are ex-
amples of convertible filters, which converts from a filter to a non-filter automatically or
mechanically. Both have or are undergoing clinical studies, but the results are not known
yet. The Sentry filter is a stent-like configuration with a filtration part in the center, which
is held together by a bioabsorbable polymeric fragment. As the polymer dissolves the filter
opens up and the stent made of non-bioabsorbable metal remains. The VenaTech convert-
ible filter does not convert on its own, but needs a mechanical intervention to remove the
apical cap, as seen in Figure 3.4(B) and does not incorporate a bioabsorbable part[21].
Figure 3.3: Sentry filter. Used from [22]
Additional studies include a non-commercial self-convertible metal filter, which is non-
bioabsorbable with an outer diameter (OD) of 25 mm. It consists of three parts: anchoring
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Figure 3.4: VenaTech filter. When implanted the filter in closed and able to filtrate. When no
longer needed the apical cap (arrow) is removed with a snare and the filter converts into open
state. Modified from [21]
struts, convertible struts and abioabsorbable switch in the centermadeof ≤-polycaprolactone
(PCL) and poly(L-lactide) (PLLA) (75/25). As the PCL degrades the filter (Figure 3.5(a)) con-
verts into a stent (Figure 3.5(b)). The filter was tested under clot simulation in vitro with
up to 5 mm clots. A serie of clots (n=5) were deployed into the filter, and the success rate
of the filter decreased with number of clots. Their in vivo study showed migration as the
convertible filter did not have any barbs to hold it in place [23].
(a) (b)
Figure 3.5: Self-convertible filter before 3.5(a) and 3.5(b) after conversion. Used from [23]
3.3 Bioabsorbable or ’true’ temporary filters
The retrieval window of the optional filters depends on the type of filter. In some cases,
retrieval is complicated, and the filter is left in situ. A different concept to overcome this and
most long-term and some short-term complications is the bioabsorbable filter, which is a
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’true’ temporary device. In such that no part of the filter is left behind over time, and the
retrieval procedure is eliminated. The indications for a ’true’ temporary filter are shown by
the dotted box in Figure 3.6 and are at first the same as for the permanent and optional filter
indications.
Figure 3.6: Flow chart for choosing correct treatment of PE. Purple dotted box is the market
share , where ’true’ temporary filters can be used. Modified from [6]
Unlike the bioabsorbable stents, there are currently no commercial available ’true’ tem-
porary bioabsorbable filters. The bioabsorbable filter must be made of a material which is
engineered to dissolve or degrade by a non-invasive stimulus, whether it is external or from
the physiological environment in which it exists. The degradation of the material must be
highly predictable so that fragmentation of thematerial and embolisms, as a result, are elim-
inated. Nor must a massive embolism be trapped in the filter as it dissolves, which could
result in a PE and harm the patient. There are currently a few examples of temporary filters,
and somewhich are ’true’ temporary filters, but only at the research and animal testing level
as described in further detail in section 3.4.
13
3. BACKGROUND
3.3.1 Bioabsorbable filter concept
There are numerous patents on a bioabsorbable filter, whether ’true’ temporary filter or not,
butmost are on design features. The bioabsorbable filter concept in this project was initially
based on a conversion concept design (Patent US2011213404). The filter is a two step bioab-
sorbable filter design. At stage 1, the filter has one or two active filtration levels (see Figure
3.7(a)). The filtration struts are connected in the center of the device until there is no longer
need for blood filtration. At stage 2 the filtration struts flip towards the vessel wall, in order
not to limit blood flow or to break off as fragments (see Figure 3.7(b)). Filtration and fixation
struts shall be embedded in the tissue and slowly be absorbed over time. The design used in
this project is still based on the concept of conversion from a filter to a non-functional filter.
The design involves a stent-base and a filtration cone on top of the stent
(a) (b)
Figure 3.7: Bioabsorbable filter concept based on patent application US2011213404 by C.
Binkert, which has a functioning filtration stage (3.7(a)) and conversion stage (3.7(b))
3.3.2 Functional requirements for a ’true’ temporary IVC filter
The material or materials used for the design of a bioabsorbable filter must ensure that the
bioabsorbable filter fulfills the functional and the biological criteria as the present filters do
so that an appropriate filter function can be achieved.
Initial filter specifications
• 6-8 filtration struts
• Strut diameter in range of 0.4-1 mm
• 30-70 mm in length
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• For use in cava sizes in 15-30 mm
• Filtration ability for approximately 1-3months*
• Completely absorbed in 1-2 years
• Applicable for percutaneous placement methods
Additionally
• The material should posses an appropriate degradation profile andmechanical char-
acteristics
• It must be ensured that the degradation process does not lead to adverse effects
*According to Sing et al. [24] 54% of PEs occur seven days after a trauma has occurred. After
28 days the risk of PE is down to 5.5% and a filtration indication time up to 3months is more
than acceptable.
The properties of the final bioabsorbable filter depend on the material properties of
which it is made. Based on the type of particular material some properties are an issue,
and others are not. The requirements in this projects rely solely on a bioabsorbable filter
made from bioabsorbable polymers. An obvious possible adverse effect is the migration
of the filter due to shape changes or the release of large filter fragments during the degra-
dation process. If the design is based on the conversion design described in section 3.3.1.
Both material and design must, therefore, be susceptible to tissue coverage when placed in
the adjacent vessel wall. Material stability and radial force are only needed until sufficient
coverage has occurred to avoid device migration.
3.3.3 Commercial requirements
The advantage of a bioabsorbable filter is clear compared to the non-bioabsorbable filters.
However, from a cost-benefit analysis point of view, the device price must match the clin-
ical advantages of placing it. If the polymer is commercially available and the processing
does not rely on vendors, the price can be kept to a minimum. If processed by a vendor, the
processingmust be predictable and regulated. The devicemust be proven to be biocompat-
ible, and preferably clinical data already exist on the material, which makes the regulatory
approval of an IVC filter application easier. The procedure must be as easy as the current
procedures and the storage of the device up until procedure, must not be complicated. If
storage is complicated and the device is not ’on the shelf’ the acute procedures might not
involve the use of a bioabsorbable filter.
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3.3.4 Material requirements and challenges
There are challenges with creating a bioabsorbable filter of bioabsorbable polymers. The
considerations and requirements are listed in the following paragraphs.
Radial force Adequate radial force of the filter is crucial. If the force is not adequate, there
is a risk of migration of the whole device, both as the IVC compresses the filter continuously
and if a large blood clot is trapped inside the filter. It might be possible to create a braided
filter from a bioabsorbable monofilament, but there are certain challenges with it. The ra-
dial force of a braided stent is expected to be low, depending on the material of which it
is braided. The advantage is that it is possible to choose in which direction the stent must
have its strength, depending on braiding design. Some currentmetal non-bioabsorbable fil-
ters hold the vein open constantly, but could possibly disturb the blood flow. It is therefore
not a requirement that the radial force of a bioabsorbable filter is large enough to keep the
vein open. In comparison a bioabsorbable coronary stent made from for example poly(L-
lactide) would need a cross-sectional area 240% higher than that of cobalt chromium, to
match mechanical strength[25].
Migration Migration is one of the primary concerns for the bioabsorbable filter and filter
should be adjacent to the vessel wall. Migration can occur both due to lack of radial force or
be time-dependent. The latter is a situationwhere the initial radial force is adequate, but the
device loses integrity over time due to an either permanent set obtained from continuous
cyclic compression or stress relaxation of the polymer. The stent-base would then no longer
be circumferential and possibly not adhere to the wall, and tissue coverage is no longer
possible. Therefore tissue coverage must occur before the permanent set or relaxation. The
tissue response of PLLA in veins is poorly investigated.
Fatigue properties The vena cava is a soft vein due to the low pressure of the blood run-
ning through it[26]. Because of this, the vein collapses during respiration. If the radial force
of a bioabsorbable filter is not large enough to keep the vein open at all times, the filter will
be compressed continuously. Advantages of a braided filter with lesser radial forcemight be
that it would be able to deform with the vessel during compression, without the risk of per-
manent deformation. The fatigue properties are therefore important, and the filter should
be able to withstand the continuous cyclic compression during a respiratory cycle 20,000
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times a day [27]. It is difficult to find a polymer which both exhibits the adequate stiffness
and strength to ensure a high radial force and have adequate flexibility to withstand the
cyclic compression. Poor fatigue properties might lead to cracks and fragmented polymeric
pieces. The pieces themselves, might be harmful to the patient and cause PE, and the frac-
tured filter could migrate due to the loss in device integrity.
Device profile Devices for the vascular system can either be balloon-expandable, where
the device is crimped onto a deflated balloon and expands in the vessel as the balloon is
inflated or the device can be self-expandable. A braided filter would in most cases require
balloon-expansion where a laser cut tube design could be self-expandable. The advantages
for each are listed in Figure 3.8. The self-expandable way is favorable for large vein diam-
eters, such as the vena cava, where the profile of the device itself is large and no need for
a balloon upon delivery is preferable. Therefore the filter would from the start have a large
profile, regardless of material. During loading into a delivery sheath, a braided filter might
risk uneven crimping. Another concern with the balloon expandable is that the inflation
during expansion toward the vessel wall must be controlled to avoid device damage. Re-
gardless of the device profile, it might not be possible to create just one filter, which can
meet vein diameters ranging from 15-30mm. It might bemore realistic to have two or three
set of filters, which covers different vein diameter intervals.
(a) (b)
Figure 3.8: The advantages and disadvantages of using braidedmonofilament (3.8(a)) or a laser
cut tubing (3.8(b)) in an IVC filter
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Molecular degradation It is a given that the filter must not degrade and be absorbed be-
fore the risk of PE has passed. Some of the more investigated bioabsorbable polymers for
medical use are used as internal sutures, which degrades within 1-2months. It sets a limita-
tion to which polymers are appropriate for the IVC filter application. It should also be noted
that as the polymer degrades, the amorphous domain is reduced, leaving the polymer crys-
talline and highly brittle. The fatigue properties are thereby reduced and the polymer would
more easily fracture and fragments can travel to the lungs and cause small PEs[28].
Permanent set Themechanical properties of for example the bioabsorbable polymers are
inferior to stainless steel or nickel-titanium and other metal alloys. Due to the permanent
deformation of some of the stiffer polymeric devices, difficulties upon crimping and expan-
sion upon delivery arise.
Change in material properties Mechanical degradation or loss of mechanical properties
are not linear with in vivo degradation [25]. Mechanical degradation, where no significant
molecular cleavage has occurred, may cause a loss of device integrity and parts of the filter
to separate and cause PE. From a regulatory point of view, it becomes harder to justify its
safety. However if the filter, both the stent and the filtration part are embedded in tissue as
described in section 3.3.1, a potential loss of device integrity and fragments thereof are not
in direct contact with the blood stream. It is no longer a potential hazard for the patient.
The mechanical degradation must, therefore, be highly predictable.
Biocompatibility As for any medical device, biocompatibility is important and the mate-
rial used should be both non-toxic and biologically inert to prevent late inflammation[25].
The body will have a natural way of covering or encapsulating any surface, which either
harms the body or creates disturbances in the blood flow. There is a fine line between the
amount of tissue coverage needed to cover the filter to make sure it stays in place and ex-
cessive narrowing on the caval wall. The reaction to bioabsorbable materials by the caval
wall is unknown, and it is possible that the reaction is different than what reported on the
arterial side for these materials.
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Regulatory approval Regulatory approval is a challenge for any material, which has not
been used in a particular clinical application previously. It is reasonable to look for poly-
mers and copolymers which have been used in similar applications without adverse ef-
fects. In general adding particles or additives to the polymer to optimize the properties
for a particular application, would make the approval process harder, unless that particular
material has been used before. In this project, the scope was to investigate the already ap-
proved commercially available polymers. It should be noted that Abbott Vascular has made
a Bioresorbable Vascular Scaffold System (BVS) for coronary use, made from highly crys-
talline PLLA (52%) with a coating of poly(D-lactide) (PDLA), which has been approved by
the FDA. The biocompatibility of the material in the vascular system is, therefore, less of a
concern, but the tissue response by the caval wall is unknown andmust be investigated.
Premise The premise for the filter used in this particular project is a stepwise configura-
tion. First, the device is delivered into the blood stream through a catheter and expanded
into the lumen preferably on its own (self-expandable) and over-expands the vessel once
it is fully expanded. The over-expansion should help the stent-base stay in place. The fil-
tration part of the filter is comprised as an extension from the stent-base (filtration struts)
and during their filtration period are connected with a small bioabsorbable wire or ’glued’
together in the center. Once the connection is broken or dissolved the filter no longer has a
filtration function and the filtration struts must move towards the vessel wall. The filtration
struts must, therefore, have enough shape memory to flip outwards once they are released
from the center. A concern is the tissue coverage at the tip of the cranial stent-base end. The
tissue might partially cover the filtration struts and prevent them from reaching the vein
wall. This concern was not tested in the animal study in this project, as the main objective
was to investigate the rate of tissue coverage and the mechanical integrity of the stent.
Radiopacity For precise placement under X-ray, the device must be radiopaque. In gen-
eral, polymers are not radiopaque[29] and therefore unlike the currently used metallic IVC
filters, the polymeric filter would not be detectable by X-ray, when implanted in the body.
For this reason, studies have been done to improve the radiopacity of bioabsorbable poly-
mers. Below is a description of some studies on bioabsorbable polymer radiopacity. Pre-
vious studies include adding barium sulfate (BaSO4) in a fine layer of powder bound to
poly(lactide-co-glycolide) (PLGA) for bone fixation plates. It released 0.5 mg of BaSO4 every
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other day and was shown in vitro not to be cytotoxic. The X-ray attenuation coefficient for
barium is 2.20 cm2/g, whereas calcium it is 0.26 cm2/g and is a good candidate[30]. Barium
sulfate (30%) was also added to a PDLAmonofilament used to braid stents [31] without sig-
nificantly reducing the mechanical properties of the fibers in vitro. Nor does the PDLA with
barium sulfate (23wt%) induce a greater inflammatory response than a steel stent would
in vivo[32]. An alternative X-ray visibility was achieved by mixing iron oxide (Fe3O4) into
a PLLA composite bone screw and showed no inflammatory response to it. The mechani-
cal properties decrease if the amount is as high as 30% but 20% proved to be less adverse
while providing strong radiopacity at least for four weeks. Perhaps a more straight forward
approach is incorporating an iodine contrast agent into the polymer, but with the risk of
leakage and radiopacity diminishing with time[33]. Normally low molecular weight con-
trast agents such as gold nanoparticles, heavymetal powders (tantalum), heavy element in-
organic salts (barium sulfate, bismuth sulfide), bromide or iodine are used but are in general
cleared quickly. They can induce pseudo-allergic reactions or renal toxicity. Bromide and
iodine also reduce the strength and toughness[34] of the polymer. It is a challenge to blend
the opacifier with the polymer backbone [29]. Therefore other pathways for reaching ra-
diopacity have been investigated[29]. Mixing 2,3,5-triiodobenzoic acid (TIB) can be mixed
in a bioabsorbable hydrogel of methoxy poly(ethylene glycol), and PLA showed strong ra-
diopacity in vivo[33]. It can be synthesized with PCL and blended with various polymers to
provide strong radiopacity ex vivo[29]. The concerns regarding radiopacity are not a part
of this Ph.D. project, and the above methods were not evaluated. Simple methods could be
adding goldmarkers onto the bioabsorbable stent-base as done for the Igaki-Tamai stent or
platinummarkers for the Bioresorbable Vascular Scaffold (BVS) stent.
3.4 What is currently out there
The literature is mainly focused on the arterial aspect of bioabsorbable vascular devices.
Limited literature exists on bioabsorbable filters and as well as bioabsorbable venous de-
vices in general. There is no direct translation between the devices on the venous side and
the arterial side and the literature on the arterial aspect of bioabsorbable devices, might
differ from the vein aspect. One study implanted Gianturco stents in both the IVC, portal
vein and the infrarenal arterial aorta. A faster incorporation, as well as degree of tissue cov-
erage, is seen for the IVC than the aorta [35]. The thickness of the neointima in the IVC
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was 249±49µm yet only 137±42µm in the aorta. Also, it was detected that a stent with the
same radial force would create an outwards force on the IVC and a hyperplasia of themedia,
whereas a hyperplasia of the intima would be seen in the aorta[35]. Additionally, the tissue
response to a metal and a polymeric stent is the same in the arteries [36]. It is very possible
that the reaction to a metal stent in vena cava is the same as for the polymeric stent and
that the thickness of neointima is slightly larger for a bioabsorbable polymer in the veins
compared to the arteries. This could however not be confirmed by the literature and the tis-
sue response to the stent might solely depend on the radial force exerted on the vein, rather
than the cells reacting to the material itself.
3.4.1 Bioabsorbable filter configurations
There are currently two studies, which investigated a 100% bioabsorbable IVC filter, none
of which have been clinically evaluated. The most interesting study was done by Eggers et
al. [5], who evaluated different sutures, including PDSII made from polydioxanone (PDS),
Monocryl made from PCL and Vicryl made from polyglycolide (PGA)[5], on which they
chose PDS as material for the filter and assessed it in vivo in a porcine model. The filter
was braided into conically shaped filters (OD=20 mm). However, the device was not self-
expandable. PDS is a suture which exhibits excellent stiffness and strength for 35 days, ac-
cording to their study. Their braided filter exhibited nomigration andmaintained intact for
12 weeks. The filter was also able to withstand simulated thrombus trapping in vivo even at
35 days[37].
Thors and Muck [38] investigated the effect of the IVC filter made from PLGA strands as
filtration cone and anchored to a self-expandable non-bioabsorbable nitinol Z-stent (Cook
Medical Inc.) (see Figure 3.9). It was evaluated in a porcine model for six weeks, but the
functionality of the filter was not modeled. At termination, only the nitinol stent remained
in all but one animal, where one PLGA strand remained incorporated into the caval wall
and covered in neointima. Device integrity was not high, as half of the devices experienced
some rotation in the horizontal plane. Histology showed intense inflammatory response
and thickening of the intima and media. The filter from Thors and Muck was not a true
temporary filter, yet only an evaluation of the response to PLGA strands as the filtration
cone during degradation.
Zhang et al. [39] continued the idea by creating a bioabsorbable filtermade fromPCL, an
elastomer, as a stent-base (OD=18 mm) and PLGA as bioabsorbable filtration cone (Figure
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Figure 3.9: IVC filter with a bioabsorbable PLGA filtration cone. Used from [38]
3.10(a)). The filter was evaluated in a canine animal model in an IVC with the diameter of
12 mm for 6 weeks at which mainly the stent-base remained. Migration due to the PCL’s
poor mechanical strength and stiffness was observed. There was no evidence of PE caused
by degradation products from the PLGA filtration struts. The PLGA struts were still present
and adhered to the caval wall resulting in an obstruction of the lumen. Inflammation was
present to a great extent and where the struts had been.
(a) (b)
Figure 3.10: Sketch (3.10(a)) and prototype (3.10(b)) of a bioabsorbable filter made of PCL as
the stent-base and PLGA as the filtration cone. Used from [39]
The main concern with the filters using monofilament for filtration struts, regardless of
the stent-base, is the risk of debris from degradation products or fragments as degradation
occurs causing a PE[39][28].
Xiao-ping et al. [28] focused on the feasibility of a bioabsorbable filter designed along
the lines of the permanent TrapEase filter in Figure 3.1. The bioabsorbable version made
from PLLA is shown in Figure 3.11. They reported an in vitro study which evaluated the clot
trapping ability of PLLA strands cut from film and incorporated in a filter. One drawback
was that upon delivery the device deformed to half its initial diameter. Therefore it needed
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a center line expansion mechanism to open the device to its original diameter as seen in
Figure 3.11 step 1. As it starts to degrade fragments would be released (Figure 3.11(a) step 2)
to the system, especially the central line, which could potentially cause PEs.
(a) (b)
Figure 3.11: Filter made from PLLA strands as sketched (3.11(a)) and as prototype (3.11(b)).
Modified from [28]
3.4.2 Bioabsorbable stent configurations
As previously stated literature on ’true’ temporary or bioabsorbable filters is sparse. One
should note that there is a great deal of literature on the subject of a bioabsorbable stent
for arterial use. Due to the vast literature as well as one already commercially available
bioabsorbable stent, it makes sense to apply some, but certainly not all, of the thoughts
and challenges to the creation of a bioabsorbable filter. Some of the requirements apply for
both metal and polymeric bioabsorbable stents and are good biocompatibility, adequate
radiopacity for visualization and sufficient radial strength [40]. In short, a stent is used to
treat stenosis or obstructed vascular vessel and used as a scaffold supporting the vessel wall
to provide support to an obstructed lumen[41]. They can be divided into two groups (self-
expandable or balloon expandable) depending on the application and the dimensions and
the way they are meant to be delivered.
Stents are best described as comprised of repeating elements denoted as struts in the
circumferential direction. The struts that form a close loop are called cells. The continuous
series of struts or cells in the circumferential direction are denoted columns, whereas two
adjacent cells or struts in the longitudinal direction are denoted bridges. The junctions of
which the struts connect are called connection points. Upon loading, it is required that the
stent can be transformed into a compressed state during loading and transformed into the
initial shape upon implantation. The design must include an efficient crimp, by folding or
packing the cells to a diameter below the maximal diameter for loading.
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For balloon expandable stents, there are two key considerations regarding the mechan-
ical behavior. The stent must be ductile enough not to be plastically deformed during ex-
pansion in the target vessel. For self-expandable stents, the stent must have enough radial
force to open fully up on its own. For both groups, the stent must not creep and remain
vessel patency[41] until its surface is covered in tissue. In this project the word stent relates
solely to a stent functioning as a stent and stent-base refers to a construct which resembles
the stent, but does not necessarily function as a stent. Stents are typically made of stainless
steel, nitinol, cobalt alloys or recentlymade of polymers. Permanentmetal stents have long-
term complications such as hyperplasia. To overcome this some of them are drug-eluting,
to minimize this hyperplasia. However, when the drug is no longer eluted over time, the hy-
perplasia becomes an issue[42]. The stentsmade of nitinol have a significant shapememory
effect and superelasticity over the polymeric ones. It also has the advantage over a bioab-
sorbable polymer, that it is stable at body temperature. Great shape memory is not the case
for most of the commercially available bioabsorbable polymers.
As seen in Table A.1 in Appendix A.1, most of the bioabsorbable stents are made from
polymers, but the bioabsorbable metal stents are also under development. They comprise
primarily of magnesium and iron as pure or in alloys. Today there is only one commercial
available stent, the Bioresorbable Vascular Stent (BVS) by Abbott Vascular. A commercial
available bioabsorbable stent for arterial use means that approval of using the same type of
polymer in the vascular system, but on the vein site of it, becomes easier. Having that said,
themechanical requirements for such as device might not be the same as for arterial stents.
To sum up, more and more IVC filters are placed and primarily due to the long-term
complication, FDA has issued a concern regarding the use of IVC filters. There is a present
need for a bioabsorbable IVCfilter, but the creation of such hasmany challenges. The bioab-
sorbablematerials today are primarily polymeric and have beenwidely investigated for sev-
eral applications, but not approved for a bioabsorbable IVC filter. The materials have their
short comings compared to the non-bioabsorbable metals used for IVC filters today. In the
selection of a bioabsorbable polymer, the above-mentioned requirements must be fulfilled.
An extensive characterization of the initial properties as well as changes over time are de-
scribed and investigated in Chapter 5.
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4.1 Characterizationmethods
The following section applies to the experimental methods used to characterize the behav-
ior and properties of the materials as a result of processing and are portrayed in Figure 4.1.
The methods used to characterize the behavior in vitro are portrayed in Figure 4.2.
Figure 4.1: Flowchart of methods used for characterization of materials
Themost predominant method for characterizing themechanical properties of thema-
terials was tensile testing. Radial force testing was done to evaluate the force the filter can
exert when placed in a vein. Compression testing was done to evaluate fatigue properties of
thematerial over time to simulatewhen implanted in vivo. The effect of processingwas eval-
uated both regarding mechanical properties and in relation to the changes in crystallinity
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Figure 4.2: Flowchart of methods used for characterization materials in vitro. *Finite element
analysis was performed retrospectively
and orientation of thematerial and characterized by differential scanning calorimetry (DSC)
and wide angle X-ray scattering (WAXS), respectively.
4.1.1 Mechanical testing
Tensile testingofmonofilament Several types ofmonofilamentwere tested to get an overview
of thematerial candidates for a bioabsorbable filter. The raw data was supplied by S. Tanner
(Cook Research Inc.) and performed on an Instron 5544 using a 10 N load cell at a testing
speed of 25 mm/min and a gauge length of 25.4 mm. Samples were tested until fracture.
The monofilaments were also braided into stents (OD 8 mm, length 40 mm) and further
evaluated through radial force testing when crimped from 10-2.1 mm. The data analysis
was performed using MatLab 2016a.
Tensile test of expanded tubes Specimens for mechanical testing were cut from the tubes
both circumferentially and axially along the tube with a width of 5 mm and a length of 18
mm (Figure 4.3). The cross-sectional area was determined as the average thickness times
the width of the specimens. Uniaxial tensile testing was performed at a testing speed of 2.7
mm/min on an Instron 5564 using a 500 N load cell and the tubes were pulled to fracture.
Stress (æ) is a force over the initial cross-sectional area (A0), and strain (≤) is the difference
in length over the initial length. From the stress-strain curves, elastic modulus (E=æ/≤) was
determined in the interval of 20-40 MPa and yield stress (æy ) was determined as the first
localmaximum. Data from tensile testing was collected using Bluehillr software V3.25. The
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analysis was performed using MatLab 2016a. The definitions of the mechanical properties
are shown in Appendix B.1 in Figure B.1. A representative script showing the data analysis
for tensile testing (both monofilament and tubes) is found in the Appendix B.2.1.
Figure 4.3: Specimens cut from tubing in the axial and circumferential direction. Protective
clamps were added to each end
Radial force testing Radial force testing was done to determine the effect of processing
and design of a stent-base. It was performed in a compression station, and the stent-base
was crimped from 30 mm to 6 mm (0.5 s/min) three times in a controlled dry environment
at 37 ±C. The compression stationmeasures the crush resistance or said, in other words, the
chronic outward force under constant displacement (Figure 4.4). Circumferential crimping
down to 6mm does not resemble the physiological compression on the stented vein but
gives an idea of resistance to permanent deformation or if the device can to be loaded into
a delivery sheath more than once. Data was analyzed using MatLab 2016a. The graph was
smoothed with a built-in local regression function and the filter was set to 0.02.
Figure 4.4: Compression station for radial force testing
Cyclic testing The cyclic test was performed onboth single stent cells and stent-bases. The
former was fixed in an Instron 5942 fixed with custom made grips as seen on Figure 4.5(a)
and tested using a 50 N load cell. The cell was compressed to half of their height in a relaxed
state with a speed of 200 mm/s for 10-77 cycles. The area underneath the curve after each
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cycle was calculated using a built-in ’trapz’-function in Matlab 2016a, which returns the
approximate integral of the load. Due to the difference in thickness for each specimen, the
areas were normalized between 0 and 1 for better comparison.
(a) (b)
Figure 4.5: Single stent cell fixed in Instron with customized grip during cyclic compression
test 4.5(a) and stent-base fixed in a silicone tube during cyclic compression test under ambient
conditions (4.5(b))
Cyclic test of the entire stent was performed on a custom made flat-plate compression
station (see Figure 4.5(b)) to evaluate the fatigue properties. The degree of compression is
the distance of which the top-flat plate travels towards the bottomflat plate and set toª30%.
The device was placed in a silicon tube to mimic the vein wall and placed between the two
flat plates. It gave the option of adding fluids, controlling the temperature and adding flow
to the model. The temperature was controlled by a sensor in a small water tank next to
the system from which the solution was pumped through the silicone tube between the
flat plates. All stents were delivered through a 6 mm sheath, which corresponds to the first
crimping in the radial force test. The test would run for 150,000 cycles over the course of 3
days result in a compression speed of approximately 6 mm/s.
4.1.2 Statistical analysis
Statistical analysis was done using a double-sided t-test in MatLab 2016a for comparison of
two groups at a significance level of Æ=0.05%. It was assumed that the distribution of the
mean of each test series is normal and that the variance in each test series is similar.
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4.1.3 Differential scanning calorimetry
Differential scanning calorimetry (DSC) is a technique which measures the differences in
heat flow rate of a sample and a reference during heating or cooling or said in order words,
the amount of heat needed to increase the temperature of each. It gives information about
the glass transition temperature (Tg ), heat capacity (Cp ), cold crystallization temperature
(Tcc ) ormelting temperature (Tm) and the heat of fusion during constant heating or cooling
rate during a DSC scan[43]. It was used to determine the thermal properties of the mate-
rial before and after processing. DSC scan of the processed materials, can both provide an
idea of the degree of crystallinity (Xc ) obtained by different processing and the mechanical
behavior thereof. It can also provide information about whether or not the material will be
affected by the body temperature. Additionally, the changes in the material due to storage,
the presence of moisture from sterilization or physiological environment can be detected
by changes in the glass transition temperature (Tg ) or Xc . Figure 4.6 shows a representative
DSC scan for the extruded PLLA used in this project.
DSC was performed either on Netzsch DSC 200 F3 Maia as described in [44] or carried
out on TA Instruments DSC Q200. Heat rate was 10±C/min regardless of instrument. The
samples (5-10mg) were heated from∑20±C to∏180±C. The Tg was found as themidline be-
tween onset and offset before and the transition. The Xc was calculated from the measured
enthalpy induced by melting (¢Hm) minus the measured heat fusion induced by crystal-
lization (¢Hc ) relative to the enthalpy of fusion (¢H0m=93 J/g[45]) of a 100% crystalline PLLA
sample (Equation 4.1). Data was analyzed using Netzsch Proteus Analysis software v 6.1.
Xc (%)=
µ
¢Hm °¢Hc
¢H0m
∂
·100 (4.1)
Figure 4.6: Representative DSC scan of extruded PLLA and the determination of Tg , Tcc and Tm
and the area of crystallization andmelting peak
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4.1.4 Wide angle X-ray diffraction
Wide angle X-ray scattering (WAXS) was used to determine the textural orientation of the
polymer as a result of processing. WAXS gives information on the structure of the crystalline
domain, the Xc , crystallite size, and their orientation. The principle behind the technique
is placing the sample in front of an X-ray beam. The reflected X-rays at specific angles and
intensities are recorded in this case by a diffractometer (Figure 4.7(a)). The structure will
produce a unique set of the angular distribution of diffracted intensities. The crystals will
give rise to sharp diffractions, whereas the amorphous domains will produce diffuse scat-
tering. The width of the reflections in a specific crystallographic axis corresponds to the size
and disorder of the crystallites. The wider the reflection, the smaller the crystals. The orien-
tation is calculated from arc lengths or angular spread of a chosen reflection along the fiber
axis[46].
(a) (b)
Figure 4.7: The principle of WAXS, where the X-ray is emitted to the sample and the scattering
angle (2µ) at which the projected beam is detected (4.7(a)). The scattering plane defined by
the wave vector of incoming and scattered X-ray beam outside the sample, which defines the
scattering plane and the scattering vector q between. Modified from [47] and [48]. Figure 4.7(b)
show the azimuthal angle (¡). Modified from [49]
In this project, a custom-made 2D diffraction setup equipped with a rotating anode Cu
KÆ X-ray source, monochromatized and focused by 1D multilayer optics was used. It was
operated at 50 kV and 200 mA with a 123 mm distance between detector and sample for 30
min. The sample was cut in half and placed with the axial direction vertical and perpendic-
ular to the beam. The crystalline orientation of the lamellae in the stretching direction was
determined using Herman’s orientation function (Equation 4.2 and 4.3) and a second-order
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orientation factor (Equation 4.4)[50]. An orientation factor (F2) of 1 corresponds to com-
plete orientation. The scattering intensity is integrated as a function of Bragg’s angle (2µ)
and the azimuthal angle (¡). The azimuthal angle, ¡ = 0± is defined at the position of the
circumferential direction and the normal direction to the (200/110) plane in the interval of
scattering vectors q=1.13-1.24 Å °1 between 0-360±.
fH =
3
≠
cos2¡
Æ°1
2
(4.2)
where
≠
cos2¡
Æ
is
≠
cos2¡
Æ= Rº0 I (¡)cos2¡sin¡d¡Rº
0 I (¡)sin¡d¡
(4.3)
F2 =C°1 · fH (4.4)
where C is a conversion factor (Equation 4.5) from the orientation of a lamellar normal with
respect to the stretching direction[50]
C = 3
≠
cos2™
Æ°1
2
(4.5)
where™ is the angle of the lamella normal to the lamella interface and would in this case be
™=90± resulting in C=-1/2.
The mean crystal size (D(hkl )) (Equation 4.6) was found in both the circumferential di-
rection (scattering vector q=2.2-2.25 Å°1) and axial direction (scattering vector q=1.13-1.24
Å°1 ) corresponding to the (018) and (110/200) planes, respectively. It uses Scherrer’s equa-
tionwith the shape factor K=0.9[51], thewavelength∏= 1.5418 Å andØ1/2, which is thewidth
at half the maximum of the peak height at the particular Bragg diffraction angle, µ.
D(hkl ) = K ·∏
Ø1/2 ·µ (4.6)
Diffraction patterns were analyzed in Matlab 2016a, using a predefined script (WAXS
package version 9.4) written by Dag W. Breiby (2011) (Figure B.2 in Appendix B.3). Further
analysis of the intensities and angles, were analyzed in Matlab 2016a.
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(a) (b)
Figure 4.8: Sketch of WAXS setup (4.8(a)) and WAXS images of an amorphous extruded PLLA
tube and semi-crystalline strain-induced PLLA tube (4.8(b)). The most common diffraction
crystal planes are shown.
4.1.5 Gel permeation chromatography
Gel permeation chromatography (GPC)were used to determine the averagemolecularweights
using differential refractometer and a right angle laser light scattering (RALLS) detector.
The column set consisted of one Waters styragel 10µm HT 6E column and one PLgel 5µm
mixed D column. Approximately 2.5 mg/ml PLLA was dissolved in tetrahydrofuran (THF)
and filtered by 0.45µm polytetrafluoroethylene (PTFE) filter under constant temperature
(22±C) with the flow rate of 0.5 ml/min. From this number average molecular weight (Mn)
and weight, average molecular weight (Mw ) were determined based on calibration with
polystyrene standards using TriSEC software.
4.2 Histology processing
The procedure, interim and follow-up of the in vivo study are described later in Chapter 9.
Below are the histology processing described.
4.2.1 Hematoxylin and eosin staining (H&E)
To avoid the tissue from changing and drying out, the explanted tissue was fixated for 48
hours in 10% formalin. The fixated vein was dehydrated with alcohol and embedded in
paraffin and cut into slices (5µm thick) using a microtome. The slices were hydrated using
Xylene, and stained with first hematoxylin (H) and then eosin (E). Hematoxylin strains pur-
ple acidic structures such as DNA in the nucleus. Eosin stains pink but is more non-specific
and stains most proteins[52].
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4.2.2 Antibody straining and immunochemistry
Two sets of antibodies were used, a primary and a secondary antibody. After staining the
tissue was visualized by confocal laser scanning microscopy. The staining can either be
done in one or two steps. The one-step method uses antibodies, which are fluorescent,
and can bind to directly the tissue and antigen in question. The two-step method uses two
antibodies. The primary antibody, which in unlabeled, is raised against an antigen of the
cell or tissue for examination and therefore binds to it. Subsequently, a secondary antibody,
which is fluorescently labeled, is added and binds to the primary antibody because it has
been raised against it. Themethods are portrayed in Figure 4.9. In this project, the two-step
method was used.
Figure 4.9: Principle of directly labeling of antigen with fluorescent secondary antibody (2±) or
indirectly labeling to a primary antibody (1± ), which have bonded to the antigen (dashed box)
Primary Antibody (1± AB) The specific targets for visualizing the response to the implant
were the precursor for fibrin, fibrinogen, and the inflammatory response regarding the pres-
ence of macrophages. The tissue coverage as a result of implantation was expressed by en-
dothelial cells. Anti-Fibrinogen gamma chain antibody (IgG2b) (ab119948 from Abcam)[53]
binds to the gamma chain of fibrinogen molecules. Fibrinogen yields monomers to poly-
merize into fibrin and acts as a cofactor in platelet aggregation. Purified rat anti-mouse
CD31 (IgG2a) (MEC 13.3 from BD Biosciences)[54] is an antibody against CD31 and reacts
with platelet endothelial cell adhesion molecule-1 expressed on adult and embryonic en-
dothelial cells and many peripheral leukocytes and platelets. Anti-Macrophage antibody
(IgG1) (ab22506, MAC 387 from Abcam)[55] binds to an intracytoplasmic antigen expressed
by granulocytes, monocytes and by tissue macrophages.
33
4. EXPERIMENTALMATERIALS ANDMETHODS
Secondary Antibody (2± AB) Secondary antibodies were used to fluorescently stain the
primary antibodies for visualization under a fluorescent microscope. DAPI, wheat germ
agglutinin (WGA) and phalloidin were used to counter stain the nuclei, actin-filament and
residuals found on the cell membrane surface, respectively.
DAPI (4’,6-diamidino-2-phenylindole) (D1306 fromThermoFischer Scientific)[56] (1:500)
binds the AT regions within the DNA of the cell and emits blue fluorescence upon at wave-
length at 461 nm. WGA (Alexa Fluor 488 (AF488) from ThermoFischer Scientific)[57] (1:500)
is an agglutinin which binds to sialic acid and N-acetyl glucosaminyl residues found in
the cell membrane and emits green at the wavelength of 519 nm. Phalloidin (Alexa Fluor
488 (AF488) from ThermoFischer Scientific)[58] is a peptide, which binds actin in cells and
tissues, and emits green fluorescence at the wavelength of 518 nm. Donkey anti-mouse
secondary antibody (IgG), Alexa Flour 555 (AF555) binds to IgG anti-fibrinogen or anti-
macrophages and emits red at a wavelength of 556 nm[59]. Chicken anti-rat secondary
antibody (IgG), Alexa Flour 647 (AF647) binds to anti-CD31 and emits at a wavelength of
647 nm in the far red spectra[60].
For antibody staining, the fixed tissue was rinsed in phosphate buffered saline (PBS)
blocked with 10% donkey serum in 0.2% bovine serum albumin (BSA) and permeabilized
with 0.2% TritonX-100 overnight. Tissue was incubated with a primary antibody against fib-
rinogen (IgG2b 1:100) or macrophages (IgG1 1:100), diluted in 0.2% BSA and PBS, for two
days at 4±C and then rinsed three times of 30 min. Samples were next stained with sec-
ondary labeling reagents for nuclei (DAPI 1:500), actin filaments (AF488 phalloidin, 1:100),
and AF555-conjugated anti-mouse secondary antibody (AF555 1:500) for 2 days at 4±C, then
rinsed 3x30 minutes and stored at 4±C until imaged.
4.2.3 Optical clearing
For optimal confocal imaging, the explanted tissue was cleared to ensure greater visibility
by incubating the tissue in solutions of gradually increasing fructose concentration. D-(-)-
fructose (JT Baker, Center Valley, PA) was dissolved in milliQ water with 0.5% ∞-thioglycerol
(Sigma-Aldrich St. Louis, MO) at various concentrations (20, 40, 60, 80, 100% wt/vol and
115% wt/wt). The explanted tissues were incubated in each solution for 12-24 hours under
gentle rocking.
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4.2.4 Confocal imaging
Confocal imaging was used to visualize the newly formed tissue around the connection
points without disrupting the tissue. To increase the optical resolution and the contrast
of the probe, a spatial pinhole was placed at the confocal plane of the lens to eliminate out-
of-focus light. Tissue samples were imaged with an inverted confocal laser microscope (710
LMS, Zeiss, Germany) with laser wavelengths from 405 to 639nm. Images were obtained as
1024x1024 pixels with ZEN 2011 software and taken as the best compromise between over-
laid laser wavelengths.
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5Material selection
The following chapter highlights the most common bioabsorbable polymers used in re-
search and commercial devices today. Their advantages and disadvantages are summarized
for the sole purpose of choosing the right polymer. The objective was to find the best mate-
rial candidate for a bioabsorbable filterwith processing inmind to improve the performance
of the bioabsorbable filter. Based on the screening of materials in the literature review, cer-
tain polymers in the form of monofilament were mechanically evaluated, before a choice of
material was made.
5.1 Background on bioabsorbable polymers in biomedical appli-
cations
There are certain requirements for choosing a biomaterial, including bioabsorbable poly-
mers for a specific application. Not only must it have the appropriate mechanical prop-
erties, but it must also be non-toxic and endotoxin-free and thereby biocompatible[61],
which is no different than when designing traditional medical devices[62]. As for the bioab-
sorbable polymers, the degradation products must be non-toxic and be cleared by the body
itself. For any given biomaterial, the host-response and tissue response to a polymer de-
pends on the chemical, physical and biological properties of thematerial[61]. Below are the
general requirements for a bioabsorbable IVC filter[61][62]
• biocompatible
• appropriate degradation time
• appropriate mechanical properties
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• produce non-toxic degradation product
• processing must be easy
The understanding of the properties become more complex over time as they change, thus
resulting in a different host response distinct from the initial[61]. The polymer must also
be commercially available and easily processed to tailor its properties. Degradation rate,
strength loss, andmass loss must be controlled and fully known and will vary depending on
the application. Applications of bioabsorbable polymers in medical devices are numerous
and include sutures, orthopedic devices including screws plates, etc., temporary scaffolds
for tissue regeneration, drug-eluting cores or strings on nano- or microscale for drug deliv-
ery, stents for vascular use andmuchmore.
Bioabsorbable materials have been investigated for decades in different fields including
the biomedical field. The predominant reason for this in some applications is the elimina-
tion of a second operation to retrieve the device [63] or eliminate long-term complications.
Is some applications a retrieval operation is not possible for example with placements of
vascular stents. Depending on the application some bioabsorbable polymers has shown
greater promise than others. The properties of a bioabsorbable polymer depend on mate-
rial chemistry, molecular weight, hydrophobicity, surface charge, water absorption, degra-
dation and erosion mechanism[61]. Their main disadvantage is that they are highly time-
dependent. As they degrade, they undergo irreversible damage, such as fatigue or creep[64].
5.1.1 Types of polymers: natural or synthetic
There are currently both natural (Table 5.1) and synthetic bioabsorbable polymers (Table
5.2) and both have been investigated extensively[65]. The polymers are often divided into
groups, according to their degradation pathway, either enzymatically or hydrolytically[65]
as later described in section 5.1.2. A drawback for natural bioabsorbable polymers is that
many of themare enzymatic degradable and varies depending on the implant site and avail-
ability of enzymes. It is therefore difficult to predict the degradation rate clinically[62][65].
They have the advantages of possessing bioactivity and interacting with the cells, which
is some instances, unfortunately, trigger an immunogenic response from the body. This
immunogenic response can be avoided by using the synthetically manufactured polymers,
where properties are more predictable, and batch to batch variation is low. Keeping the
commercial aspect in mind, the natural polymers are therefore not further reviewed in this
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thesis. The synthetic ones give us the possibility of tailoring properties to our specific appli-
cation [62][61]. Synthetic bioabsorbable polymers are often synthesized by either step (con-
densation) polymerization to make polyanhydrides, poly(ortho esters) and polyurethanes
or and addition (chain) polymerization. The latter include ring opening polymerization
to make hydrolytic sensitive poly(Æ-esters) and polyphosphazenes. Degradation rate usu-
ally depends on chemical bonds, water diffusion, monomer solubility, device geometry, and
size. Depending on the industry, different requirements apply. For example in the packag-
ing industry, the specific degradation time is less significant as some polymers will degrade
long after the packaging need has been filled. In the biomedical field, they are used in tem-
porary medical devices, where a function or support is required for a certain period. In a
biomedical application, the specifics on strength andmass loss over time is very crucial.
Table 5.1: List of some natural polymers
Natural polymers
Name
Degradation
type
Application
Proteins and Poly(aminoacids)
Poly(amino acids) enzymatic[65] scaffolds[65]
Albumin enzymatic[65] coating[65]
Collagen (protein) enzymatic[65] wound dressings and drug delivery[65]
Elastin enzymatic[65] scaffolds, coating and drug delivery[65]
Fibrin enzymatic[65] drug delivery[65]
Polysaccharides
Alginate (polysaccharides) enzymatic[65] drug delivery and scaffolds[65]
Chitin, chitosan enzymatic[65] drug delivery[65]
5.1.2 Degradation pathways
The bioabsorbable polymers can be divided into hydrolytically and enzymatically degrad-
able polymers. Hydrolytic bioabsorbable polymers have hydrolytically labile chemical bonds
in their backbone[65] and include polyesters, polyamides, poly(anhydrides), poly(ortho es-
ters), poly(phosphoesters), poly(cyanoacrylates), or poly(phosphazenes)[66][61]. For the
production of bioabsorbable biomedical devices hydrolytically degradable polymers can be
preferred over the enzymatically, due tominimal site-to-site variation as well as low patient-
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to-patient variations[65]. The degradation rate depends on howhydrophilic or hydrophobic
the side groups are. The degradation rate decreases when containing the following bonds:
ester-, carbonate-, urethane- and amide bonds and in that order[66]. If the polymer is crys-
talline, the degradation is also slower. The hydrolytically degradable polymers can either
degrade by bulk or surface erosion as portrayed in Figure 5.1 or even as a combination of
both[61]. In surface erosion (as seen in Figure 5.1(a)) the water diffuse at the surface far
exceeds the diffusion into the bulk and the molecular weight stays almost constant, while a
fast mass loss occurs. The strength will follow the rate of the mass loss decrease. Bulk ero-
sion (as seen in Figure 5.1(b)) is characterized by a faster water diffusion into the bulk, and
mass loss is retained, but a fast molecular weight (Mw ) loss is observed. The strength will
decrease with decreasing molecular weight (Mw ). The degradation pathway must be taken
into account when choosing the material for a bioabsorbable IVC filter. Surface erosion is
an advantage during drug release in drug delivery systems, but a disadvantage if too quick
in a load bearing application. The device would see a more gradual loss in mass than the
delayed loss for the bulk degradation (see Figure 5.1). A drawback of bulk degradation is
that some polymers such as the carboxylic acid derivatives produce a highly acidic environ-
ment during bulk degradation, which can speed up the degradation process fromwithin the
bulk[67]. Other polymers such as the polyurethanes are degraded by oxidation controlled
by the macrophages, and is therefore not a very controlled degradation pathway and not
suitable in all applications[66].
Applications Table 5.1 and 5.2 show the most common polymers used in the biomedical
field, each one having suitable properties for a specific application or from a more neg-
ative perspective, they all have their shortcomings. To overcome this blends and copoly-
mers and composites have been investigated. Their variety of properties ranges from elas-
tomers to harder polymers, used as a scaffold for tissue engineering or as in orthopedic im-
plants, respectively. PLLA have also been used in studies as a coating on drug-eluting stents
(DES), Excel (JWMedical Systems, China), Cura (OrbusNeich, Fort Lauderdale, Florida) and
Supralimus (Sahajanand Medical Technologies, India). Polyurethane can also be used as a
coating for a controlled DES[72]. Bioabsorbable polymers, such as PLLA has also been used
as a biodegradable stent itself as listed in Table A.1 in Appendix A.1. Bioabsorbable poly-
mers in orthopedic devices have an advantage over the traditional metal devices as they can
transfer gradually less stress over time to the wounded area as it heals. The non-absorbable
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(a) (b)
Figure 5.1: Sketch of surface (5.1(a)) and bulk degradation (5.1(b)) and the changes inmolecular
weight (Mw ), mass and strength loss. During surface erosion the molar mass of the remaining
polymer remains constant, but a fast mass loss can be observed. Its strength is dependent on
the residual amount of polymer and follows the Mw . In bulk erosion the mass loss is retarded
but the molecular weight is reduced faster.
device will not do so, and it is known that regeneration of bone tissue is poorer and break
after removal of the device[63]. Some bioabsorbable polymers can also respond to stimuli
from the environment. Some are sensitive to pH changes light and temperature. They are
known as intelligent or smart polymers, which can be used for drug delivery systems and tis-
sue engineering[72]. However, for a device which must maintain its integrity, it must not be
susceptible to environmental changes. The pH value in blood and most tissues are primar-
ily stable at pH 7.4, which is close to the pH of the water. Polymers which are not sensitive
to pH changes, water or saline, makes up for an excellent in vitro testing media. There are
a great number of polypeptides, which are sensitive to pH [72] for use in drug delivery to
tumors, with a lower pH level than blood and normal tissue.
5.1.3 Bioabsorbable polyesters
A large group of bioabsorbable polymers is the aliphatic polyesters, with reactive groups
such as carboxyl, hydroxyl, amino, ketal, brom, chloro and carbon-carbon [72]. Depending
on the monomeric unit, they can be polymerized via ring opening (most efficient) and con-
densation polymerization routes[65]. Additionally homopolymer or their copolymers are
prepared by homopolymerization or copolymerization of cyclic monomers[72] (see Figure
5.2). The most extensively investigated bioabsorbable polymers are the aliphatic synthetic
polyesters e.g. polylactide (PLA), polyglycolide (PGA), polycaprolactone (PCL). Additionally,
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Table 5.2: List of some synthetic polymers
Name Advantages Disadvantages
Degradation
type
Application
Synthetic polymers: Æ- polyesters
Poly(L-lactide) PLLA
Highly processable, many
commercial vendors[61]
Limited degradation
frame, highly acidic
degradation products[61]
Bulk, hy-
drolysis
[65]
Orthopedic, oral and maxillofacial
surgery[68]
Poly(D,L-lactide) PDLLA
Bulk,
hydrolysis[65]
Drug delivery[69], orthopedic, oral
and maxillofacial surgery [68]
Poly(glycolide) PGA
Tg close to body temper-
ature
Bulk, hy-
drolysis
[69]
Orthopedic and general surgery,
sutures
[68]
Poly(lactic-co-glycolic
acid) PLGA
Bulk,
hydrolysis[65]
Drug delivery[69], sutures, gen-
eral, periodontal, oral and max-
illofacial
[68]
Poly(≤-caprolactone) PCL
Highly processable, many
commercial vendors[61]
Limited degra-
dation frame[61]
Bulk, hy-
drolysis
[65] Drug delivery, sutures[68]
Poly(p-dioxanone) (PDS)
Loss in strength (1-2
months)[65]
Bulk, hy-
drolysis
[65]
Orthopedic and general surgery,
sutures [68]
Poly(trimethylene car-
bonate) PTMC
Polycarbonate
has chemistry-
dependent mechanical
properties[61]
Polycarbonate has lim-
ited degradation and
require copolymerization
[61]
Enzymatic
surface
erosion
[65]
Soft tissue engineering [70] and
drug delivery [65]
Other Synthetic polymers
Poly (ortho esters) POE
Controlled degradation
rate and pH sensitive[61]
Complex synthesis
and weak mechanical
properties[61]
Surface, hy-
drolysis
[65] Drug delivery [69]
Polyurethanes PU
Mechanically strong,
handle stress well[61]
Limited degradation
frame and require co-
polymerization with
other polymers[61]
Hydrolysis [65][71] Vascular grafts[65]
Pseudo poly (amino
acids)
High crystallinity, low
degradation rate[61]
Unfavorable mechan-
ical properties, and
immunogenicity[61]
Hydrolysis,
enzymatic[65]
Load bearing applications, drug
delivery[65]
Polyanhydrides
Sign. monomer flexibil-
ity, controlled mechani-
cal properties[61]
Low Mw and weak me-
chanical properties[61]
Surface
hydrolysis[65]
Drug delivery [65]and bone tissue
engineering[72]
Poly (ester amide) PEA
Bulk hydrol-
ysis
Suture, drug delivery [65]
Polyphosphazenes
(PPHOs)[73]
Sign. monomer flexibil-
ity, controlled mechani-
cal properties[61]
Complex synthesis[61]
Bulk and
surface
hydrolysis[74]
Drug delivery [65]
Poly (alkyl cyanoacry-
lates) (PCA)
Toxic degradation prod-
ucts
[65]
Fast bulk hy-
drolysis
Skin adhesives and glue,
drug delivery [65]
polydioxanone (PDS), polyhydroxyalkanoates (PHAs) and polyethylene oxide (PEO), among
others have been investigated[64], which can be processed in the same way as most ther-
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moplasts. Most bioabsorbable polyesters undergo bulk erosion, but with some exceptions
as listed in Table 5.2.
Figure 5.2: Polymerization af aliphatic polymers with reactive group (R). Modified from [72].
Among the polyesters, the most investigated are the aliphatic polyesters such as PLA,
PCL, PGA and their co-polymers [65] and have been approved by the FDA for a broad range
of medical applications. Research includes the following applications: bone, cartilage, car-
diovascular, heart valves, small intestine tissue engineering, and arterial replacement [72].
Their chemical structures are shown in Figure 5.3.
Figure 5.3: Structure of some common bioabsorbable polymers. Modified from [62]
Mechanical and thermal properties In general some Æ- hydroxy acids are high in crys-
tallinity potential and brittle with a low elongation at break (≤b). To compensate for this, one
can produce block copolymers. The properties of such copolymers can be seen in Table 5.3.
PGA and PLA and their copolymers have the highmolecular weight are typically strong, stiff
materials with high modulus and strength[62]. The polymers are sensitive to temperature
and when used as a medical device. It has previously been seen that for PLLA the modulus
and ultimate tensile stress (UTS) are significantly reduced (by ª 60 % in modulus, ª 35% in
UTS) as the temperature reaches just above the Tg [77]. The Tg has an impact on how the
polymer behaves at body temperature not only regarding mechanical properties but also
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Table 5.3:Mechanical and thermal properties of themost commonbiodegradable thermoplasts
and their degradation time
Polymer Tg ±C Tm±C Xc (%) E (GPa) UTS (MPa) ≤ (%)
Deg. time
(months)
Strength loss
(months)
PGA 35-40a 200b 45-55b ª7a 70a 15 c 6-12 a 1-2
PLLA 60-65a 175b ª 37b 2.8-4.2a 55-80a 2.1 c 24 6 b
PDLA 59c - amorph c 3.2 c 27-50d 8.7c 12-16b 1-2b
PDS -10-0b - 37-55e 1.5b 139 d 62d 6-12 1-2
PCL -60b 55-60b 0.40a 20-35a 300d 24-36 d -
PCLA 75/25 15-30 f 130-150 f 0.3-1.4a ª 8a (50%) 2 ª24 f
PCLA 50/50 -17 f 90-120 f 0.9 f ª 8a (50%) 4-6 6-8 f
PCLA 20/80 amorph b 0.3-1.4a ª 5a 16 d -
PDLGA 50/50 45-50a amorpha 1.4-2.8 a 45-50a 3-10g 1-2a
PDLGA 75/25 50-55a amorpha 1.4-2.8a 40-55a 3-10 4-5a
PDLGA 85/15 50-55a amorpha 1.4-2.8a 40-55a 3-10 5-6a
a [40], b [65],c [62], d [64], e [75], f [76],g [63]
how the molecular chains move and position themselves over time. This is described later
in section 6.5. PLLA is brittle and a good candidate for load bearing medical devices due to
its high modulus and strength and also the slower strength loss over time (6 months) com-
pared to PGA, a more hydrophilic polymer. PGA in general exhibit excellent mechanical
properties for load bearing devices with a high modulus and strength, but its Tg is close to
body temperature, which means it becomes softer upon implantation. Being a more hy-
drophilic polymer, it loses it strength more rapidly than PLLA. The polyether ester poly-
dioxanone (PDS) has a lower modulus than the lactides and also loses its strength rapidly
(1-2 months) and therefore not ideal for all applications. PCL has an even lower modulus
but exhibits an extremely high ≤b . Poly(trimethylene carbonate) (PTMC) is an elastomeric
polyester, which also exhibits high flexibility and can, therefore, be incorporated into the
stiffer polymers to ensure greater elasticity[65].
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Figure 5.4: Different stereoisomeric configurations for lactic acid
Configuration Apart from the thermal properties of the polymer, themolecular configura-
tion, and their orientation have an impact of the properties of the polymer[75]. An example
is the lactic acid, which exists as two stereomers: the enantiomers L-lactide and D-lactide
[78][79]. It can also exist as a mixture of the two, the D, L-lactide (meso-lactide). Either
enantiomers are commercially available on their own or in form of a racemic mixture (rac-
lactide), which consists of an equimolar mixture of D- and L-lactides [78] and portrayed in
Figure 5.4.
PLA can exist in blocks of isotactic, syndiotactic and heterotactic and the formation de-
pends on the configuration of the basis lactide molecule[79]. The different tacticities are
portrayed in Figure C.1 in Appendix C.1. Ring-opening polymerization (ROP) or the less
used condensation of D or L-lactides often leads to isotactic polymers (PLLA or PDLA), pri-
marily consisting of isotactic diads with little meso-lactide. They are both crystalline with
a high melting temperature (Tm=180±C)[78]. Syndiotactic diads occur during meso-lactide
polymerization [62]. Meso-lactide has lower Tg and Tm due to the different stereotactic con-
figuration [80] than the enantiomers. Poly(D,L-lactide) (PDLLA), when prepared from rac-
and meso-lactides with an atactic sequence of D and L units is randomly placed along the
chain and thereby becomes amorphous. When polymerized into sequences of both D- and
L- lactide units regularly, the polymer becomes crystalline. Stereo-block copolymers (sb-
PLA) consists of both isotactic PLLA and PDLA involving block a two-step copolymerization
using ROP, which is not described further in detail here. At either end of the PLLA/PDLA
ratio in a copolymer, the polymer exhibits lower crystallinity[78]. The methods are prefer-
able because stereo complex crystals (regularly alternating D- and L-lactide packed side by
side[81]) can be obtained with low amounts of the more expensive D-lactide.
As seen in Table 5.3 the properties between PLLA and PDLLA differ. Both PLLA and
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PDLA are semi-crystalline polymers due to the enantiomeric purity of the monomers and
the following stereoregularity. PDLLA is a random copolymer of D- and L-lactide and amor-
phous due to its irregular structure and therefore have different mechanical properties. It is
most used in pharmaceutical applications[80]. It might be a reason that PLLA ismuchmore
investigated. PDLA and PLLA have the same thermal properties[80].
Degradation Hydrolytic cleavage of ester bonds occur randomly and attacks the amor-
phous phase first. It lowers the plastic flow, reduces ductility and toughness[64] and leaves
the polymer more crystalline [75]. The polymer then becomes brittle. For PLLA, which is
already considered a brittle polymer, this becomes an issue over the course of hydrolysis.
The idea is to process a polymeric material, which is not too brittle at first. The PHA is also a
class of aliphatic polyesters and covers over a large range of polymers. They give the possi-
bility of creating favorable mechanical properties and degradation times, but they have not
been as widely investigated. The information about their physical properties is limited as
well as crystallinity, purity, blending composition and processing [64]. PCL is hydrophobic
and degrades slowly [64] and therefore retains its strength for a longer period of time. How-
ever, its Tg is well below room temperature and behaves like an elastomer. It is very ductile
compared to PLLA.When it is used in combination with PLLA in various amounts, the elon-
gation is enhanced. PLLA is, in general, a slow degrading polymer. It swells significantly
over time, whereas the pseudo-poly(amino acids) only take up water (5%) towards the end
of the degradation stage and then a mass loss is seen. Thereby it is possible to keep the
shape and device integrity longer in applications when needed[65]. Auto-catalytic degra-
dation is a concern for some of the polymers such as PLLA, due their acidic degradation
products, but not a concern for pseudo-poly(amino acids) such as tyrosine-derived carbon-
ates. In general, the Æ-polyester are degraded by hydrolytic cleavage of the ester bonds in
the polymer backbone. Both PLA and PCL can, however, undergo enzymatic degradation
as well [75]. Through hydrolysis, PLA and PGA will be broken down into lactic acid and
glycolic acid, respectively. Subsequently, they will be broken down into pyruvic acid and
through a metabolic cycle are eliminated as carbon dioxide and water. PCL will turn into
hydrohexanoic acid, which is a metabolite [75]. As listed in the Table 5.2, many of the poly-
mers undergo hydrolysis of the bulk, which is only dependent on the water uptake. Such
uncontrolled bulk degradation is undesirable for drug delivery [73]. One of the few surface
degradation polymers not listed in the table is poly(trimethylene carbonate) (PTMC). It has
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relatively poor mechanical performance and even when present as co-polymer is has a low
stiffness and degrades within 3-4 months. A drawback is that in vivo degradation is much
faster than in vitro degradation most likely due to the enzymatic degradation in vivo[65].
For the hydrolytically degradable polymers, the rate in vivo and in-vitro are much the same
and dependent on water absorption.
Co-polymers and blends The configuration of which the polymer is shaped into the de-
vice plays a role in the mechanical performance. For example orientation of PGA, fibers in-
crease the stiffness and strength. When used as fibers in a braided suture, they can lose up to
50%of their strength after twoweeks, while 100%absorption occurs after 4-6months[75][63].
Usually, PGA is used in combination with PLLA to increase the degradation rate of PGA[64].
Additionally mixing PGA and PLLA will decrease the melting temperature and reduce the
mechanical properties with the amount of L-lactide as seen in Table 5.3 compared to pure
PGA. Through copolymerization of glycolide with lactide the Tg can be increased above
body temperature (Tg=54±C) compared to pure PGA and therefore more suitable for long-
term implantation. PGA can exhibit a high degree of crystallinity (Xc ) (40-55%). However,
when copolymerized with L-lactide in the ratio of 25/75, it becomes amorphous[62].
Copolymers from ≤-caprolactone and D, L-lactide yields materials with faster degrada-
tion rate. When ≤-caprolactone is copolymerized with glycolide, the stiffness is reduced
compared to pure PDLA.
The degradation rate is higher for PDLA, and the modulus and strength are less than for
PLLA. A 50/50 PDLLAhas proven to bemore resistant to hydrolysis than both pure PLLA and
PDLA [82]. PDLLA is amorphous due to the random distribution of L- and D-Lactide units
and shows a faster degradation than its crystalline counter units[82]. PLA with 90% or more
L-lactide will be crystalline, but when below the PLA tends to be amorphous[82]. PLLA is
semi-crystalline and can be quenched into its amorphous state upon processing. As far as
crystallinity goes, it consists of both crystalline and amorphous domains with tie-molecules
within both domains. Blending L-lactide with D-lactide influences the mechanical prop-
erties as well as the thermal properties [83]. In general blending D-lactide will reduce Tg
from 58 to 53±C, but increase Tcc from 110 to 130±C up to 60% D-lactide. D-lactide of ∏80%
will result in an amorphous polymer. The stiffness and strength values decrease with in-
creasing amount of D-lactide. The flexibility or the ≤b also decrease with D-lactide content,
but only up to a ratio of 50/50 after which the elongation increase [62][83]. Incorporation
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of rac-lactide into a dilactide will reduce the crystallinity potential and with just 25% dilac-
tide become amorphous. Co-polymerization between lactide and glycolide, does not make
a linear relationship between the copolymers’ properties. For example a 50/50 copolymer
of D, L-lactide and glycolide degrade faster than either homopolymer (see Table 5.3). The
composition can also lead to amorphous polymers due to disruption in the regularity of the
polymer backbone[63].
5.1.4 Selection
As stated in requirement (see section 3.3.4), a adequate radial force of filter is needed, and it
mustwithhold its strength until sufficient tissue coverage has occurred. The polymer should
be flexible to a degree where permanent deformation is avoided, while still have enough
radial force. Significant molecular weight degradation must not occur within the first three
months. These requirementsmight be difficult tomeet with the polymers as they are. There
is room for improvement. To sum up the above findings, PCL is too soft. PDS, PDLA, and
PGA lose their strength too quickly (1-2 months). PGA clearly shows the highest stiffness of
the three, but asmentioned previously it has a Tg close to body temperature, and it degrades
fast. However, the elongation appearsmore suitable than PLLA. The copolymer PLGA could
be a suitable compromise. PLGA 50/50 raises the Tg , but strength loss still occurs still after
1-2months. 75/25 PLGA has an even higher Tg and the strength is preserved up to 5months
and is a possible combination. The stiffness is at the lower end of what it would be for PLLA
and using PGA as the reinforcement element in the copolymer does not work as intended.
There are several ways to reinforce or manipulate the mechanical properties of poly-
mers. As mentioned the properties of the bioabsorbable polymers could be tailored by
copolymerization or blending polymers. Blending polymers does not necessarily have a
chemical bond between them (e.g. be miscible or immiscible respectively) and is obtained
by mixing the blends. Copolymers have a chemical bond between them and is produced by
copolymerization of two or more monomers[84]. Improving the mechanical properties can
be done through processing as well. An example is applying a strain to the polymer during
processing with the attempt to orient the material and optimize the mechanical properties.
Monofilament of different blends and processing were characterized in the following sec-
tion 5.2.
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There are different approaches on how to create a stent-base for a bioabsorbable filter.
One possibility is to create the stent-base frommonofilament as described in the following
section 5.2.
5.2 Results and analysis: Bioabsorbable monofilaments and their
properties
The previous section of this chapter highlighted the background on some of the most com-
mon polymeric candidates for a bioabsorbable filter. Some polymers are more easily avail-
able than others, and some aremedical while others are industrial grade. Based on the liter-
ature described, some of the most common polyesters were evaluated for further selection
of the best bioabsorbable candidate. Mechanical characterization (both tensile and radial
force testing) was done on several monofilaments internally at Cook Research Inc., and the
raw data was provided to this project.
From a processing perspective testing monofilament for material characterization and
selection is favorable as it is readily available in many compositions and sizes and can be
braided into simple stents. Monofilaments can be positioned in a braided configuration in
a way that the strength of the filament is in the radial direction and for the optimal radial
force. Monofilaments of different polymers were purchased from Corbian (previous Pu-
rac) under the name Purasorb as a medical grade and the medical grade Absorb from Zeus.
All filaments were tested by S. Tanner at Cook Research Inc., and raw data was provided for
analysis in this project. The comparison between polymerswas used to choose the best pos-
sible material candidate for bioabsorbable vascular devices. Based on the literature PLLA
and PDLA have the appropriate degradation profile and retain strength over time, but does
not have the highest modulus or strength. To optimize these properties, the monofilament
were oriented in the extrusion detection and compared with the plain extruded filament.
PLLAmonofilaments were tested alone as well as in a 50:50 blend with PDLA (PDLA-PLLA).
As previously mentioned PGA alone has a low Tg and looses its strength too fast. For that
reason, it was tested in combination with PLLA as a random copolymer (PLGA 85:15) and
oriented. It was also assumed that the incorporating PGA would increase the ≤b compared
to pure PLLA. Information of each polymer is listed in Appendix C.2, Figure C.1. For im-
provement of ≤b , PLLA was also tested in combination with PLLA-PCL (70:30) (PLLA-PCL)
as a blockly copolymer. For optimal radial force, stiffness and strength were supposedly
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optimized by an elongation of themonofilament during extrusion and tested up against the
non-elongated. Elongation of the polymer canhave the same effect as straining of a polymer
and improve its mechanical properties in the straining direction. Orientation or elongation
of the polymer can be thought of as fibrous orientation. The monofilament is processed
under high axial deformation, leading to the orientation of crystals in the deformation di-
rection and thereby improved stiffness and strength[85].
To evaluate the different types of material and their mechanical behavior small scale
stents were braided with a diameter of 8 mm and 40 mm in length from various types of
monofilaments (OD 2.5 mm) (Figure 5.5(a)). Tensile testing of the monofilament on its own
and the radial force of the whole stent was measured as the stent was crimped.
(a)
(b)
Figure 5.5: Braided stent (OD 8mm, length 40mm) of 2.5 mmPLLA 5.5(a) and PLLA-PCL 5.5(b)
monofilament after radial force testing Image provided by Shaun Tanner (Cook Research Inc.)
It is expected that PLLA would have a larger modulus than extruded PDLA-PLLA, but
there is no significant difference between their stiffnesses as seen in Figure 5.6(a). The ori-
entation of the monofilament does not induce an increase in stiffness at it has almost the
same stiffness as the extruded PLLA. The elastic modulus is not significantly different for
PLLA whether extruded or oriented and the same goes for PDLA-PLLA. However, there is a
difference in radial force as seen in Figure 5.6(d). It is, a bit unexpected that the radial force
of the corresponding stents differs.
As expected from Table 5.3 from the literature the experimental data are seen in Fig-
ure 5.6(a) show that PGA becomes sensitive to the amount of L-lactide as the modulus is
reduced fromnormally 6.0-7.0 GPa as stated by themanufacturer to less than 2 GPa, and ex-
hibits the longest ≤b , despite its large variation. Another noticeable polymer is the block-co-
polymer PLLA-PCL (85/15), which has significantly larger elastic modulus than both elon-
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Figure 5.6: Elastic modulus (5.6(a)), ≤b (5.6(b)) and æy (5.6(c))of materials used for braided stents
obtained by tensile testing. Materials are ordered according to the radial force ranking. Radial
force of the second cycle (crimped down to 40% of initial OD) on braided stents is shown in 5.6(d).
Experimental data supplied by Shaun Tanner (Cook Research Incorporated)
gated and extruded copolymer is PLLA-PCL (70/30), due to the higher content of PLLA. The
addition of 30% PLLA-PCL to PLLA does not induce a longer ≤b , yet only reduces the stiff-
ness and strength. It is therefore hypothesized that a bioabsorbable filter would not benefit
from using 70/30 co-polymer. The ≤b is higher than expected for all polymers, possibly due
to their processing into monofilaments (see Figure 5.6(b)). However, it was not anticipated
that PLGAwould have an ≤b much higher than any of the copolymers containing PLLA-PCL,
which has a far superior ≤b to any of the other polymers. It is possible that there are mi-
cro cracks in the PLLA-PCL, which occurred during processing and ≤b is less. This was not
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evaluated further.
The stents underwent crimping for two cycles during radial force testing. The first cycle
is portrayed in Appendix D.1 Figure D.1 was done to simulate the size of the sheath, which
it would be loading into during placement. During the second cycle, the stent is crimped
down to the target vessel size. During the second cycle, all braided stents lost a significant
amount of radial force. The PLLA-PCL 85:15 blocky showed the greatest difference between
the two cycles and a lower radial force and the polymer with the least loss in radial force. It is
more susceptible to permanent deformation as seen in Figure 5.7(a) with the largest change
in diameter after crimping.
Figure 5.6(d) and 5.6(a) show that there is some correlation between elastic modulus of
the monofilament and the radial force of the braided stent. Crimping the stent changed the
diameter for all stents (Figure 5.7(a)). PLLA-PCL (70/30) was damaged during crimping or
did not crimp evenly andwas not included in Figure 5.6(d). Instead, a different composition
of PLLA-PCL (85/15) was tried, which showed the highest change in diameter after crimping
(Figure 5.7(a)). PLLA as extruded showed little change in diameter as well, but the results
were unreliable due to a significant variation. Oriented PLGA showed the least change in
diameter as well as the least change in length 5.7(b).
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Figure 5.7: Change in diameter (5.7(a)) and length (5.7(b)) of braided stents (OD 8 mm and
length 40 mm) made from different 2.8 mm diameter monofilaments crimping. Experimental
data supplied by Shaun Tanner (Cook Research Inc.)
From the above study, it was seen that oriented PLLA did not show as promising a ra-
dial force as expected, and for that reason, an additional oriented PLLA provided by Zeus
was purchased and compared with an extruded non-oriented monofilament. The thermal
properties, Tg and Tm , were the same despite (Table 5.4) the orientation of thematerial and
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in accordance with the literature (Table 5.3). How the orientation was obtained is unknown,
butWAXS analysis showed a high crystal orientation of 0.8 andDSC showed a crystallinity of
61 %, which is at the top end of reachable crystallinity for PLLA. The non-oriented monofil-
ament had 13% crystallinity (Table 5.4). Automatically the higher crystallinity means that
the oriented monofilament has superior stiffness and strength, solely due to the large crys-
tallinity as well as a high degree of crystal orientation. The rationale of crystal orientation
and the mechanical properties are described later in section 6.1.4.
The oriented PLLA from Zeus does not have the samemechanical properties (Table 5.5)
as oriented PLLA from Corbion. Their orientation process and crystallinity possibly differ
along with differences in molecular weight (Mw ) distribution. Despite the low Xc of non-
oriented PLLA monofilament, the ≤b is very poor and it does not undergo strain-hardening
above yield stress (æy ), thus æy and UTS becomes the same (see Figure D.2(a) in Appendix
D.2). As expected the stiffness and strength of oriented PLLA monofilament from Zeus far
exceeds the ones of the non-oriented PLLA from the same supplier.
Table 5.4: Thermal properties of extruded and oriented PLLAmonofilament from Zeus
Tg (±C) Tm (±C) Xc% F2 Dax Dci r c
Monofilament 64 182 13 - - -
Monofilament oriented 65 183 63 0.8 90 139
Monofilament oriented
annealed 80±15min - - - 0.8 65 145
From Table 5.5 it is seen that the orientation, which improves the stiffness and strength,
is lost during annealing even at low temperature (70±C). The stiffness and strength decreased
as a function of annealing temperature. An interesting point is that annealing at 80±C for
15 min, induces a higher stiffness and strength, which are not significantly different from
when not annealed. Annealing, in general, induces the material with a longer ≤b , which
means that the molecular chains might have been relaxed upon heating or microcracks
have disappeared during heating. Increasing the annealing temperature to above Tcc does
not change the stiffness or strength, indicating that crystal was not formed at such short an-
nealing times. Annealing the orientedmonofilament from Zeus for just 15min at 80±C does
not change the crystal orientation from 0.8. The crystal size differs, and the crystal become
narrower and longer as seen in Table 5.4. Stress-strain curves can be found in Appendix D.2
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in Figure D.2(b). The fact that the mechanical properties decrease with further annealing is
a downside as the monofilament needs to be heat treated after braided into a stent to keep
its shape.
Table 5.5:Mechanical properties of extruded and oriented PLLAmonofilament from Zeus
E (MPa) UTS (MPa) æy (MPa) ≤ f (%)
Monofilament 2635±245 80±0 80±0 5±1
Monofilament oriented 5972±124 374±29 134±12 31±2
Monofilament oriented
annealed 70±1min 5117±215 353±23 127±4 33±4
Monofilament oriented
annealed 80±1min 4856±159 357±31 120±4 33±3
Monofilament oriented
annealed 80±15min 5713±154 350±33 128±2 34±1
Monofilament oriented
annealed 90±1min 4670±198 338±24 113±2 36±2
Monofilament oriented
annealed 110±1min 4535±342 339±17 111±3 36±2
The conclusion made from the above literature review on materials and the initial me-
chanical testing of monofilaments, whether braided or not, shows that the ideal material
for bioabsorbable filters, does not exist, and the choice of material lies in the best compro-
mised between properties. As the risk of migration is a major concern, a high radial force
was chosen over the flexibility of the stent-base. Copolymers of PLLA and PLLA-PCL were
not used for further investigation. It was determined that PLGA shows the best recoverabil-
ity after crimping, but as it did not show as a high radial force as PDLLA or PLLA and it was
not chosen. PLLA was selected over PDLLA, due to it slower degradation rate and thereby
also greater strength retention during implantation. Further experimentation is related to
improving the properties of PLLA.
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6Biaxial straining of Poly(L-lactide)
tubes
This chapter describes the nature of the raw material used in extruded tubes for later ex-
pansion into larger tubing for IVC filter prototypes. It describes the background on ther-
mal properties, crystallization andmechanical properties of the PLLA and the investigation
of processing parameters such as strain processing temperature (Tp ) and processing strain
rate (≤˙p ) performed in this project. It also includes the results andfindings of themechanical
behavior and thermal properties as a result of strain-inducing PLLA tubing. Furthermore,
an investigation was done to evaluate the influence of further processing such as thermal
treatment for permanent set into a stent-base configuration and the effect of sterilization.
Some observations were performed retrospectively in search for an explanation to the re-
sults of the in vivo study. For comparison between the biaxial straining process and other
processed tubes, Zeus supplied an oriented and non-orientated PLLA tube. The mechani-
cal and thermal properties are shown in Table in D.1 and Table D.2 in Appendix D.2, respec-
tively, but not discussed further.
6.1 Background on crystallization, thermal properties and strain-
inducing of PLLA
PLLA can exhibit 3 different crystal structures, Æ, Ø or ∞. The two former can easily be
obtained at moderate processing conditions (reasonable temperatures and stress). Hot-
drawing melt-spun or solution-spun PLLA fibers to a high draw ratio lead to the Ø-crystal
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form with the lattice dimension of its orthorhombic unit cell a=1.031 nm, b=1.821 nm, and
c=0.900 nmand a chain conformationwith left-handed 31 helices. TheÆ-crystal form grows
from amelt or cold crystallization at high temperatures[86]. The lattice dimension of its or-
thorhombic unit cell is as followed, a = 1.066 nm, b = 0.616 nm, c = 2.888 with a left-handed
103 helix chain configuration [80]. Additionally, a disordered form, Æ’, with the same space
group and lattice dimensions as Æ-crystals has been detected [87][88][86], which appears at
low temperatures, and is characterized by slightly larger lattice dimensions andmore disor-
dered. Heating crystalline PLLA containing the Æ’-form, can alter them into Æ-form and is
seen by the possible appearances of multiple endotherm and exotherm peaks during DSC
scans.
6.1.1 Background: Crystal structure of PLLA
When examining strain-induced crystalline samples that contain Æ or Æ’ with WAXS, the
diffraction patterns are very similar. There is a slight difference in position of the diffraction
peaks for the Æ- and Æ’-crystals. The peaks for the Æ-crystals appear at (010), (110/200),
(203), (204), (015), and (207) planes and their corresponding Bragg angles 2µ=15±, 16.7±,
19.1±, 21±, 22.3± and 27.4±. The Æ’-crystals shows peaks at (110/200), (018), (203), and (206)
planes at their corresponding Bragg angles 2µ=16.4±, 18.7± and 24.5± and 33.1± [88] .
Crystallization at T∏ 145±C only forms the Æ-crystal. At T∑95 ±C only the Æ’-crystals
form. At temperatures in between, 105±C ∑ Tc ∑125±C the two forms co-exists[86]. As the
highest Tp was 93±C in this project only Æ’-crystals are expected to form in the strained
tubes. It is said that formation ofÆ’-crystals will ultimately with its disorder and loose chain
packaging leads to a lower stiffness and strength[89].
6.1.2 Background: Crystallization
Crystallization can occur after or simultaneous with polymerization[90]. High regularity in
the chains are capable of crystallizing, but the conditions must be favorable[85]. In short,
the concept of nucleation is related to thermodynamics, where the onset of crystallization
occurs when there is a change in thermodynamic (cooling from the melt). The cooled melt
fluctuations can overcome Gibb’s free energy barrier, and nucleation can take place and
transformation to the crystalline domain begins[90]. Crystallization is a process in which
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a material is either a heated from an amorphous solid or a cooled liquid amorphous struc-
ture to convert into an organized solid crystalline structure[90]. The former has a cold crys-
tallization temperature, Tcc , and the latter has a crystallization temperature when cooling
frommelt Tc . A third possibility is the strain-induced crystallization, which has a crystalliza-
tion temperature interval as later described in section 6.1.4. Annealed at a given tempera-
ture, depending on the thermal properties of the material, is named isothermal crystalliza-
tion and depends on the thermal history of the material, annealing temperature and time.
Quenching of the extruded tube induces crystallinity with thin crystals, but with many de-
fects. If the cooling rate is slower, the crystals are thicker and the dislocations fewer. Usually,
cavitation occurs at slower cooling. Isothermal crystallization with slow cooling induces
higher crystallinity and thicker crystals, fewer tie molecules in the amorphous domain and
a greater degree of cavitations[91].
6.1.3 Background: Thermal properties
The theoretical heat of fusion enthalpy for a 100% crystalline for crystals of infinite size are
most commonly reported as¢H0m=93-94J/g[45][80]. The Xc is calculated from the difference
in enthalpy for the crystalline (¢Hc ) and themelting (¢Hm) peaks over the referencemelting
enthalpy for PLLA (see equation4.1 in section 4) in a DSC experiment.
Typical DSC scans for PLLA and PDLLA are seen in Figure 6.1. The amorphous PDLLA
and PLLA quenched into an amorphous state does not have the same enthalpies. As noted
previously, their Tg are the same. PLLA is initially amorphous and as temperature rising
during a DSC scan with the heat rate of 10±C/min, shows a crystallization peak at Tc=132±C
starting at 100±Cand amelting peakTm=182±C (Figure 6.1(a)). The¢Hc=38J/g and¢Hm=38J/g
and therefore Xc=0%. Amorphous PDLLA can show an aging peak between 65-90±C of up 10
J/g if aged. The longer the aging time or, the closer the aging temperature is to Tg , the more
intense the peak is[80]. The phenomenon is described later in section 6.5. PLLA, which has
been processed into crystallinity, has a different DSC scan than the amorphous and is por-
trayed in Figure 6.1(b). Upon the first heat cycle to above Tm , no new crystals are formed,
and no crystallization peak occurs. At a second heat cycle, the thermal memory is erased,
and the DSC scan resembles the amorphous[80].
All thermal components, Tg ,Tcc ,Tm , and their respective enthalpies vary and depend
on the Mw of the material. The Xc depends on the on Mw as well and increases with it.
Highest Xc reported in [80] was 71% for PLLA, but this is not commonly seen elsewhere in
57
6. BIAXIAL STRAININGOF POLY(L-LACTIDE) TUBES
(a) (b)
Figure 6.1: Differential scanning calorimetry scans of amorphous PLLA and PDLLA (6.1(a)) and
for crystalline PLLA (6.1(b)) (heating rate 10±C/min). Used from [80].
the literature. When the crystallinity is high for a material the Tg will be higher, because
the crystalline domains hinder mobility of the amorphous chains. The Xc increase with
annealing time, but also with increasing temperature. A higher annealing temperature will
provide a greater mobility and thereby a greater ability to crystallize[80].
6.1.4 Background: Strained semi-crystalline polymers
Semi-crystalline polymers such as PLLA can undergo strain-induced crystallization (SIC),
when in a rubbery state between Tg and Tcc . Normally slow crystallizing polymers, such
as PLLA, are quenched into its glassy state below Tg and subsequently heated into its rub-
bery state, where the SIC will take place under applied strain. This processing technique
has previously been used in the industry, when processing films and can be applied to other
polymers such as polyethylene terephthalate (PET), polyethylene naphthalate (PEN), and
polyether ether ketone (PEEK). The SIC of films, both include simultaneous and sequential
biaxial strain. Ou and Cakmak have described in detail the phenomenon of both simultane-
ous and sequential biaxial straining of PLLA films and the presence of a bimodal orientation
texture upon transverse stretching [92][93].
Selection of straining temperatures highly depends on the thermal properties. To induce
crystallinity by straining, the temperature must be above Tg and below Tcc [92].
The tube expansion used in this project is similar to film blowing. The material is ex-
truded through an annular die forming a tube. The molten polymer tube is further filled
with air and expanded to the desired diameter. This process resembles the simultaneous
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and sequential biaxial strain process used for tube expansion in this project. The small tube
(OD 3.4mm) was first extruded and then cooled into an amorphous state, after which it was
placed in the tubemold and heated into the rubbery state, and air was injected as described
in section 6.2.1.
There are certain restrictions for filmblowing of PLLA. It is not desired to havemore than
15 wt% meso-lactide and the rest should be L-lactide[94]. Strain-inducing semi-crystalline
polymers promote structural changes, which involves both the amorphous and the crys-
talline domain of the polymer. The mechanical properties are said to primarily depend on
the crystalline domain[88]. To optimize themechanical properties of the tube circumferen-
tially as opposed to axially different pathway of processing were investigated.
6.1.5 Background: Themechanical properties of crystalline PLLA
Crystallinity has an impact on how the polymer performs mechanically. The force in which
themolecules are held into the crystalline lattice restricts themobility of the polymer chains.
Both the Xc and the crystal sizes influences the mechanical properties. Both the E, æy , and
impact strength increases with crystallinity. The UTS is more complex, as in some cases it
increaseswith crystallinity, but in others theUTSdecrease as a result of stress-concentration
and brittle failure. The ≤b decreases with crystallinity as a result of limited mobility. Amor-
phous PLLA (grade 4060, ª10% D-isomer) from NatureWorks has an E of 2.5 GPa, tensile
strength (TS) of 44 MPa and ≤b of 7%, where the semi-crystalline PLLA (grade 4032, ª1.5%
D-isomer) has E of 2.6 GPa, UTS of 54 MPa and ≤b of 9%. One thing should be noted that
most commercial PLA is copolymerized L-Lactide with small amounts of meso-lactide, to
lower crystallinity and ultimately brittleness. Increasing the Mw reduces the variation in
properties. For PDLLA increasing the Mw will increase æy , E, UTS and flexural modulus,
but the ≤b diminishes. [95]. Despite PLLA having a Tg above body temperature, it does not
mean that themechanical properties remain unaffected during implantation. When storing
quenched amorphous PLLA at body temperature, the flexural strength is reduced by 23%,
≤b by 4% and elastic modulus by 5%. The reduction is more dramatic for a crystalline PLLA
(Xc=52%), where the flexural strength was reduced by 27%, ≤b by 10% and E by 13%, ulti-
mately ending up with similar properties. Heating further near Tg , which is not relevant for
implant use, the amorphous PDLLA is down to 0.4% of it initial flexural strength, 1% of the
E and increase in ≤b by nearly 200%. The flexural strength and E for the crystalline PLLA
are down to 24% and 22%, respectively and the ≤b increased 156%[95]. Crystalline PLLA is
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less influenced by the body temperature, and this should be taken into account during in
vitro testing of the material or device. Furthermore, it proves that processing, annealing,
orientation and crystal nucleation is useful for the final properties of the device.
Strain-induced crystallinity Themechanical properties of PLA can be improved by strain-
ing and orientation. In principle when the polymer chains are stretched, the chains are no
longer is theirmost probable conformation, which leads to a decrease in conformational en-
tropy. The tendency to crystallize is greatly enhanced, hence less conformational entropy is
needed to transform from amorph to the crystalline state[85]. In strain-induced PLLA, crys-
tallization and subsequent melting temperatures are moved to higher temperatures during
a DSC scan, meaning that a strain-induced polymer can not as easily be crystallized. At the
same time, the deformation increases the crystallization rate greatly. Without the presence
of deformation, the crystalline texture is obtained by merely cooling, which results in a ran-
dom distribution of crystals next to each other. Also, the strain-induced crystalline chains
are oriented parallel to the stretching direction, and the extent of orientation depends on
the degree of strain, temperature, and rate. The strain-induced oriented crystallites have
a higher modulus than the amorphous chains. Additionally, the crystallites act as physi-
cal cross-links and gives the polymer as a whole an increased modulus. At a larger degree
of strain, the amorphous chains are aligned and oriented [85]. There are three conditions
which must be met to obtain strain-induce crystallinity in semi-crystalline polymers. For
one the temperature must be above Tg and below Tcc to ensure chain mobility. Secondly,
the strain ratemust be adequate and thirdly the degree of strainmust be sufficient to achieve
adequate alignment of the chains to form crystals[92]. During SIC the molecular chains are
oriented along the stretching direction, and when a certain level of orientation is achieved,
the formation of highly oriented crystals occurs. The polymer chains are randomly bundled
and amorphous as seen in Figure 6.2a. Upon strain they remain in the amorphous structure
but become more ordered (Figure 6.2b) until a certain degree of strain is achieved, before
becoming more ordered and crystalline (Figure 6.2c). With further extension both the crys-
talline and the amorphous domain are further aligned as seen in Figure 6.2[92].
During simultaneous biaxial strain, the axial and transverse strain occur simultaneously
and orients the polymer chains in the plane of which they are stretched, creating in-plan
isotropy. The crystalline orientation is not very high as some of the chains are randomly ori-
ented and tend not to crystallize because they are unable to find chains in their orientation
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Figure 6.2: Structural mode during axial
stretching. Modified from [92]
Figure 6.3: Structural mode during simulta-
neous biaxial stretching. Modified from [92]
to crystallize with. This is especially an issue if they are formed at low strains, but crystal-
lization increases with increased deformation (Figure 6.3). Applied transverse stretching to
crystals formed in the axial stretched material with a weak crystalline domain, reduces ori-
entation in the axial direction as seen for the sequential biaxial strain, (Figure 6.4). High de-
gree of transverse stretching would lead to crystallite destruction formed during axial strain,
while new crystals are formed in the transverse direction, resulting in a bimodal texture,
with a better structural order than seen in the axial direction.
A similar structure is seen initiallywhen applying transverse stretch to an axially stretched
material with a strong crystalline domain. As the transverse stretch continues, the strain
transmits forces deep into the polymer using the pre-existing axial crystals and physical
cross-linking points and axial orientation is destroyed. A new poorly orientation crystal do-
main occurs in the transverse direction (Figure 6.5)[92].
In general semi-crystalline polymers are comprised of a complicated structure, both the
crystalline lamella domain and the amorphous domain and formation of spherulite struc-
ture. Upon deformation both in tension and compression, the spherulitic structure is trans-
formed into a fibrillar structure. When applying a force, the material first undergoes elastic
deformation, which quickly changes as yield point is reached into the permanent plastic
deformation if further force is applied. Plastic deformation first occurs in the softer amor-
phous domain and later the stiffer crystalline domain. As for the crystalline structure, defor-
mation furthermore occurs, without the polymer fracturing. This state is known as twinning
or chain slip, which occurs only in the crystalline plane and in two ways. One is a continu-
ous deformation of the lamellar structure, and the other is sectioning into crystalline blocks.
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Figure 6.4: Structural mode during sequen-
tial biaxial stretching with a weak crystalline
domain after axial strain. Modified from [92]
Figure 6.5: Structural mode during sequen-
tial biaxial stretching with a strong crystalline
domain after axial strain. Modified from [92]
The chain slipwillmost likely occur in the places of screwdislocation among the crystals un-
der the influence of a shear force. With a further degree of deformation, new dislocations
form from which the crystal chains can slip. As opposed to compression disentanglement
of the amorphous chains can happen during tensile deformation[91]. It is possible that this
phenomenon is seen during expansion and straining of tubes. On a macroscopic level lo-
calized deformation will occur at the site with the smallest cross-sectional area, fromwhich
necking propagates. When the deformations paths as described above are exhausted the
polymer will undergo strain-hardening, until the final break. It should be noted that crys-
tallization induces thematerial with embrittlement, and thematerial has a reduced fracture
toughness.
Deformation of crystals Any fracture of the expanded tubes can be related to the pro-
cessing and possible formation of crazes and cavitations before or after processing. Plastic
deformation is easily obtained in the amorphous polymer under Tg , which can either con-
tribute to microscopic shear processes within the material or create crazes and depend on
strain rate and temperature. The crazes consist of elongated voids with oriented microfib-
rils. Their presence will allow the crazes to transfer shear stresses adding to the total de-
formation. For semi-crystalline polymers, this phenomenon can also occur at higher tem-
peratures than Tg [91]. The PLLA can fracture from crazes. They increase in size with the
degree of deformation and are elongated in the direction of deformation. The deformation
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is understood as a combinedmechanism of cavitation and fibrillated shear. Upon deforma-
tion, polymeric chains are extended, and the craze spans. The crazing results in the polymer
being brittle in tensile and impact testing. The crack propagation is also different when an-
nealed or quenched. For the annealed PLLA, the craze propagation is through spherulites
and along the spherulite boundaries with few or no crazes formed from the main crack,
whereas the quenched sample show various crazes in at vicinity of the crack tip. [95]. Once
crystallized the E, tensile and flexural strength and impact resistance increase and the ≤b is
reduced. This is however only true up to 65% deformation, afterward, material embrittle-
ment is an issue[95]. The greater the crystallinity of the polymer after processing, the more
ordered and tightly bound a structure resides, where slippage between adjacent polymer
chains is limited. The tightly bound structure leads to superior mechanical properties [75].
The resistance to slippage is time dependent under constant load, due to the viscoelastic
behavior[96]. However, the greater the crystallinity, the less ductile the polymer would be-
have. In an application where is it exposed to multiple compression cycles it is important
that polymer still exhibits some flexibility. Therefore the crystallinity must be controlled to
reasonable levels to ensure great strength and stiffness while allowing some slippage be-
tween polymer chains.
6.2 Results and analysis: Biaxially strained PLLA
As previously seen the radial force of a stent is somewhat related to the stiffness of themate-
rial of which it is made, if the orientation is placed in the circumferential direction (section
5.2). The idea was to orient the material circumferentially by straining the material and cre-
ate a high radial force to avoidmigration during implantation. For this biaxial strain was ap-
plied to a hollow extruded PLLA tubing (an expansion process), from which the stent-base
would be laser cut. Below are the investigations of strain degree and strain temperatures
during processing. The investigation was performed on non-medical PLLA tubing, unlike
the investigation of monofilament is section 5.2. The reasoning why is described in section
6.2.3.
6.2.1 Rawmaterial for tube extrusion
PLLA 2003D pellets were purchased from NatureWorks LLC (Minnetonka, MN, USA) (ª4.1
% D-isomer; molecular weight (Mw ), 1.85kg/mol), heated to 194±C and extruded into tubes
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with outer diameters and inner diameters (ID) as listed in Table 6.1 or into 10.5 mm tubes,
with 0.2 mm wall thickness. After extrusion, the tubes were quenched well below Tg in a
cooling medium at 15.5±C/s for 14.5 s, leaving the tube with a low crystallinity (ª1%), as
determined by DSC. Figure 6.6 show the different extruded tubes used in this study. The
wall thickness of the rawmaterial proved to be nonsignificant as seen in Figure 6.7(a).
Figure 6.6: Extruded tubes with the outer diameters 13.2Fr, 10.2Fr and 16.5Fr
Table 6.1: Extruded tubes size available in this study and their outer and inner diameter
French size OD (mm) ID (mm)
10.2 Fr 3.4 1.7
11.7 Fr 3.9 1.7
13.2 Fr 4.4 1.7
16.5 Fr 5.5 1.7
30Fr 10.5 9.2
0
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Upper wall
Lower wall
Right wall
Left wall
(a) (b)
Figure 6.7:Wall thickness of an extruded tubemeasured at six different cross sections over the a
distance of 150 cm. No *means that samples are not significantly different at the level of p∑0.05
(6.7(a)). The cross-section of the extruded tube is seen in 6.7(b)
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According to NatureWorks an extruded sheet processed at 190±C from the same rawma-
terial has an E of 3.5 GPa, ≤b of 6 % and a æy of 60 MPa. Tensile testing of the extruded 10
mm tubes showed an axial E of 3292±403 MPa and a æy , which was also the UTS, of 50 ±4
MPa. The samples were very brittle, despite no crystallinity or crystal orientation (see Figure
6.8(a)) and showed a short ≤b below 4% (see Figure 6.8(b)). Circumferentially the samples
showed a smaller modulus of 1628±61 and a æy of 55±2 MPa. The ≤b was longer circum-
ferentially (see 6.8(b)). This proves that the extrusion creates an orientation axially, but it
is not related to any crystal orientation as seen in Figure 6.8(a), which only shows amor-
phous scattering. Due to the lesser stiffness and strength circumferentially, extrusion of the
larger tube, was not chosen as an optimal processing way for creating optimal circumferen-
tial stiffness and strength. Instead, the smaller extruded tubes were used and expanded to a
larger diameter. The process is described in section 6.2.2.
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Figure 6.8: WAXS image of a 10.5 mm extruded tube (6.8(a)). Stress-strain curves for extruded
PLLA (OD 10.5 mm and thickness 0.22 mm) in both axial and circumferential direction6.8(b)
6.2.2 Straining of extruded PLLA tubes
Table 6.1 shows the extruded tube sizes available in this study. To achieve the appropriate
size of the stent-base device, 16.5Fr (OD 5.5 mm) tubes were used, but for mechanical eval-
uation, the 10.2Fr (OD 3.4 mm) tubes were tested as they were easier to handle. As opposed
to the extruded 10 mm tubes, expanded tubes were believed to have a higher mechanical
strength circumferential and preferable for a stent in need of a high radial force. Tubes for
mechanical evaluation were made of 10.2Fr (OD 3.4 mm) or 11.7Fr (OD 3.9 mm) and a wall
thickness of 1.7 mm and expanded into tubes, 50 mm in length. Tubes with the outer di-
ameter of 5.5 mm and an initial wall thickness of 2.7 mm were placed in a mold of 100 mm
in length. The tube were heated to the desired temperature. For sequential biaxial strain,
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an external force was used to axially strain the tubes after heating. To ensure completion
of an axial strain, the tubes were heated for additional 3 s before a pressure (air injection)
from one end of the lumen was applied resulting in the tubes to expand to 8.5, 9.5 or 10.5
mm in diameter. Figure 6.9 portrays a sketch of the extruded tube, after axial elongation and
radial expansion and Figure 6.10 shows the expanded tube. To achieve simultaneous biaxial
strain, pressure was applied before the axial strain. After expansion is finished the tube is
quenched below Tg within 35 s.
The degree of axial strain during processing (≤a) is given for each specimen as the change
in length (¢L) over the original length (L0) (Equation 6.1). The radial strain (≤r ) is given as
the change in diameter (¢R) over the diameter prior to axial strain (R0) minus the reduction
in thickness due to the axial strain (ta)(Equation 6.2).
≤a = ¢LL0 (6.1)
≤r = ¢RR0° ta (6.2)
Total area expansion (Aexp ), or the degree of expansion, is the relation between the ra-
dius after any axial strain and the radius after expansion (R2) (Equation 6.3). The radius after
axial (R1) strain is calculated with the assumption that the volume of the material (V) is the
same before (V0) and after axial strain (V1). V is calculated as the cross-sectional area before
(A0) and after (A1) the axial strain times the length before (L0) and after (L1) the axial strain.
The R0 is the radius after the axial strain and seen in Equation 6.4.
Aexp = R2R1 (6.3)
V1 =V0) A1 ·L1 = A0 ·L0)º ·R21 ·L1 =º ·R20 ·L0)R1 =
s
R20 ·L0
L0+¢L (6.4)
6.2.3 Industrial vs. medical grade
Creating a medical device made from bioabsorbable polymers entails specifics of the pu-
rity and degradation profile of it. Loosely the polymers can be divided into ’industrial’ and
’medical’ grade. Previous studies were conducted on the industrial grades and some also
on PLLA purchased from NatureWorks [97][87][92][93][98][88]. Often a wider Mw is to be
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Figure 6.9: Sketch of biaxial straining. The extruded tube is placed in a cylindrical mold of a
given diameter with heating elements surrounding the mold. During the simultaneous biaxial
strain, the pressure (air injection) was applied before the axial strain. During the sequential
biaxial strain, the pressure was applied after the axial strain. Used from [44]
Figure 6.10: Biaxially strained 16.5Fr tubes to 10.5mm diameter
expected for the industrial grade. Both industrial and medical grade PLLA pellets were ex-
truded into tubes and after straining tested for differences in mechanical properties. The
difference within the properties of the two grades can also be related to differences in crys-
tallization rate during expansion. In a comparison of the two grades, mechanical testing
of tubes with a total area expansion equal to ª300% showed a significantly higher modulus
and æy for themedical tubes provided by Zeus than the industrial tubes. Themedical grade
in Figure 6.11(a) show a significantly higher E and æy and a longer ≤b . The variation appears
the same for the two groups. In general, medical grade pellets have a higher price. When
processing in-house the industrial tubes have a price of 0.40 USD/pc. Moreover, 16.10 US-
D/pc. for the medical grade. Special handling of the medical grade is believed to raise the
price further by 2-4USD. The up-scaling cost is not an issue at the development stage, but
the processing of medical grade is less convenient during handling. Purchasing already ex-
truded medical tubes from a supplier is highly expensive with a cost close to 150 USD for
50 cm of tubing (usually 25-30 cm are used for 5 cm tubes as tested in this study). For this
reason, test specimens and prototypes were made from the industrial grade. Ideally, further
testing should be done for a medical grade, as the degradation properties might differ from
the industrial grade. The profile must be very predictable in a bioabsorbable device.
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Figure 6.11: Stress-strain curves for biaxially strained PLLA tubes in the circumferential di-
rection after an Aexp=ª300%. Both medical (6.11(a)) and industrial (6.11(b)) grade PLLA were
tested
6.2.4 Degree of strain
In general, the shape of the stress-strain curve of the tubes in each direction depends on
the degree of strain in each direction. The influence of the degree of strain as a whole is
the total area expansion (Aexp ) as portrayed in section 6.2.4.1 regardless of simultaneous
or sequential biaxial strain. In summary, an increase in the degree of strain in both direc-
tions results in isotropy at high strains, but only for the sequential biaxially strained tubes.
This was not detected for simultaneous biaxially strained tubes. At the same time, it was
seen that crystal orientation was diminished at high strains for sequential biaxially strained
tubes, compared to the simultaneous biaxially strained. There is no direct method to quan-
tify the amorphous strength. It was therefore hypothesized that any strength not related to
crystal orientation was related to amorphous orientation. One can assume that the entan-
gled amorphous chains act as in a solid frozen melt and when disentangled act as in a melt
state. The strength of the melt acts as a negative pressure formed during spherulite crys-
tallization. The pressure is built up within the material as it is being stretched and leads to
cavitations. Theoretically, this deformation pressure, p, is -1/3 of the tensile stress[91], but
not described further here in detail. For biaxially strained PLLA tubes the crystallinity was
nomore than 32% for any strain or process, and it was thereby concluded that the improved
stiffness and strength properties were not in relation to crystallization and more likely re-
lated to the strength or deformation pressure of the amorphous domains.
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6.2.4.1 Article: Characterization of biaxial strain of poly(L-lactide) tubes
The influence of the degree of strain is described in detail in the following article ’Charac-
terization of biaxial strain of poly(L-lactide) tubes’ by Løvdal et al. [44]. There is a mistake
in the references, where reference 30 in Table 3 should be 31. Additionally, there is a typo
in Figure 7 and Table 3, where (1.0;4.3) should be (1.0;3.3) and (0.2;4.3) should be (0.2;2.3)
instead.
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6.2.4.2 The influence of total area expansion
It was seen that for both axial or radial processing strains (≤a and ≤r , respectively), the Aexp
is the main contributor to the increased stiffness and strength. It is not solely dependent on
the degree of Aexp , but also the degree of ≤a versus ≤r . The shape of the stress-strain curves
is similar for (0.2;2.0) and (0.5;2.4) in both directions (Figure 6.12), but there is a significant
difference in stiffness, æy , UTS and the ≤b for the axial samples. The same can not be said
for the circumferential samples. There is a significant difference between the stiffness and
æy , but the UTS and ≤b are not significantly different. To obtain the highest stiffness and
strength in the circumferential direction, a larger strain both axially and radially strainwould
be preferred. It was not possible to determine the influence of the extrusion direction on
the orientation. However as previously seen in Figure 6.8, an extruded tube, which have not
been expanded further, would have superior properties in the axial direction. It is therefore
believed that the extrusion direction will have some effect on developing orientation in the
axial direction. Perhaps it is amplified during straining and had it not been extruded prior,
the effect of axial strain could be less.
0 0.1 0.2 0.3 0.4 0.5 0.6
ϵ
0
50
100
150
200
250
σ
 (M
Pa
)
(0.2;2.0) Circ
(0.4;2.4) Circ
(a)
0 0.1 0.2 0.3 0.4 0.5 0.6
ϵ
0
50
100
150
200
250
σ
 (M
Pa
)
(0.2;2.0) Axial
(0.4;2.4) Axial
(b)
Figure 6.12: Stress-strain curves for simultaneous biaxially strained PLLA tubes in both circum-
ferential (circ) (6.12(a)) and axial direction (6.12(b))
As seen in Table 6.2, the degree of strain is much larger in the circumferential than the
axial direction and for this reason, the circumferential mechanical properties are greater.
The stent-base used in this project was made from a diamond-shaped stent with cells and
cut at an angle of 40± to the axial direction. The properties would be between the axial and
circumferential properties.
It is the ratio between ≤a and ≤r , which determines the degree of orientation of the amor-
phous chain and thereby the mechanical properties. The Aexp can in some instances be the
same, while the ratio (≤a ;≤r ) is different. As seen in Table 6.2 a larger axial strain ≤a=0.4 does
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Table 6.2: Mechanical properties of simultaneous biaxial strained PLLA tubes at different axial
strains and thereby different Aexp .
Eaxial
(MPa)
æy,ax
(MPa)
UTSax
(MPa)
≤ f ,ax
(%)
Eci r c
(MPa)
æy,ci r c
(MPa)
UTScir c
(MPa)
≤ f ,ci r c
(%)
Xc (%)
(0.2;2.0)
Aexp=269% 2614±219 75±6 75±6 6±2 3274±198 76±2 119±10 53±5 30
(0.4;2.4)
Aexp=300% 2320±273 78±3 66±7 4±1 3456±195 79±2 119±8 54±3 30
Table 6.3: Mechanical properties of sequential biaxial strained PLLA tubes in axial, circumfer-
ential and 40± direction at different axial and radial strains but same Aexp . Data was provided
by T. Noorzae
Eaxial
(MPa)
UTSax
(MPa)
æy,ax
(MPa)
≤ f ,ax
(%)
Eci r c
(MPa)
æy,ci r c
(MPa)
UTScir c
(MPa)
≤ f ,ci r c
(%)
Xc (%)
(0.2;2.3)
Aexp=333% 2418±258 68±5 68±5 40±28 3748±323 86±5 119±10 37±3 30±2
(0.2;2.3)
Aexp=333% , 40± 2263±270 63±4 63±4 39±7 - - - - -
(0.8;2.3)
Aexp=333% 3020±335 82±7 82±7 48±9 3154±220 69±4 95±8 54±4 33±1
(0.8;2.3)
Aexp=333%, 40± 2647±298 70±6 70±6 50±14 - - - - -
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Figure 6.13: Stress-strain curves for sequential biaxially strained PLLA tubes (0.2;2.3,
Aexp=332%) obtained in the circumferential 6.13(a), axial 6.13(b) and diagonal6.13(c) direction.
Raw data supplied by T. Noorzae.
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not mean that the axial stiffness and strength are greater than seen for ≤a=0.2. Because the
≤r is greater in the latter instance (2.4) the Aexp is larger for (0.4;2.4). To achieve a larger axial
stiffness and strength, one must keep the ≤a high and/or the ≤r low. Specimens cut in the
axial direction in this particular setup did not undergo necking and fractured much sooner
that the circumferential, which resulted in a shortening of ≤b than normally seen.
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Figure 6.14: Stress-strain curves for sequential biaxially strained PLLA tubes (0.8;2.3,
Aexp=332%) obtained in the circumferential 6.14(a), axial 6.14(b) and 40± 6.14(c) direction. Raw
data supplied by T. Noorzae.
The stent-base design is usually cut at about 40± angle from the axial direction. It is
therefore hypothesized that the properties will be between the axial and circumferential
properties for an isotropicmaterial. The question is, what happens if thematerial is anisotropic
as a result of different ≤a and ≤r . It is seen that the stress-strain curves for the 40± samples
after sequential biaxial strain (Figure 6.13(c) and 6.14(c)) resemble the shape of the curve
in the axial direction (Figure (6.13(b) and 6.14(b))) more than in the circumferential direc-
tion (Figure 6.13(a) and 6.14(a)). Regardless of axial strain degree, the properties at a 40±
angle are not in between the axial and circumferential properties, but inferior to the axial
properties (Table 6.3). This is by the hypothesis that the molecules are stretched in the ax-
ial direction first and then in the circumferential direction during the expansion. Because
the radial strain is much larger than the axial, it appears that all molecules are aligned cir-
cumferentially and some in the axial direction, depending on the degree of radial strain and
not so much in 40± direction. Despite the same Aexp the mechanical properties in each di-
rection (axial and circumferential) is dependent on the degree of strain in each direction.
Therefore a large axial strain (0.8) results in a larger axial stiffness and strength (as given in
Table 6.3), possibly due to a more profound alignment of the molecular chains in the axial
direction than if the axial strain is less (0.2). Less axial strain (0.2) results in less molecu-
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lar chain alignment and allows a greater alignment in the circumferential direction during
the radial strain. At the same time, a large initial axial strain allows for a greater ≤b in the
circumferential direction, yet with a large variation. Why this occurs is unknown. In conclu-
sion, it appears that the properties at an angle of 40± therefore, does not benefit from radial
expansion, but from the degree of axial strain.
6.2.5 Investigation of thermal properties of strained PLLA tubes
It was previously seen that the quicker the heating rate, the higher the Tg as well as Tcc
[13]. The Tm remains constant. It is important that all measurements must be run at the
same heating rate. Several phenomena during aDSC scan occur for different extruded PLLA
tubes. One shows the traditional glass transition, with an endothermic peak followed by a
cold crystallization and subsequently melting peak (Figure 6.15 turquoise curve). Another
is the double melting peak as seen in Figure 6.15 (blue curve). The double exothermic peak
has been investigated before and is attributed to recrystallization [99]. The first endothermic
peak is the melting of the formed crystals, then an exothermic peak representing recrystal-
lization and the last endothermic peak is the melting of the recrystallization. In general, the
double peak occurs when the heating rate is low [99] or in certain combinations of the cool-
ing rates and sequent heating rates during the DSC scan[100]. The first was confirmed in
previous DSCmeasurements of the samematerial using a heating rate of 2±C/min [13].
Figure 6.15: DSC scan for axially strain and sequential biaxially strained tubes strained at 73±C,
and sterilized at 25kGy using ∞-radiation along with the scan for an extruded tube
In Figure 6.15 only one of the DSC curves (∞-sterilized) shows this double peak despite
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the same heating rate (10±C/min). This phenomenon is later analyzed in section 6.4.2.1.
If the sequential biaxially strained tube is ∞-sterilized (Figure6.15 green curve), the double
melting peak is not present and resembles the curve the sequential biaxially strained tubes
(Figure6.15 red curve), where no cold crystallization peak occurs. It is later shown that fur-
ther crystallization is possible, but not at the rate of which the DSC scan is running.
The untreated extruded tube, shows a cold crystallization peak at 129±C and a melt-
ing peak at 156±C and remains amorphous (<1%) (Figure 6.16). When the extruded tube is
strained between Tg and 73±C at a ≤a below 100% the thermal analysis shows that Tcc has
shifted to the right at 107±C, whereas the Tm remains constant. Even lower degrees of axial
strain (68%) will move the Tcc peak to 88 ±C . This means that when the polymer has been
strained the energy needed to form crystals is less. A low ≤a of 68% very little crystallinity is
seen(3%). Increasing the strain to 88% induces a Xc of 8% (Figure 6.16). The double melting
peak occurs just as the chains are stretched enough (38%) to form crystals. Only at strain
degree close to 100%, the amorphous chains are so alignment that little energy in the form
of heat is needed to form crystals and the crystallinity increases to 35-36%.
Figure 6.16: DSC scan for axially strained tubes at different ≤a along with the an untreated ex-
truded tube
Figure 6.17 shows that the processing strain temperature (Tp ) may be as low at 65±C
to induce crystals, with a XC between 24 and 29% as long as the degree of strain is close
to 100%. Straining at 65 or 70±C shows an unexpected crystallization peak around 85±C.
Normally crystallization from the cold would indicate the onset of the crystallization peak
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to be about 100±C and 129±C at the peak. Increasing the Tp to 73±C shifts the Tg higher to
63±C as opposed to 59±C. At this Tp , the crystallization peak is non-existent resulting in a
higher crystallinity of 35-36%. Increasing the temperature further will not induce crystals.
Increasing the straining temperature will increase the Tcc from 85±C to 118±C at 90±C. This
means thatmore energy is needed to further crystallize. It is hypothesized that the chains at
high Tp relax due to a high degree of mobility and are therefore not able to crystallize. The
phenomenon is further described in section 6.2.7.
Figure 6.17: DSC scan for axially strained tubes (0.8;0) at different Tp
Table 6.4: Thermal properties of axially strained tubes at different ≤a alongwith the anuntreated
extruded tube
Tg (±C) Tcc (±C) Tm(±C) Xc%
Rawmaterial 58±- 128 ±- 154±0 1±-
(0;0) 61±0 129 ±- 156±0 0±-
(0.8;0) 62±0 107 ±0 154±0 3±1
(0.9;0) 63±0 88 ±1 153±0 8±1
(1.0;0) 63±0 - ±- 151±0 36±0
At Tp close to the onset of Tcc , the material would be soft. Experimental work at a high
Tp showed that after the axial strain the tube becomes soft and relax from its normal shape.
It starts to bend in themold leading to a considerable variation in thickness after expansion.
To avoid the bending, a metal rod was placed inside the tube, and it was possible to strain
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the tube at a maximum temperature of 93±C . At lower temperatures, this was not an issue.
The tubes would be thicker toward the ends of themold. However, it was confirmed that
it hadno significant influence on the thermal characteristics of the tube and the crystallinity,
Tg and Tm remained constant throughout the entire length of the tube [13]. Thickness vari-
ation along the tube did not correlate with any variances inmechanical properties for spec-
imens taken along the tube, and it is hypothesized that the amorphous chains are stretched
somewhat uniformly along the tube at least for straining of 10.2Fr and 13.2Fr tubes.
6.2.6 Processing strain rate and temperature
In investigation of axial processing strain rate (≤˙p ) and processing temperature (Tp ) the de-
gree of axial processing strain ≤a was kept constant at nearly 100% and the Aexp=432% as
done in section 6.2.4.1. The (≤˙p ) was set to 0.1, 0.2 or 2.1 s°1. In summery it was seen that
crystals form during an axial strain (≤a), only occurs when then ≤˙p is above 0.2 s°1 and at
Tp<85±. Both ≤˙p of 0.1 and 0.2 s°1 are too slow for the crystals to form during strain and the
chains either does not become oriented in the first place or the chains have enough time
to relax from oriented to non-oriented state and crystals are not formed. The faster the de-
formation, the less chance for the polymer chains to relax, which is seen by an increase in
UTS and æy of the material. According to Pawlak et al. [91] the improvement of properties
is related to the crystal strength and not the amorphous chains. When the polymer is not as
soft, cavitations during high strain rates aremore likely. This should be seen by a shortening
in ≤b and is only seen vaguely for sequential biaxial strained PLLA tubes in this study with
increasing ≤˙p . At higher Tp the plastic deformation degree is smaller, and the ≤b is improved,
and therefore cavities are not formed during deformation. This is seen by the degree of ≤b
for tubes strained at Tp=93±C.Overall cavities are expectedwhen the chainmobility is insuf-
ficient for lamellar deformation through crystal plan slip and the amorphous deformation
occurs[91]. Therefore a minimum Tp=68±C has previously been identified to avoid the cav-
ities and shortening of ≤b and discussed later in section 6.2.9. Zhang et al. [87] showed that
increasing the strain temperature for PLLA (2002D) specimens from 70 to 90±C eliminates
the formation of cavities as the PLLA is deformed. At higher Tp , the PLLA can be strained
further before cavities occur compared to lower Tp . This is also seen for sequential biaxially
strained PLLA tubes, as the ≤b increases with increasing Tp .
One thing that should be noted is that the higher the Tp , the more mobility within the
material. The final tube upon expansion is much thinner than at lower strain temperatures.
85
6. BIAXIAL STRAININGOF POLY(L-LACTIDE) TUBES
It is possible that the distribution of the material is more uniform at higher Tp . Despite
the improvedmechanical properties, the thinner tubes are not preferable when creating the
filter. Again it must be remembered that there is a limit to how thin the wall thickness of
a filter can be to exert to appropriate radial force on the vessel wall. Therefore the optimal
filter would be made of material, which showed excellent strength and stiffness while being
as thin as possible. It is most likely be a compromise between adequate radial force andwall
thickness.
6.2.7 Article: Mechanical Properties ofBiaxially StrainedofPoly(L-lactide) Tubes:
Strain Rate and Temperature Dependence
The influence of ≤p and Tp are clarified in the following submitted article.
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6.2.8 Opaque nature of strained PLLA tubes
Based on literature it is known, that to induce the PLLAwith crystallinity upon strain, the Tp
must be above the Tg . The Tg for the extruded tube is 63±C. Temperatures below 73±C but
above Tg made thematerialmilky-white as opposed to transparent. It became apparent that
low Tp created opaque tubes (Figure 6.18(a)) compared to the transparent tubes processed
at higher temperature (Figure 6.18(b)).The opaque nature might be related to stresses built
up within the polymer or due to microvoids created during straining. It was not possible to
release the stresses through heat treatment. The cooling rate at which the tubes are exposed
appears to create microvoids, which are not possible to remove through heat treatment. It
is thus important to both select a Tp as well as a degree of strain to limit the presence of
microvoids or stresses.
(a) (b)
Figure 6.18: Sequential biaxially strained tubes which is of opaque nature 6.18(a) and of trans-
parent nature 6.18(b)
Small angle X-ray diffraction (SAXS) will show that for PP the cavitations and thewhiten-
ing of the material occur at yield point and that the voids are formed perpendicular to the
deformation direction[91]. SAXS was used in the attempt to determine a higher degree of
cavitation within the material in this project. Two tubes which processed the same way, but
one of the tubes appeared white, where the other appeared transparent. The SAXS signal
was too weak for the biaxially strained PLLA tubes to confirm differences between the two
tubes. It is a possibility that the lower the Tp , the higher the risk of inducing stresses within
the material leaving it white. Supposedly the polymer can become opaque when crystals
form from the un-nucleated state due to the formation of larger spherulites, but WAXS did
not show larger individual crystals. Both incidences showed radial crystal sizes of 56 and
60 Å and axial crystal sizes of 142 Å. It is a possibility that the white represents clusters of
crystals of the same size, creating a different light refractive index. The tubeswere processed
in the same fashion, and the orientation factor for (200/100) plane is the same, despite the
99
6. BIAXIAL STRAININGOF POLY(L-LACTIDE) TUBES
white tube shows more amorphous scattering overall (Figure 6.19(b)). It can therefore not
be concluded that the opaque nature of the expanded PLLA tubes is related to crystals.
(a) (b)
Figure 6.19:WAXS images of transparent (6.19(a)) and opaque tubes after expansion (6.19(b))
Additionally, the Bragg’s angles showed that the packing of crystals was the same (Figure
6.20). Small differences in the extruded tube, despite the same processing parameters, lead
to slightly different tubes. An investigation of the expansion machine was not done, and
tubeswhichwere optically not processed correctlywere discarded for further investigations.
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Figure 6.20: Intensity as a function of Bragg’s angle (2µ). The figure shows both the intensity for
transparent and opaque tube after expansion. The most common peak for the Æ’ crystals for
PLLA are denoted
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6.2.9 Cooling during processing
Experimental data show that cooling the mold follow a linear cooling function of the tube
itself (Figure 6.21). Cooling the mold for 14 s before axial strain would reduce the outer
temperature of the tube from73 to 68 ±C. At this temperature, the inside of the tube is usually
60 ±C. The tubes are opaque rather than transparent at this stage. From Figure 6.22(a) it
is then seen that a lower straining temperature will cause a shortening in ≤b presumably
caused by microvoids or cavities formed during the strain.
Figure 6.21: Cooling ofmold from 100±C to room temperature and the tube temperature during
cooling
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Figure 6.22: Strain-stress curves for tubes testing in the circumferential direction. The tubes
have been cooled to 60±C before expansion (6.22(a)) or heated in themold after expansion for 2
s (6.22(b)) or 10 s (6.22(c))
6.2.10 Tube thickness variation
In general, the biaxially strained tubes were thicker in the proximal than the distal end (to
the pressure air injection) and thinnest in the middle. Overall sequential biaxial appears
to show the least thickness variation going from distal to proximal. Additionally, it was seen
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that a larger degree of axial strain, would automatically reduce the thickness variation. From
Figure 6.23 and 6.24 it was seen that 0.3 axial strain as opposed to 0.5 strain, results in the
thicker wall at both ends of the tube over 100 mm and more variation along the length.
Therefore when possible prototypes were made, laser cutting was done in the middle of
the tube. Unfortunately, in retrospect, the prototypes from tubes used in the animal study
showed a larger variation from one end to another. The proximal end had a much larger
thickness (0.80 mm), and the distal end had a thickness of 0.45 mm (see Table 9.1 in section
9.1.1). A possible explanation for this could be that the tubes were not completely straight
but bend upwards (3.1±) when received from the supplier (see Figure 6.25). The tubes for
the animal study were processed in the same way as previously despite the large thickness
variation along the tube. It is possible that an uneven heating of the material occurred,
and some part of the material would be softer and thinner after axial strain from which
point the expansion would develop. The uneven heating of thematerial might be due to the
disturbance in the heating element of the mold or due to the material bending and parts of
it were closer to the heated mold and thereby became soft and the weakest point.
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Figure 6.23: Simultaneous (SIM) and sequential (SEQ) biaxially strained tubes (OD 5.5 mm).
Strain temperature was either 70 or 73±C
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Figure 6.24: Sequential biaxial strain of OD 5.5mm tubes. Strain temperature was 73±C
Figure 6.25: Extruded PLLA tube (16.5Fr)
6.3 Annealing and loss of orientation
6.3.1 Annealing
As previously stated mechanical properties depend on crystallinity. Regarding annealing,
isothermal crystallization of the extruded tube occurs at 80±C and above but depend on the
annealing time. At 80±C a Xc of 28% could be obtained after 3 hours, whereas heating the
temperature at 90±C induces a Xc of 30% after only 1 hour. Heating the temperature further
to 100±C and above induces a Xc of 38% after just 30min and 41% at 130±C. A maximum Xc
of 44% was achieved at 140±C [13]. As crystallinity increases as a function of temperature
the mean crystal size for the three isothermal rings portrayed byWAXS (see Figure 6.26), in-
creased from 131, 118 and 186 Å to 190, 165 and 193 Å. It should be noted that the crystals
do not grow in any specific orientation plane as seen for biaxially strained PLLA tubes. An-
nealing the raw material leads to double melting peaks at 90 and 100±C next to each other
[13].
When annealing the strained material the double melting peak occurs only at 120±C
(Figure D.4 in Appendix D.3). Below this temperature the two melting peaks are further
apart. The Tg is more difficult to determine, as it come is two different transitions due to
a noisy signal. For annealing at 130±C the first is at 60±C and the second is 67±C. An in-
crease in annealing temperature increases the Xc to 41±0%. FromTable 6.5 and 6.6 it is seen
that crystallization increase as a function of temperature despite the already strain-induced
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(a) (b) (c)
Figure 6.26:WAXS images of annealed extruded tube at 100±C (6.26(a)), 120± (6.26(b)) and 140±
(6.26(c)) for 30 min
Table 6.5: Isothermal annealing of the extruded tube [13]
Tg 1st Tm 2nd Tm Xc
(0;0) 100±C, 30min 60 149 156 38
(0;0) 110±C, 30min 61 - 156 40
(0;0) 120±C, 30min 59 - 155 41
(0;0) 130±C, 30min 60 - 157 41
(0;0) 140±C, 30min 58 - 160 44
crystallinity. However it is also seen that the temperature must be above 90±C to induce fur-
ther crystallinity in strained tubes, whereas crystallinity during isothermal annealing can
occur, but takes longer.
Table 6.6: Isothermal annealing of sequential biaxially strained tubes
1st Tg 2nd Tg 1st Tm 2nd Tm Xc
(0.2;2.3) 90±C, 60min - 65 - 152 30
(0.2;2.3) 100±C,30min 60±0 66±1 108±0 153±0 31±0
(0.2;2.3) 110±C, 30min 60±0 67±0 117±0 152±0 34±2
(0.2;2.3) 120±C, 30min 59±1 70±1 128±0 152±0 37±1
(0.2;2.3) 130±C, 30min 60±1 71±1 137±0 152±0 41±1
The crystallization rate differ between strained tubes and the extruded tube as seen on
Figure 6.27, where the crystallization rate of strained tubes is approximately linear. The
crystallization rate is quicker for the extruded tube, and its function is not linear, though
the Xc is the same at 130±C for both materials. It means that more energy is required to the
system to crystallize already strained samples further.
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Figure 6.27: Crystallinity as a function of annealing temperature during 30min annealing for
sequetial biaxially strained or extruded tubes
As shown above, annealing does not only influence the amorphous samples but also al-
ready crystalline samples. The process is referred to post-annealing and is an isothermal
heat treatment of the samples. It was previously shown that the orientation of amorphous
chains is sensitive to the expansion temperature (section 6.2.4.1). The orientation of an ax-
ially strained tube is reduced from 0.7 to 0.3 with post annealing for merely 20s at 120±C,
leaving the tube nearly 80±C inside (Figure6.28). The change in crystallinity from 34 to 36%,
is likely due to the experimental equipment error and is not considered significant. The
same tendency is seen for sequentially biaxially strained tubes, where the orientation factor
is reduced from 0.3 to 0.1 when annealed up to 80±. Upon annealing if the tube is first cooled
to room temperature at the speed of 0.4±C/s, then subsequently annealed to 80±C, the ori-
entationmaintained for that particular plane. At the same time, the stiffness of the material
remains unchanged as seen in Figure 6.29 regardless of the annealing pathway. This is by
the fact that crystal orientation is diminished upon heating and that the amorphous ori-
entation remains at 80±C. There is a change in the æy , which is significantly lower when
annealed than when cooled before annealing compared to the sequential biaxially strained
tube in Figure 6.29(c). Another interesting point is the crystal sizes after annealing. Upon
annealing the crystals for the (110/200) plane grow in the axial direction from 134 to 145 Å,
regardless of the cooling and annealing pathway. Annealing of only axial strain makes the
crystals diminish in in the circumferential direction from 183 Å to 160 Å but grow in the axial
direction from 62 to 126 Å.
Annealing for 60min at 90±C eliminated any orientation obtained through straining and
the modulus and æy comes closer to molded PLLA specimens, without straining. At the
same time, the crystallinity was reduced from 31-32 % to 28-30 %. This was described in
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Figure 6.28: WAXS images of post-annealed axial strained tubes 6.28(a) and post-annealed bi-
axially strained tubes 6.28(b)
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Figure 6.29: Sequential biaxially strained tubes strained at 73±C (6.29(a)), cooled and annealed
for 85s at 100±C (6.29(b)), or expanded at 73±C and annealed for 30 s (6.29(c)). Tubes were tested
in the circumferential direction
further detail in section 6.2.4.1 [44]. It is therefore believed that strain-induced crystallinity
is not well preserved during annealing and is a concern in further processing of the tubes.
6.3.2 Pre-annealing
Annealing in an oven was done before straining for 1, 3 or 5 min at 80 or 90±C after which
they were slowly cooled at room temperature. Based on the previous measurement it is
unlikely that the pre-annealing induced any crystallinity. Sequential biaxial straining was
done at 73±C subsequently. Annealing at 80±C leads to amodulus andæy significantly lower
than the non-pre-annealed tubes (Figure 6.30). Annealing at 90±C leads to amodulus andæy
which were not significantly different from the non-pre-annealed tubes, but the properties
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were different at 80±C. It could not be explained why that is, and since the properties were
not significantly improved, the idea of beneficial pre-annealing was not pursued.
Preferably the Xc should be moderate after the expansion process, heat treatment (be-
fore or after) and sterilization to avoid complications during loading of the device into the
delivery system and to avoid fractures during cyclic compression in the vein. For compar-
ison, the already commercially available BVS stent from Abbott Vascular was analyzed and
showed a high crystallinity of 52%, while having a low orientation factor of 0.02 (see Table
D.2 in Appendix D.2). The stent was very brittle as a result of the high Xc . It is not likely that
the stent would not be suitable for the larger diameters under cyclic compression.
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Figure 6.30: Sequential biaxially strained tubes expanded at 73±C (6.30(a)), pre-annealed for
5min (6.30(b)) at 80±C or 90 ±C (6.30(c)). The tubes were tested in the circumferential direction
6.4 Sterilization
6.4.1 Background on sterilization
Sterilization, in general, will have an impact on most polymers whether bioabsorbable or
not. The most common sterilization methods are dry heat, ethylene oxide (EO) gas and ∞-
radiation[101]. The sterilization can potentially impact the mechanical performance, such
as stiffness and elasticity but also the viscoelastic properties of the polymer [41]. During
EO sterilization the molecular weight can be reduced for PLLA [41]. Because bioabsorbable
polymer is sensitive to both temperature and moisture, sterilization can become a chal-
lenge. Exposure to high temperatures and moisture will result in severe degradation and
hydrolysis, with a reduction inmolecular weight (Mw ) of 11% after a short sterilization cycle
of 70min at 45±C [41]. If the reducedMw is acceptable, EO still becomes of interest. EO ster-
ilization at 53±C at 75% humidity is acceptable in terms of residual microbes. The key is to
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evaluate whether a long expose time tomoisture at low temperatures is less harmful than at
higher temperature. PLLAmicrospheres showed that a cool EO sterilization cycle well below
Tg will reduce the Tg , whereas warm EO sterilization cycle closer to the Tg , will increase the
Tg . In general the Tg can change by storage at elevated temperatures and hydration. Water
can act as a plasticizer and lower the Tg andmake the polymer soft[64]. Also after awarmEO
sterilization cycle, a cold crystallization peak will not be detected during DSC [101], where
it remains at 85.5 ±C after a cold cycle. A cold crystallinity temperature was detected for a
cold EO sterilization cycle. The warn EO sterilization cycle induces a greater crystallinity
as opposed to the cold cycle, which only induces a slight increase in crystallinity. This re-
sults in a greater chain mobility in the amorphous domain during the warm cycle [101].
At lower sterilization temperature there is not enough mobility among the chains to create
crystalline domains. Radiation has the advantage of being performed at room temperature
and without the need of moisture as a carrier for sterilization to occur. However, it is also
known to reducemolecular weight, by cleaving themolecular chains ultimately altering the
degradation profile of the polymer. EO has the advantage over ∞-radiation of not reduc-
ing molecular weight and from a manufacturing perspective of being cheaper. Sterilization
at 25kGy using ∞ radiation does not change the modulus or æy significantly. Radiation of
50kGy significantly increases the modulus and well as the æy . The crystallinity increase at
25kGy, but the dose is increased to 50kGy, the crystallinity is reduced[102].
6.4.2 Results on sterilization of biaxially strained tubes
6.4.2.1 ∞ - sterilization
In this project, no real difference in modulus was detected after a single 25kGy radiation or
two times 25kGy (e.g. 50kGy). However, in both instances, the ≤b is reduced. Specifically for
PLLA it is expected that the major effect of radiation is chain scission of the backbone and
through hydrogen abstraction, resulting in a reduction of Mw [103]. As predicted radiation
sterilization in this study (2x 25kGy), theMw was reduced to 67,000g/mol from the preexist-
ing 185,000g/mol (see Table D.3 in Appendix D.4). A small increase in crystallinity (37-38%)
was detected upon ∞-radiation, which correlates well with the fact that stiffness increase
significantly as a result hereof (Figure 6.31(c). The æy increases from 83±3MPa to 94±8MPa
and the reduced ≤b , indicates that oriented amorphous chains have changed, or cavitations
have formed. From the literature, it has previously been pointed out that the mechanical
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strength (section 5.1.2) is reduced with molecular weight (Mw ) reduction. Radiation of the
extruded tube does not change the thermal properties or the crystallization, and the tubes
remain amorphous. Itmeans amorphous chains cannot form crystals upon radiation if they
were not induced previously during extrusion.
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Figure 6.31: Stress-strain curves for sequential biaxially strained PLLA tubes sterilized with ∞-
radiation at 25kGY 6.31(b) and 50kGy 6.31(c). 6.31(a) shows non-radiated PLLA as a reference.
All tubes were tested in the circumferential direction
Table 6.7:Mechanical properties of sequential biaxially strained PLLA tubes before and after ∞-
or EO sterilization
E (MPa) æy (MPa) æmax(MPa) ≤ f%
Unsterilized 3288±291 83±4 128±13 45±5
25kGy 3553±306 93±7 106±14 31±10
50kGy 3498±367 94±5 99±8 16±15
Table 6.8: Thermal properties of sequential biaxially strained PLLA tubes before and after ∞-
sterilization. DSC scans can found be in Appendix D.3 Figure D.5
Tg (±C) Tcc (±C) Tm(±C) Xc% Aging area (J)
Unsterilized biaxially strained 64±1 - 150±1 33±1 -
Unsterilized extruded tube 61±1 119±1 157±1 1±0 3±0
25kGy extruded 62±0 129±1 156±0 1±1 2±0
50kGy extruded 60±0 122±2 158±1 1±1 4±1
25kGy biaxially strained 62±0 - 154±0 38±2 4±1
50kGy biaxially strained 64±0 127±2 156±2 36±0 -
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6.4.2.2 Heat treatment and EO sterilization of PLLA
The prototypes in this project were thermally set above Tg and below the Tcc to scaled to an
appropriate IVC filter diameter. The first heating temperature was 63±C for 5 min. The sec-
ond temperature was 93±C at which the laser cut tube could be further expanded to 27 mm
and a stent cell height of 12 mm. The Tg increased from 63±C to 67±C upon heat treatment,
while decreasing the Xc from 32-33% to 26-27% (Table 6.9), if cooled fast. At this temper-
ature, no further crystallization takes place during subsequent sterilization or annealing,
regardless of fast cooling or slow cooling. However, the mechanical properties were greatly
influenced by the thermal treatment.
Table 6.9: Thermal properties of sequential biaxially strained PLLA tubes before and after EO
sterilization in combination with or without heat treatment. DSC scans can be found in Ap-
pendix D.3 Figure D.6
Tg (±C) Tcc (±C) Tm(±C) Xc%
Unsterilized 64±1 - 150±1 33±1
63±C, 93±C, rapid cooling 66±1 - 153±0 27±1
63±C, 93±C, slow cooling 67±0 - 152±0 30±1
63±C, 93±C, 53±C 8h 68±1 118±3 153±0 27±2
53±C 8h 67±0 - 152±0 30±3
EO 38±C 66±0 - 152±- 31±2
EO 53±C 69±0 - 152±- 32±1
EO 53±C, 63±C, 93±C 67±0 - 153±0 29±0
EO 38±C, (63±C, 93±C) 67±1 110±1 152±- 26±0
From Figure 6.32 it can be seen that both the æy and the elastic modulus are signifi-
cantly reduced. Subsequently annealing thematerial at a temperature below Tg for 8 hours,
restores the properties, but still to a value lower than prior to annealing. The regain is not re-
lated to an increase in crystallinity nor changes in Tg . It appears that the higher the temper-
ature, themore rearrangement of themolecular chains and highermodulus andæy . Adding
moisture, as occurred during EO sterilization does not change the properties significantly.
Heating thematerial reduces crystallinity and at the same time, the ≤b increases at 40±C. In-
creasing the temperature and adding moisture reduces the elongation. From Figure 6.33 is
it clear that sterilization at a low temperature for 8 hours does not change themodulus oræy
significantly, but the ≤b is increased significantly. Heat treatment up to 93±C first allows the
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Figure 6.32: Elastic modulus, æy and ≤b for sequential biaxially strained tubes, which have un-
dergone heat treatment and annealing for 8h at either 40 or 53±C or sterilized by EO at 53±C.
*p∑0.05 and signifies if their means are significant different. No * means that they are non sig-
nificantly different
molecular chains to relax from the strained position during biaxial straining. Somememory
of the strained position might be expressed as the polymer is annealed and the properties
slowly return to the level before sterilization, heat treatment or annealing. The presence of
moisture at this temperature has no effect on the recovery of the chain alignment. If the
heat treatment has not been applied, the annealing does not change the position of the
chains, and the mechanical stiffness and strength remain unchanged. It can, therefore, be
said that the moisture and annealing at low temperature can only change the position of
the molecular chains if they have been previously thermally treated and lost their orienta-
tion. The sequential biaxial straining, therefore, locks the molecular chains in an aligned
position, which can only be relaxed when annealing above Tg . It is expected that upon EO
sterilization the both the æy and the elastic modulus are reduced ([102]). There is a signifi-
cant increase in modulus and æy when increasing the sterilization temperature. There is no
significant difference in modulus or ≤b when adding moisture as a part of the sterilization
process, a significant difference in æy .
Prior to sterilization the expanded tubes (1.0;3.2) showed a crystallinity of 33% and that
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Figure 6.33: Elastic modulus, æy and ≤b for sequential biaxially strained tubes, which have un-
dergone heat treatment and annealing for 8h at either 40 or 53±C or sterilized by EO at 38±C.
and *p∑0.05 signifies if their means are significant different. No * means that they are non sig-
nificantly different
after heat treatment was lowered to 27%. When exposed to cold sterilization at 38±C the
crystallinity remained constant (26%). The Tg went from 64±C to 68±C and after steriliza-
tion was to 67-69±C depending on temperature and the presence of humidity. Heating the
material appears to reduce the crystalline domain and the energy to achieve chain mobility
is more. It was unexpected that the low sterilization temperature caused lower crystallinity.
Both heat treating and sterilization at 53±C increase the Tg , whether it occurs with rapid
cooling or slow cooling. To reduce the crystallinity when quenching below Tg the spray
cooling was used. There is still a slight increase in Tg and Tm , but the Xc differs. It appears
that thermal treatment brings the polymer to a disordered state ormelts the smaller crystals
so that the Xc is reduced to 30%. Rapid cooling was done with the freeze spray, which is a
mixture of flourocarbons (80-95%Norfluran and 5-10% dimethylether)[104] (Kema FS-35A,
ITW Spraytec Nordic), which cools small objects down to -35±C and evaporate completely
and is not miscible to the PLLA[105]. The rapid cooling done with freeze spray has more
of an impact on Xc which is reduced to 27%. It is a possibility that heat treatment melts
the smaller crystals, and if cooled slowly, some crystals are formed again. From the thermal
characterization of sequential biaxially strained tubes in section 6.3 it is known that anneal-
ing 100±C and below does not change the crystallinity, and it is not likely that new crystals
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are formed during heat treatment. Cooling after heat treatment also has an effect on the
mechanical properties as well. As with annealing, heat treating the material for a shorter
period (5 min at 93±C) reduces the values of the mechanical properties by a 1/3. Cooling
at room temperature proved to sustain the stiffness and strength better than rapid cooling
with freeze spray. Upon cooling at room temperature (slow cooling) the axial elastic mod-
ulus is reduced by 11%, the æy by 14%, the UTS by 15%, while the ≤b increased by 6%. The
circumferential elastic modulus is reduced by 6%, the æy by 9%, the UTS by 13%, while the
≤b increased by 42%. Rapid cooling resulted in a reduction of an axial elastic modulus, æy
and UTS by 10-11%, but the ≤b increased by 3%. The circumferential elastic modulus is
reduced by 16%, the æy by 19%, the UTS by 13%, but the ≤b increase by 25%. The rapid
cooling reduced the elastic modulus, and æy circumferentially by 22-24% and increased the
≤b by 50%. Thermal properties did not change regardless of cooling method. Regardless of
cooling rate, the ≤b increased after heat treatment.
Annealing the polymer for 8 hours (equivalent time frame to sterilization) close to Tg in-
crease Tg slightly, but reduces the overall crystallinity. It is possible that relaxation or aging
occurs during this time frame. EO sterilization close to Tg , increases the Tg of the polymer
even further, but the crystallinity remains constant. If EO sterilization temperature is low-
ered, the effect of the moisture from the process is less predominant. EO sterilization alone
did not change the crystallinity of the polymer.
Thickness after EO sterilization Heat treatment of the laser cut stents at 63 and 93 ± for
5 min, increases the thickness from 10.5±0.6 to 12.4±0.7 mm (see Appendix D.5 Figure
D.8). Heat treating the specimens at 53±C for 8 hours, reduced the thickness of the tubes to
8.4±1.1 mm. After sterilization, the thickness was 12.0±0.4 mm. The heat and the steriliza-
tionwill therebymake the specimens shrink in the axial direction and leaving the specimens
thicker circumferentially. As for the rings cut from tubes, the laser cut stent also increased in
wall thickness after sterilization (Figure 6.34). Furthermore, the increased thickness showed
more variation along the tube after sterilization than before. It is possible that the strained
tube did not have a uniformly distribution of stretched chains and therefore some shrink
more than others. The variation seems higher for prototypes made from a tube with a low
degree of axial strain (0.3;2.2) than (0.6;2.4).
The biaxially strained tubes are very sensitive to temperatures above 90±C in the sense
that both the mechanical properties and the thermal properties change with temperature.
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Figure 6.34:Wall thickness of stent cells circumferential measured at the most distal and proxi-
mal end of a laser cut stent-base before and after sterilization
Exposure to both humidity and higher temperature, whether it is body temperature or close
to Tg , it being short term (8 hours) or over an extended period (2 weeks), the conditions
are favorable enough for the molecular chains to move. The chain which was ordered as
crystals, become less ordered and reduce the crystallinity.
6.5 Storage and physical aging
Physical aging is both relevant during storage of the extruded tubes, the sequential biaxi-
ally strained tubes and the final sterilized device. It also becomes relevant when implanted
in the body. During processing the polymer is quenched below Tg and molecular mobil-
ity slows down and is unable to reach equilibrium. Storage or implantation close to Tg will
cause the polymer to move toward an equilibrium state, which as described below influ-
ences the properties of thematerial. It is unknown if and how the amorphous chains, which
have undergone biaxial strain, would behave during aging. Therefore during storage of se-
quential biaxially strained tubes were kept under vacuum in air under ambient conditions,
at 37±C in air, water or bovine serum. Below is a short description of the aging phenomenon
and the expected changes as described in section6.5.1. Further down in section 6.5.3 are the
results from this project shown and discussed. In comparison, the results on the aging of
the extruded PLLA is shown and discussed in section 6.5.2.
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6.5.1 Background on physical aging
Physical aging is a phenomenon which can occur when PLLA is quenched from the melt
and the polymer chains are in a non-equilibrium glassy state, where mobility is low. De-
spite the short distance in which the molecules can move in this state, they rearrange to a
degree which drives toward a thermodynamic equilibrium. The closer to the Tg the faster
the aging or relaxation or put in another way, the greater the ability is to eliminate excess
free volume [95]. Aging causes rearrangement of the polymer chains, which affects the me-
chanical properties[106]. The rate of relaxation and rearrangement of the polymer chains
are therefore dependent on how close the aging temperature is to Tg .
In terms of mechanical properties, the elongation of annealed, yet unaged PLLA has
been reported to undergo necking during tensile testing. Ductility and flexibility increased
the ≤b 300% of its original length. The ≤b is significantly reduced as a result of aging, yet an
increase in stiffness and strength is observed[106].
When PLLA is quenched from rubber state above Tg the polymer chains become ’frozen’
and segmental mobility is greatly reduced along with a reduction in the free volume (the
space in which the polymer chains can move freely). The Tg is, therefore, dependent on
the free volume of the system. Due to the reduced segmental mobility, the system requires
more energy to finishmorphological rearrangement occurring during glass transition and as
a result of the Tg increase. During aging the slowmobility over time, causes chain relaxation
and reduction in free volume. Furthermore aged PLLA during DSC scan will show a smaller
enthalpy and potential energy andmore energy is required for the Tg as seen by the increase
of the area of endothermic peak [106]. It has previously been shown that the longer the
aging, the larger the endothermic peak will occur on a DSC scan as well as the area during
Tg . Any small peak at the end of the endothermic peak is possibly due to energy consumed
by a crystalline domain developed during quenching[106].
When the polymer chains are oriented, as in tensile deformation, the free volume, and
potential energy increase. The potential energy is related to the required energy to ensure
yielding upondeformation. In unaged, nearly amorphous PLLA, there is a larger free volume
and strain ismore easily transferred through the disordered arranged polymer chains during
tensile deformation. Thematerial is more flexible and tough[106]. It is expected that for any
of the aged samples, the ≤b and stiffness increase. As most of the experiments in this study
are done on sequential biaxially strained tubes, where the polymer chains are thought to
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be oriented, and not the quenched amorphous PLLA, it is unsure if the same apply during
aging of such.
6.5.2 Results on storage of extruded tubes
The extruded tube in itself appears to have undergone some aging as seen previously in
Figure 4.6.
During initial stages of the project, an interesting observation regarding tube expansion
was made. The expansion process becomes difficult if the tube has been kept in a moist
environment in advance. The normal procedure for expansion of for example polyethy-
lene tube for balloon expansion is kept in a moist environment. Straining of extruded PLLA
tubes previously kept in a moist environment, using the same processing parameters as on
dry tubes, the tubes are punctured when air pressure is applied. It is possible that the tubes
experienced some form of aging. It was previously reported that when the extruded tubes
were kept in a moist environment between 13 and 97 % humidity at room temperature, the
Tg is reduced from 63 to 59±C whereas it increased to 67±C when raising the temperature
to 37±C. Additionally, the endothermic peak was shifted to higher temperatures as well as
an increase in its area. Despite that fact that aging most likely is only related to the amor-
phous domains, the Tcc and its onset is reduced to 122±C from 129 ±C, when exposed to
moisture[13]. The temperature window for inducing crystallinity is bigger for samples with
moisture content. The effect is less apparent on tubes kept at room temperature in a moist
environment. The storage is important before straining PLLA.
6.5.3 Results on storage of sequential biaxially strained tubes
The sequential biaxially strained tubes were kept in a dry environment with and without
the presence of moisture and in water or bovine serum (Statens Serum Institut, Denmark)
at 37±C. From Table 6.10 it appears that moisture and temperature have little effect on the
endothermal aging peak during glass transition. Instead, it appears that it is the tempera-
ture, which causes the increase in Tg . Diffusion and water uptake occur instantly and not
only start the degradation by hydrolysis but can also lead to recrystallization. As previously
mentionedwater acts as a plasticizer and lowers the Tg . However keeping the tubes inwater
or bovine serum at 37±C increases the Tg (Table 6.10) and keeps the crystallinity constant.
This is in accordance with the fact that a polymer with a high Xc reduces the affect of plas-
ticizers, as it is not able to separate the molecules in the crystalline structure. The diffusion
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of water molecules to the bulk are limited to the amorphous domain and is restricted by the
crystalline domain. Permeability depends on the solubility and diffusion, which are both
reduced by the crystallinity[90].
It has previously been shown that over the course of nearly 2weeks the presence of water
at 37 ±C changes the mass about 1% for the extruded tube, with a small reduction is Mw
from 1.85 to 1.74kg/mol[13]. It was reported that the Tg for the extruded tube aged for 2
weeks in water, increased by 2±C. For the sequential biaxially strained tube in this project,
the increase was as large as 6±C . In both instances, the water does not act as a plasticizer.
Interestingly it has previously been reported that in water at ambient temperature, the Tg
is reduced and the water acts a plasticizer[13], but this is not seen for sequential biaxially
strained tubes. Increasing the temperature increases the Tg further, which was unexpected
compared to the results of the extruded tubes. It is unlikely that increasing the temperature
restricts the chance for water molecules to get in between the polymer chains. However, the
higher temperature might enhance chain mobility and order them in a fashion that does
not allow the water molecules to separate the chains. In terms of mechanical properties,
the only significant increase in stiffness and strength and reduction in ≤b was observed after
two weeks at 37±C, regardless of the presence of fluids. This could not be explained by an
increase in crystallinity, which remained constant regardless of conditions. Aging close to
Tg would change the density of the amorphous chains and ultimately reduce the Tg . If aging
is defined by an increase in enthalpy release during DSC scan, aging could not be detected
at ambient conditions.
Table 6.10: Thermal properties of sequential biaxially strained PLLA tubes stored in water at 37±
and vacuumat ambient temperature and in air at ambient conditions for 2weeks. All tubeswere
sequential biaxially strained (1.0;3.2). The DSC scans are summarized in Figure D.7 in Appendix
D.3. Raw data collected from [15]
Tg (±C) Tcc (±C) Tm(±C) Xc (%) ¢Haged
Reference tube 64±0 - 152±0 32±2
In air (1.0;3.2) 65±0 - 152±0 30±3 1±0.1
In vacuum (1.0;3.2) 65±0 - 152±0 28±1 0.3±0.1
In 37±C (1.0;3.2) 68±1 - 152±0 31±1 1.1±0.1
In 37±Cwater (1.0;3.2) 69±0 - 152±0 30±2 1.1±0.3
In 37±C serum (1.0;3.2) 68±1 - 152±0 30±1 1.1±0.1
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It was previously seen that there is no significant difference in stiffness between samples
kept in a dry environment and in serum at 37±C for two weeks. There was a significant
difference in æy both at body temperature and additionally when kept in serum (see Table
6.11). The UTS was unaffected by the fluids, and the significance lies within raising the
temperature to 37±C. This is in agreement with the constant Xc . There is no significance
in endothermic enthalpy during the glass transition (see Table6.10), except for tubes kept
in vacuum, which is significantly lower than for the rest of the tubes. Whether it is due to
an error, or the vacuum prevents the aging from happening is unknown. Had the material
become more brittle as a result of changes in crystallinity over the course of two weeks, the
specimens would have beenmore likely to fracture.
Table 6.11: Mechanical properties of simultaneous biaxially strained PLLA tubes at aged in at
37±C in serum or under dry conditions. All tubes were strained to (1.0;3.2) at 73±C
Eaxial
(MPa)
æy,ax
(MPa)
UTSax
(MPa)
≤ f ,ax
(%)
Eci r c
(MPa)
æy,ci r c
(MPa)
UTScir c
(MPa)
≤ f ,ci r c
(%)
(1.0;3.2) 3021±355 80±5 80±5 39±28 3578±332 74±7 117±15 50±8
(1.0;3.2)
37±C 3226±131 87±4 87±4 33±21 3714±375 79±7 109±12 48±6
(1.0;3.2)
Serum 37±C 3111±229 87±6 87±6 34±24 3650±285 81±6 104±10 45±4
Aging was taken one step further as sequential biaxially strained tubes, were stored in
vacuum for 8 and 18 months. The crystallinity was reduced as a function of aging, whereas
the aging caused the Tg to increase. The area of the endothermic glass transition peak was
three times higher than after sequential biaxial straining. Unfortunately, the mechanical
properties after aging were not evaluated. In conclusion storage at ambient conditions in a
vacuum is not enough to slow down the aging of thematerial and the rate of which it occurs
seems to be related to the aging temperature. Therefore it is possible that the devicemust be
stored at lower temperatures to avoid the aging. Figure 6.35 showed that the Tg of strained
induced tubes increased over the course of 8-18 months. The thermal properties are sum-
marized in Table 6.12. The crystallinity remained constant and showed that the amorphous
chains were not subjected to degradation, and it is expected that the storage of sequen-
tial biaxially strained tubes was sufficient under vacuum. The sequential biaxially strained
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tubes underwent aging over the course of the first 8 months, by an increase in endother-
mic enthalpy from the system (see Figure 6.35), which increase by a 3-4 fold. The aging is
then suppressed, and no further change is detected after 18 months. It is a concern that the
amorphous chains possible relax during this period and no longer are the primary source
of stiffness and strength to the system. Changes in themechanical properties, including the
radial force of an aged stent-base, was not confirmed.
Table 6.12: Thermal properties of aged sequential biaxially strained 16.5Fr tubes stored under
vacuum at ambient temperature for 8 and 18months. All tubes were strained to (0.2;1.2) at 73±C
Tg 1st Tm 2nd Tm Xc ¢Haged
Extruded reference 59±0 110±1 153±0 29±1 -0.4±0
Aged for 8months in vacuum 63±2 117±2 152±1 27±1 -1.7±0
Aged for 18months in vacuum 63±0 111±2 152±1 28±3 -1.7±0.4
Figure 6.35: DSC scan for 16.5Fr tubes which have been aged at ambient temperature under
vacuum for 0, 8 and 18 months. All tubes were strained to (0.2;1.2) at 73±C
It appears that laser cutting and heat treatment reduced the crystallinity, which was not
seen to such extend for heat treated tubes in section 6.4.2.2. Furthermore, the crystallinity
was reduced after two weeks implantation to merely 15%. The effect of aging is very slow
at ambient temperature, compared to body temperature. The Tg increased by 4-5±C after 2
weeks, regardless of being explanted prototypes or under physiological conditions in vitro
for two weeks (see Figure 6.36).
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Figure 6.36: DSC scans for sequential biaxially strained tubes (0.2;1.2) at Tp=73±C, as tubes and
filter prototype 0708 before and after implantation for 2 weeks
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7Analysis: Prototypes
This chapter includes the main prototypes made from expanded PLLA tubes which have
been tested before reaching the final prototype used in the in vivo study. Below is an overview
of the concepts relevant in this project.
7.1 Laser cutting
The laser cuttingwas performed atMeKo (Germany), but the type of laser used in this case is
unknown and kept confidential by the vendor. It is expected that laser cutting increases the
molecular weight (Mw ) by 8%, which was seen when using a CO2 -laser[41]. Additionally,
laser cutting could potentially change the crystallinity locally in some polymers, but it is
not expected to change the crystallinity for PLLA[41]. The tubes used in this study whether
10.2Fr or 16.5Fr have on an average between different lots a Mw =1.95±4kg/mol between
different lots after extrusion. Laser cutting and heat treatment first at 63±C and secondly at
93±C for 5min, respectively, did not affect theMw significantly (see Appendix D.4 Table D.3).
7.2 Concepts
Ideas on the filter or stent-base concepts were not a part of the scope of the project, but
evaluation of them was and is described in section 8.
7.2.1 Concept03
The filter concept was cut from a biaxially strained tube with 9.5 mm in diameter in a par-
allel z-stent configuration (Figure 7.2). It was primarily used to investigate flipping of filtra-
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Figure 7.1: An example of a laser cut stent-base design after the initial heat treatment at 63±C
tion struts after heat-treatment of the material (80±C for 5 min). Two different versions of
the concept were made, one with 0.25 mm strut cut from a tube (0.2;1.6) with Aexp=233%.
Another with a 0.75 mm strut was cut from a tube (0.5;1.9) with Aexp=263% and was heat
treated and scaled up to 15.5 mm in diameter. The stability of the stents was poor in both
concept configurations, but primarily the one with 0.25 mm strut, despite it having a thick-
ness of 0.23 mm as opposed to the 0.75 mm struts, which had a thickness of 0.14 mm. The
main reason for the instability is the end (apices) of the stents, which are free of the z-stent
in parallel. The lowwall thickness in relation to strut width of these filters contributed to in-
stability. Usually, stability would be obtained by an appropriate relationship between strut
width and thickness.
Figure 7.2: Drawing of Concept03 with a 0.75 mm strut width
7.2.2 Concept05
To ensure more stability Concept05 was developed as a diamond shape stent-base config-
uration and up-scaled to 25 mm during heat treatment. Additionally, three filtration struts
were placed at the end of the stent-base, and the remaining three free diamond ends were
cut in a Y-fork (zone B on Figure 7.3). In the Y-fork, it is then possible to mount different
co-polymers for example PCL together with PLLA to createmore elastic filtration struts with
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a better shape memory. The stent-base proved to be fragile and fractured in zone C in Fig-
ure 7.3. It was seen that first heat treating the stent-base just above Tg for 5-10 min would
release stresses within the material causing the apices to point outwards (see Figure 7.4(a))
and additional heating to 95 ±C reduced the stresses further. The apices pointing outward
could facilitate the flipability of the struts.
Figure 7.3: Drawing of Concept05
(a) (b) (c)
(d) (e)
Figure 7.4: Concept05 (see 7.4(a)), Concept0606 (see 7.4(b)) with 6, Concept0608 with 8 cells
(see 7.4(c)), Concept0706 (see 7.4(d)) and Concept0708 (see 7.4(e))
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7.2.3 Concept0606 and Concept0608
Concept0606 was made to improve stability and integrity of the stent-base further. The
apices still had a 40± angle, while the C zone also called the connection point between two
cells was widened horizontally and narrowed longitudinally. It was done to ensure a more
stress-free opening of the cells. The filtration struts were shortened to make a parabolic
shape of the filtration struts when connected as opposed to a sharp conical shape. The con-
cept was made with both 6 circumferential cells (Concept 0606) or 8 circumferential cells
(Concept 0608)(see Figure 7.5). When cut from the same tube and heat treated to the same
diameter the 8 cell concept would have a smaller cell height.
Figure 7.5: Drawing of Concept0608 with 8 cells
7.2.4 Concept0708
Concept 0706 (Figure 7.6(a)) was developed with a wider cell and 6 cells circumferential
to ensure asymmetric circumferential cells in the filtering section. Less spacing was made
between the 6 struts and point inwards as opposed to outwards. Hooks and filtration struts
were added. During implantation, the main concern was risk of migration and therefore
the cells were scaled to the equivalent size with 8 cells circumferentially to ensure better
radial force in Concept0708 (Figure 7.6(b)). The results of the two concepts are shown in
section 8. After heat treatment, the filtration struts pointed outwards, which would help
reduce the risk of migration. The hooks and filtration struts were removed for simplicity,
and the apices were elongated 4 mm forming smaller end struts. These struts were then cut
at an angle to sharpen them with the intend of anchoring the vessel wall and reduced risk
of migration. The filter with 6 cells, in general, showed less radial force what with 8 cells. To
ensure radiopacity two gold markers were shown onto the prototypes with suture.
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(a)
[]
Figure 7.6: Drawing of Concept0706 with either 6 (see 7.6(a)) and Concept0708 with 8 cells
scaled (see 7.6(b))
125
7. ANALYSIS: PROTOTYPES
126
8In vitro results
This chapter reflects on the in vitro investigations done prior to the in vivo study in Chapter
9. It includes both design based on monofilaments and the expanded PLLA tubes and re-
flections on the best possible design and process parameters found most favorable in vitro.
It was seen that it is possible to create a filter based on oriented PLLAmonofilament, but the
idea of a self-expandable stent-base made from a strained tube was more favorable. There-
fore the following section mostly describes the in vitro finding of filters and stent-bases
made from tubing. From the previous findings on choice of processing parameters, such
as processing strain rate (≤˙p ), total area expansion (Aexp ), axial and radial processing strain
degrees (≤a and ≤r ) and processing stain temperature (Tp ), a few were selected and tried in
different designs in vitro.
8.1 Flipability
The concept behind the bioabsorbable filter in this project was based on a conversion from
a fully-functional filter, which opens up and converts into a stent-base. The filtration struts
and stent-base are then most likely embedded in tissue along the caval wall after which
they will degrade. This conversion must not occur before the risk of thromboembolism has
passed. The time frame of which the filter is functional depends on themechanism holding
the filtration struts centered in place. Initial steps in investigating if PLLA the ability to con-
vert from a filter to a stent-base lies in the resistance to permanent deformation over time
and the likelihood of returning to its original shape after heat treatment. The Concept03, as
shown in Figure 7.2 works as a filter, when the filter struts were pinned together by suture.
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Before pinning the distance between the struts was 15mm. The in vitro test of the two filters
with different strut diameter (0.25 and 0.75 mm) and thickness (0.23 and 0.14 mm), showed
the ability of the filtration struts tomove towards its original position in the course of 7 days.
The filtration struts were bonded together with a thin piece of monofilament and kept in a
tube with phosphate buffered solution (PBS) (see Figure 8.1(a)) for first 14 days at ambient
temperature after which the monofilament was cut open. At release, the thinner strut filter
opened up 27% and opened up further to 53% of its original diameter at day 24. The same
was seen for the filter with thicker struts. However the result was less promising. The filter
opened up 13% upon release and 20% after day 24.
(a) (b) (c) (d)
Figure 8.1: Concept03 with a 0.25mm strut cut 8.1(a) and a 0.75mm strut 8.1(b) before immer-
sion in PBS. Figure 8.1(c) show concept at 14 days in PBS after which the conversionmechanism
was triggered and Figure 8.1(d) show the concept after further 14 days
Despite these initial results, the strut flipping ability could be diminished by relaxation
over a longer period of time, inadequate shape memory, proteins attachment or neointima
cell coverage at the transition between filtration strut and the stent-base. It is unknown
which forces apply to the stented vein in vivo as well as the tissue response to the PLLA
device in veins. The latter was examined in the animal study described in section 9.
8.2 Crimping and delivery options
From a procedural perspective, there are limitations on the size of delivery sheath during
implantation. A modified 16Fr Flexor Introducer Sheath (Cook Medical) was used. As the
stent-base was loaded into the sheath, it was crimped down to just below 6 mm. Figure 8.2
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loading of the stent-base into the sheath. To mimic the result of such delivery on the in-
tegrity of the device, the stent-base was crimped to 6 mmmultiple times in a compression
station (Figure 8.3). It is clear from Figure 8.4(a) shows that the first crimp reduces the di-
ameter from the pre-set diameter of 27 mm to 24 mm. The stent-base should therefore not
be used in IVC with a diameter close to 27 mm. It should be noted that the deviation is very
low between the two samples. As the crimping continues the diameter change reaches a
plateau and additional crimping does not reduce the diameter further, and the stent-base
should not be used in a vein of diameters above this plateau. The safeness of the stent-base
was only evaluated in vivo in veins up to 19 mm in diameter. The stent-base was able to
regain its initial expanded diameter of 27 mmwhen heated to 93±C after crimping. It shows
that heat treatment provided the stent-base with shape memory at 93±C. As seen from Fig-
ure 8.4(a) the first step of the heat treatment at 63±Cwas not enough tomake the stent-base
unfold. This subsequent treatment experiment was not repeated for multiple stent-bases
and is only an indication of the shape memory created at heat treatment, but not further
investigated.
Figure 8.2: Loading of stent-base in delivery sheath
(a) (b)
Figure 8.3: Crimping of stent-base in compression station
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Figure 8.4: Outer diameter (OD) of the stent-base after 5 times of crimping (n=2). Subsequently
the stent-base was then first heated to 63±C for 5 min and then at 93±C for 5 min
8.3 Radial force of stent-bases
8.3.1 Braided filter from oriented PLLA
A filter was braided from the oriented PLLA monofilament (OD 0.36mm ) from Zeus (see
Figure 8.5) with the diameter of 28mm, stent-base with 40 mm in length (A) and filter cone
with the length (B) 28 mm. The filter was heat treated at 85±C for 20 min. After radial force
measurement, the filter was permanently elongated to A=96 mm and 25 mm in diameter.
After slowly reheating the filter showed a tendency to retract to its original length and di-
ameter. The first cycle of the radial force test (Figure 8.6), showed uneven crimping of the
stent-base, but an even crimping at the second and third cycle. There is little difference be-
tween the second and the third cycle. The monofilament would after heating between 80
and 90±C exhibit a modulus (4.9-5.7 GPa) and UTS (338-350MPa) far beyond what has been
obtained for a sequential biaxially strained PLLA tubes (4 GPa). The maximal radial force of
the braided stent when crimped down to 6 mm was less than 9 N and in a 15 mm vein, the
filter would exert a radial force of 1.0 N. In comparison the Concept0708 PLLA stent-base of
straine PLLA implanted in the animal study exerted a radial force of 2.3 N when crimped to
15 mm (discussed later in Figure 8.8(b)).
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(a) (b)
Figure 8.5: Braided filter made from oriented PLLA (Zeus) before and after crimping to 6 mm
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Figure 8.6: Radial force of braided filter from PLLA oriented (Zeus) crimped from 30 mm to 6
mm
8.3.2 Radial force of stent-bases from strained tubes
8.3.2.1 The influence of number circumferential cells
The Concept0606 showed less radial force (Figure 8.7(a)) than Concept0608 (Figure 8.7(b)).
Concept0606 showed an even lower radial force atmaximal crimping (6mm) than the braided
PLLA sent (Figure 8.6). Both Concept0606 and 0608 showed a radial force in a 15 mm diam-
eter vein of nearly 2 N and therefore perform somewhat better than the braided stent. The
initial diameters for Concept0606 and 0608 were 25.3 and 25.5 mm and after three cycles
of crimping were down to 20.5 and 22.3 mm. Therefore such devices, should not be used
in IVC with diameters above that. The concept with 8 cells provided a larger radial force at
each crimp, but the radial force a stent-base exerts on the wall (the bottom part of a cyclic
curve during the unloading), is no different than for a stent-base with 6 cells. In general,
the stent-bases cut from strained tubes, showed a greater radial force as they open up upon
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uncrimping. Their ability to stay in place in the vein could be greater during compression
and un-compression by the vein.
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Figure 8.7: Radial force of Concept0606 (8.7(a)) and Concept 0608 (8.7(b)) when crimped from
original OD to 6 mm
8.3.2.2 The influence of processing temperature and strain degree
Themechanical properties for tubes tensile tested circumferentially improved as a function
of Tp . This phenomenon is also seen for the final stent-base device, which showed a higher
radial force at the first time of crimping at Tp=93±C than Tp=73 ±C. It was also seen that
the larger the axial strain during processing, the more permanent deformation is detected
at the second cycle. From the radial force measurement, it is shown that stents made from
tubes (0.3;1.2) strained at Tp=93 ±C recover after 3 crimping cycles (Figure 8.8). During the
first step of heat treatment (T=63±C) the (0.6;1.4, Tp=93 ±C) stent-base coiled up (Figure
8.9(a)). It appears as if the stress build up during the axial strain is released. Despite the
additional heat treatment at 93±C the shape remained so. The loss in integrity causes an
uneven crimping of the stent-base, which is unfavorable during loading of the device. As
for the (0.3;1.2,Tp=93 ±C) more integrity of the device is kept during heat treatment, but
integrity is best kept for the (0.3;1.2, Tp = 73 ±C) stent-base. The tubing used for (0.6;1.4,
Tp=93 ±C) came out slightly thinner, and the resultant radial force would, therefore, be less.
8.3.2.3 EO sterilized stent-bases
Figure 8.10 shows that for both (0.3;1.2) strained at 73 and 93 ±C, EO sterilization at 53 ±C
for 8 hours increase the radial force of the material. This corresponds well to that fact that
the elastic modulus as well as æy increased after sterilization for the sequential biaxially
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Figure 8.8: Radial force of Concept0708 from sequential biaxially strained tubes at two different
Tp and at (≤a ;≤r )
(a) (b) (c)
Figure 8.9: Concept 0708 processed at different Tp and (≤a ,≤r ) after which they were heat sat at
93 ±C. 8.9(a) and 8.9(b) were strained at 93±C with a (≤a ,≤r ) of (0.6;1.4) and (0.3;1.2) respectively.
8.9(c) was strained at 73±C with a (≤a ,≤r ) of (0.6;1.4)
strained tubes. It is a rather small increase for Tp at 73±C. Tubes with a larger axial strain
(0.6;1.2) strained at 93 ±C showed a greater radial force (Figure 8.10(b)) than its counter part
with a smaller axial strain (Figure 8.10(c)). Sterilization of tubes with a larger axial strain
showed a greater radial force before sterilization. Sterilization did not induce a greater radial
force as seen for tubes with an initial smaller axial strain. The axial strain determines if the
chains can gainmobility and become ordered during 8 hours of sterilization. For this reason
(0.6;1.4), were not used for further animal testing.
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Figure 8.10: Radial force of Concept0708 from sequential biaxially strained tubes at two differ-
ent Tp and at (≤a ;≤r ) before and after EO-sterilization.
8.4 Fatigue properties
The diameter of an IVC is influenced by the respiratory cycle, and the external stresses ap-
plied onto the vein by organs. Some IVC filters placed today, does not allow the collapse
of the IVC, whereas others do, depending on their radial force. A polymeric IVC filter will
have inferior properties compared to metals and will most likely not prevent the vein from
collapsing. It will be compressed with the vein, which appears more natural than keeping
the IVC open at all times. A device which is under continuous cyclic loading will, therefore,
need excellent fatigue properties to withstand the cyclic loading. An investigation of fatigue
properties weremodeled by finite element analysis as described in section 8.4.1 for Concept
0708 stent-base made from strained PLLA with a wall thickness of both 0.8 and 0.4 mm and
evaluated by cyclic flat-plate compression as described in section 8.4.3.
8.4.1 Finite element analysis (FEA)
Finite element analysis (FEA) was done in order to identify at which point of interest the
stent-base was most likely to fracture. The analysis was supplied from Cook Research Inc.
by Shuo Yang (CAE analyst).
FEA was used to investigate stress distributions under compression throughout the ge-
ometry of the stent-base and their displacement, and where fractures were likely to occur.
The UTS was set to 100 MPa and wall thickness to 0.4 or 0.8 mm. Under normal conditions,
the collapse index (CI) or compression degree on the vena cava has been reported between
20-35% [27]. CI is defined by the diameter upon expiration minus the minimal diameter on
inspiration divided by the diameter on expiration. For the calculation, a vena cava diameter
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of 15 mm was assumed with a compression to 9.8 mm and CI was set to 35%. The com-
pression model was a flat-plate station, representing an open and compressed state of the
stented vein (Figure 8.11(a)). There was no real difference between the model for the differ-
ence in wall thickness. The analysis showed that the stent-base is most likely to fracture in
the middle of the device indicated by the red zones and near the connection points (Figure
8.11(b)).
(a) (b)
Figure 8.11: Finite element analysis (FEA) of Concept0708 in a flat-plate compression model.
Figure 8.11(a) shows the stent-base compressed between the plates representing the collapsed
state. Figure 8.11(b) shows the side of the stent-base not in contact with the plates and where,
the most stressed zones (red) are presented.
8.4.2 Cyclic testing of single-cells
Test specimens consisting of a single stent cell were laser cut from the same tube as their
corresponding filter design, Concept0608 and 0708.
8.4.2.1 The influence of post-processing parameters and sterilization
After the first initial 10-15 cycles, the area underneath the load-extension curve increased
for some specimens, showing a large degree of noise. Figure 8.12(a) showed that the lager
cell width in Concept0708 ensures that the material is relaxed slightly quicker than in Con-
cept0608 and energy to compress the cell is reduced with the first five cycles. More variation
is seen for Concept0608 but on average preforms better than Concept0708. Heat treatment
for the permanent set should not be done at temperatures too close to Tcc , but seemed to
be beneficial for up to 15 min (Figure 8.12(b)). The influence of EO sterilization at 53±C
proved to reduce the resistance to compression slightly faster than the non-sterilized spec-
imens (Figures 8.12(c)), which was not in accordance with the radial force of stent-bases
after EO sterilization. It also showed slightly more influence on the specimens which were
made from sequential biaxially strained tubes at higher axial strains. The limitation of the
135
8. IN VITRO RESULTS
method is the large variation between test specimens. In retrospect, the stent-base could
benefit from the Concept0608, which both showed a higher radial force than Concept0708
and proved to resist permanent deformation slightly better on single cell testing.
(a) (b) (c)
Figure 8.12: The are underneath the load-extension curve for single-cell specimens under cyclic
compression to 50% their initial height. The influence of a wider cell (8.12(a)), where 0708 has
the widest. The influence of heat treatment temperature and duration for low and high Tp
(8.12(b)). The influence of EO sterilization (8.12(c)) on tubes with a high or low degree of ax-
ial strain during sequential biaxial strain at Tp 93 ±. An example of teh load extension curve can
be found in Appendix D.6 in Figure D.9
Figure 8.13: Cyclic compression of single stent cells processed at different ≤˙p , ether 5 mm/s or
100 mm/s and different (≤a ;≤r ). Raw data provided by [14]
The width of single stent cells, the degree of axial strain (≤a) and the axial processing
strain rate (≤˙p ) was previously investigatedusing the samematerial and expansion technique[14].
The test was performed on single stent cells from Concept 0706 with a cell width of 24 mm,
whereas Concept0708 had a width of 21 mm and were compressed 50% of its original cell
height for 50 cycles. The greatest compressional force is seen for the wider cell width at high
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axial processing strain rate ≤˙p (Figure 8.13). The trend is less apparent for the shorter cell
width, and the investigation would have benefited from several samples in stead of just one,
as portrayed in [14]. The ≤a has more affect on the wider cell width regardless of≤˙p . The re-
sults were in alignment with what was seen in this project, where the circumferential tensile
stiffness and strength (Table 6.3) and for the radial force of stent-bases (Figure 8.8) benefits
from lesser ≤a as well as a high ≤˙p .
It has previously been shown that single stent cells made from the same tubing and pro-
cessing parameters fracture in the same regions (connection points) as the stent-base[15]
at ambient and physiological conditions. For that reason, one could argue that single stent
cell is a good model for the whole stent-base (see Figure 8.14). During a static compres-
sion setup in water, the single stent cells would deform and fracture sooner than in ambient
conditions[15]. The result was unexpected as the stent-base which in one instance showed
fractures at ambient conditions at the connection point, but it never fractured under physi-
ological conditions (described in section 8.4.3). The presence of water is therefore not opti-
mal unless at body temperature.
(a) (b)
Figure 8.14: Fractured single stent cell after cyclic testing for ∏4000 cycles under ambient and
physiological conditions. Used from [15]
8.4.3 Cyclic testing of stent-bases
Concept06 Concept0606 with 6 cell was the first device to be tested in a hard silicone tube
(3.7 mm thickness) which fractured after less than 150.000 compressions of 30% of initial
OD (see Figure 8.15(a)). For this reason, the concept was made with 08 cells instead, which
also showed a higher radial force.
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(a) (b)
Figure 8.15: Fractured Concept0606 and Concept0708 after cyclic compression in dry condi-
tions.
Concept0708 The diameter after delivering the stent-base using a 6mm sheath went from
27.2 mm to 24.2 mm (see Figure 8.16(a)). Cyclic compression 150.000 times in water at 37
±C in a soft silicon tube (OD=19mm, t=0.45 mm) the stent-base was slightly elliptical with a
diameter of 19.2 and 23.2 mm (see Figure 8.16(b)). When testing under ambient conditions,
the stent-base fractured in multiple places (see Figure 8.15(b)) and therefore the water and
rise in temperature softens the material. This was in disagreement with single stent cells
tested under the same conditions[15].
(a) (b)
Figure 8.16: Concept0708 with 8 cells before (8.16(a)) and after (8.16(b)) cyclic compression
150.000 times. Both stent-base were compressed previously in a 6 mm sheath.
Stents cut from tubes at different strain ratio (≤a ;≤r ) not only influenced the radial force,
but also the permanent set under cyclic testing as seen in Figure 8.17. The (0.3;1.2, Tp=93
±C) stent-base had an initial OD of 21.8 mm after radial force testing, after which it under-
went 150,000 times compression (30%) resulting in an elliptical form (Figure 8.17(c)) and
the final OD was 23.3 and 19.63 mm. The (0.3;1.2, Tp=93±C) had similar initial OD of 21.1
mm, which was transformed into 24.1 and 18.5 mm and therefore slightly more susceptible
to permanent set (Figure 8.17(b)). This is in correlation with its poorer radial force as well.
(0.3;1.2 Tp=73±C had a slightly larger OD initially (23.6 mm) after radial force testing, but
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behaved similar to (0.3;1.2, Tp=93±C) with a final OD of 24.1 and 18.7 mm.
(a) (b) (c)
Figure 8.17: Concept07 with 8 cell after cyclic compression 150.000 times in water. Figure
8.17(c) was sequential biaxially strained at Tp=73 ±C at the strain ratio of (0.3;1.2). Figure 8.17(b)
and 8.17(a) Tp= 93 ±C at the strain ratio of (0.3;1.2) and (0.6;1.4) respectively.
8.5 Implantation ex vivo
Figure 8.18: Concept0708 placed in swine IVC ex vivo.
To determine the risk of migration during implantation, the stent-bases were deliv-
ered in swine cavas ex vivo. The swine cavae diameter ranged between range 18-23 mm
and therefore in the range, where this particular stent-base after sterilization is possible to
use. The stent-base was successfully deployed, and it was not possible to push or pull the
stent-base from the deployment site. From Figure 8.18 it was seen that the stent-base over-
expands the vessel limiting the risk of migration.
From the above findings, it was seen that Concept0608 and Concept0708 were possible
designs to continue with in the in vivo study. In terms of processing, a high ≤a was not
preferable, as tension was built up in the material and heat treatment made the stent-base
139
8. IN VITRO RESULTS
coil up. It also appeared that the ≤˙p must be high in order to obtain the highest compression
resistance and in coherence with section 6.2.7, wherein it was seen that the higher the ≤˙p
the greater the stiffness and strength. Additionally, the highest radial force would be seen at
Tp closer to Tg instead of close to Tcc . Sterilization was shown not to have a negative effect
on the radial force of the stent-base.
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In the attempt to evaluate the selected material and prototype as well as the fabrication
methods an animal study on three sheep was performed July-August 2015 at the Veterinar-
ian School of Purdue University (West Lafayette, Indiana, USA) in collaboration with Cook
Research Inc.
Objective Firstly, the main objective was to characterize the tissue response to a PLLA
stent-base in the veins. Secondly, the goal was to determine how long such a device must
hold radial force and withstand permanent deformation under cyclic stress before loosing
its strength. Thirdly the goal was to evaluate device integrity after implantation.
9.1 Summery of animal study and protocol
The study was set up to run over the course of 8 weeks, with termination points after 2, 4
and 8 weeks. The study was terminated earlier than expected due to loss of device integrity
(multiple fractures of the stent-base). Therefore the investigation of the mechanical perfor-
mance of a diamond shaped self-expandable bioabsorbable PLLA stent-based in vivo was
evaluated after 2 and 31/2 weeks. The sequential biaxially strained PLLA tube (0.3;1.2) was
obtained using the parameter shown in Table E.1 in Appendix E. The tube was laser cut as
Concept0708 and thermally expanded to 27 mm to accommodate larger vessel sizes. After
sterilization and loading, the stent had an OD of 24 mm. During the procedure, radiogra-
phy was used to identify device location at implantation, interim and termination points,
whereas venogram was used to evaluate vessel patency after implantation and at termina-
tion points. Venograms were only used at implantation and before termination to protect
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the animal from overexposure to contrast media. Histology of explants was conducted at 2
and 31/2 weeks to evaluate tissue response using hematoxylin and eosin stain (H&E) staining
as well as fluorescent antibody staining.
(a) (b)
Figure 9.1: Crimping of stent-base before (9.1(a)) and after (9.1(b))with stent crimper (Qual-
crimp) from Edwards Lifesciences
9.1.1 Implantation
To load the stent into the delivery sheath, a portable stent crimper was used rather than
loading it by hand. Despite successful loading and implantation during the proof of con-
cept twomonths prior in two sheep and in vitro, unexpectedly loading appeared difficult at
the time of the animal study. Table 9.1 show that the stent-bases used for this study, unfor-
tunately, showed amuch larger thickness variation from top to bottom than previously seen
for 16.5Fr tubes (see Figure 6.34). It was not possible to determine why the batch of tubes
strained for the animal study showed a larger variation. During loading of the first three
devices, fractures occurred during loading with a stent crimper, which was unable to crimp
the whole stent at a time. Due to this uneven loading and the variation in thickness along
the stent-base, it fractured at the place of most stress near a connection point. None of the
fractured stent-bases were used in the animal study. To prevent the remaining stent-bases
from fracturing, they were heated in 37±C saline prior to loading after which no fractures oc-
curred. This also corresponds to what was seen with the in vitro cyclic compression where
water and rise in temperature prevented it from fracturing. It is however not ideal that the
material is that sensitive to temperature. To minimize the risk of fracture during uneven
loading into the sheath the stent was slowly crimped using a crimping station (Figure9.1)
and loaded into the sheath with the thickest end first.
142
9.2 Article: Evaluation of a bioabsorbable self-expandable vein stent-basemade of
Poly(L-lactide) in vitro and in vivo
Prior to implantation the diameters of the vena cava were measured in right and left
anterior oblique, RAO and LAO, and anterior-posterior projection (AP) for determination
of implantation site. The vein sizes before and after implantation, where the stents were
approximately placed are listed in Table 9.1. Three adult sheep at the ages of 1-3 years were
used for the study. Anesthesia was applied using isoflurane (1-5%) by intubation and 100-
300 IU/kg of heparin was administered intravenously to avoid clotting. Vein access was
obtained by a cut-down of the jugular vein, and a 16F sheath was introduced. One stent
was placed above, and one stent was placed below the renal veins in the IVC of each animal.
After implantation position and vessel diameter was confirmed by radiography (see Table
9.1).
9.2 Article: Evaluationof abioabsorbable self-expandable vein stent-
basemade of Poly(L-lactide) in vitro and in vivo
An overall evaluation of the outcome of the animal study is written in article ’Evaluation of a
bioabsorbable self-expandable vein stent-base made of Poly(L-lactide) in vitro and in vivo’
in this section (9.2). It does not contain all results based on the animal study. Further details
on implantation and follow-up and tissue response by H&E and confocal imaging are found
in section 9.1.1, 9.2.2 and histology 9.3 below.
The Figures and Tables are listed towards the end of the article starting with Figure 1 and
Table 1.
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Main text:  2395 words (max 2400) 
Abstract  
Purpose: This study was designed to evaluate performance and tissue response to a mechanically improved self-
expandable bioabsorbable stent-base in vitro and in vivo. 
Methods: A diamond-shaped stent-base (OD=24mm, L=50mm) was cut from a sequential biaxial strained poly(L-
lactide) (PLLA) tube for optimized performance. The performance of the stent-base was evaluated in a finite element 
analysis and attempted validated in vitro through a cyclic flat-plate compression and radial force measurement. The 
performance of the stent-base was tested in vivo using 3 sheep with 2 implants each for 2 and 3½ weeks.  
Results: In vitro the stent-base showed an elliptical deformation but no fractures. In vivo the stent-base showed 
adequate radial force and no migration. All implanted stent-bases showed multiple fractures not only at the predicted 
stress zones but at all connecting points. Fragments of the caudal stayed in the vein wall indicating sufficient tissue 
coverage to avoid embolization of the fractured stent pieces, whereas fragments from the cranial device were few. 
Neointima formation was confirmed on histology at 2 and 3½ weeks.  
Conclusion: A bioabsorbable self-expandable stent-base made from PLLA for large veins seems feasible however over 
time the PLLA used in this study appears too stiff and lacks the sufficient flexibility to move with the vena cava causing 
multiple fractures.  
Keywords: self-expandable, IVC filter, bioabsorbable, PLLA, poly-(L-lactide) 
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Introduction 
Permanent metal devices, such as the inferior vena cava (IVC) filter, have been implanted on numerous occasions in the 
prevention of pulmonary embolism [1-3]. Long-term complications such as vena cava are perforation, migration and 
reoccurring deep vein thrombosis (DVT) [1] can be avoided using an IVC temporary filter. Retrieval rates of implanted 
filters can be as low as 21%  [4]. To overcome the complications related to the retrieval procedure, the need for a fully 
bioabsorbable IVC filter becomes of interest. The previous attempt to create a bioabsorbable filter include using the 
bioabsorbable polycaprolactone (PCL), an elastomer, as a stent-base  with an outer diameter (OD) of 18mm for an IVC 
filter base and poly(L-lactide-co-glycolide) as bioabsorbable filter cone, however their device resulted in migration[5]. 
Another IVC filter was made of polydiaxone (OD=20mm), a suture which exhibits good mechanical properties for 35 
days without migration; however, the device was not self-expandable [6]. 
Previous work on bioabsorbable stents focused on balloon-expandable designs with a diameter (OD = 3-10mm) [7-14]. 
These were only for arterial indications and therefore not applicable for large size veins [15]. Poly(L-lactide) (PLLA) is 
prominent bioabsorbable polymer, which has been widely investigated in medical applications  and as a candidate for a 
bioabsorbable IVC filter [16,17]. It has also been used in the BVS vascular stent (Abbott Vascular, Santa Clara, CA) 
and the Igaki-Tamai stent (Igaki Medical Planning Company, Kyoto, Japan, [12,18].  
Self-expanding stents require an adequate radial force (RF) to maintain its position in the lumen with no migration and 
must have resistance to permanent deformation [7]. Stents made from PLLA have inferior mechanical properties to 
those of metals and both radial force and resistance to a permanent deformation is low. PLLA can however be induced 
to have a greater stiffness, and provide greater resistance towards permanent deformation by straining the polymer 
above its glass temperature and thereby aligning its molecular chains [19-21]. The scope of this study was to evaluate 
the performance of PLLA used as a self-expandable PLLA stent-base (outer diameter = 24mm) in an IVC filter in vitro 
and in vivo.  
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Materials and methods: 
Stent material and design 
A PLLA stent was made from sequential biaxial straining (SEQ) previously described [22] using PLLA 2003D tubes 
(NatureWorks LLC, Minnetonka, MN) and expanded from 5.5 to 10.5mm. The tube was laser cut in a diamond-shape 
pattern (8 cells circumferentially) (Fig. 1) and thermally expanded to 27mm and sterilized with ethylene oxide. To 
ensure visibility under x-ray gold markers were sutured on the stent.  
Cyclic compression and radial force (RF) 
Finite element analysis (FEA) was used to investigate stress distributions under a parallel flat-plate compression 
mimicking load from organs and the diaphragm on the vena cava. Ultimate tensile stress (UTS) was set to 100MPa [23] 
and wall thickness to 0.8mm. Under normal conditions, the collapse index (CI) or compression degree on the vena cava 
has been reported between 20-35% [24]. CI is defined by the diameter upon expiration minus the minimal diameter on 
inspiration divided by the diameter on expiration. For the calculation, a vena cava diameter of 15.0mm was assumed 
with a compression to 9.8 mm and CI was set to 35%.  
For in-vivo testing the stent was placed into a silicone tube (OD=19mm, 0.46mm wall thickness) in water at 37°C and 
compressed (30%) using a moving flat-plate for 150,000 cycles, corresponding to 21,600-28,800 breaths per day [25]. 
The RF measurement was done in air at 37°C using an automated radial force tester from an expanded state to 6mm at a 
rate of 0.5mm/sec three times.  
Animal study 
Three adult sheep (1-3 years of age) were used as the animal model. Intubation anesthesia was applied using isoflurane 
(1-5%)(ca 1.5−2.5 L/min). A cut-down on the jugular vein was used for access and a 16F sheath was introduced into 
which 100-300 IU/kg of heparin was administered. One stent above and one stent below the renal veins were implanted 
into the IVC of each animal. Diameters of the vena cava were measured in right anterior (RAO) and left anterior (LAO) 
projection before and after stent implantation and listed in Table 1. Accurate placement and vein patency were 
confirmed by venography. Additional venography was performed 2 weeks after implant.  
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At 1 week and 2 weeks post implant, interim radiography without contrast was performed to evaluate the stent position. 
One animal was sacrificed after 2 weeks and 2 animals after 3½ week. The vena cava was perfusion fixated using 
buffered 10% formalin solution before harvesting. The fixed specimens were then examined with MRI to evaluate the 
integrity of the stents. 
Tissue examination:  
Half of each explant with the stented vein was embedded in paraffin using routine techniques, cut at 5µm, and stained 
with haematoxylin and eosin (H&E). The other half was used for confocal imaging. For optimal confocal imaging the 
explanted tissue was cleared to ensure greater visibility by incubating the tissue in solutions of gradually increasing 
fructose concentration [26]. D-(-)-fructose (JT Baker, Center Valley, PA) was dissolved in milliQ water with 0.5% α-
thioglycerol (Sigma-Aldrich St. Louis, MO) at various concentrations (20, 40, 60, 80, 100% wt/vol and 115% wt/wt) as 
described previously [27], where explanted tissues were incubated in each solution for 12-24 hours under gentle 
rocking. 
For antibody staining, the fixed tissue was rinsed in phosphate buffered saline (PBS) blocked with 10% donkey serum 
in 0.2% bovine serum albumin (BSA) and permeabilized with 0.2% TritonX-100 overnight. Tissue was incubated with 
a primary antibody against fibrinogen (1:100, Abcam, ab 119948), diluted in 0.2% BSA and PBS, for 2 days at 4°C 
then rinsed 3x30min. Samples were next stained with secondary labeling reagents for nuclei (DAPI, 1:500, 
LifeTechnologies), actin filaments (AF488 conjugated phalloidin, 1:100 LifeTechnologies), and AF555-conjugated 
anti-mouse secondary antibody (1:500, LifeTechnologies) for 2 days at 4oC, then rinsed 3x30 minutes and stored at 4oC 
until imaged. 
To increase the optical resolution and the contrast of the probe, a spatial pinhole was placed at the confocal plane of the 
lens to eliminate out-of-focus light. Tissue samples were imaged with an inverted confocal laser microscope (710 LMS, 
Zeiss, Germany) with laser wavelengths from 405 to 639nm. Images were obtained as 1024x1024 pixels with ZEN 
2011 software and taken as a best compromise between overlaid laser wavelengths.    
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Results: 
Radial force and fatigue testing 
The RF was highest after the first crimp and reduced slightly during the second and third crimp (Fig. 3). The stent in the 
physiological procedure would be crimped into the loading sheath (16Fr) and self-expand into the vessel of a given size. 
In the in vivo study, the average diameter was approximately 15-16mm and the stent would, therefore, exert an RF of 
approx. 2.8N on the vessel.  
The fatigue performance of the stent was evaluated by a flat-plate crush analysis, both theoretically by finite element 
analysis (FEA) and in vitro. The FEA results (Fig.2) show that the critical fatigue locations are found at the connection-
points on the side of the stent during compression. The critical fatigue locations in the red zone would be expected to 
fracture first, if physiological loading exceeds the capabilities of the newly-deployed stent. Neither crimping nor flat-
plate compression in vitro demonstrated a fracture of the stent.      
During crimping the stent was permanently deformed from 28 to 24mm after being circumferentially compressed into a 
16Fr sheath while maintaining its circular shape (Table 2). During compression, the stent deformed permanently from 
circular to elliptical. This is due to the fact that water or physiological fluids acts as a plasticizer and ultimately makes 
the polymer stent softer and more susceptible to a permanent set [28]. 
Imaging  
The gold markers were at the same location in all animals after implantation, at 1 week and after 2 weeks. The position 
of the gold markers confirmed a stable position of the stent without migration. Venogram confirmed patency after 2 
weeks (1 animal). The vena cava diameter was smaller than before implantation and was likely due to different 
positioning of the animal and could not be used to determine the integrity of the device. MRI images of explants after 2 
weeks illustrated numerous fractures which were visually confirmed by light microscopy. A representative section of 
the vein had 13 fractures (see Fig. 4a) after 2 weeks and similar section had 18 fractures (see Fig. 4b) after 3½ weeks. 
The fractures occurred at the connection-points and between cells adherent to each other. The cranial devices at both 
time points were minimally intact and only a few pieces remained at the site of implantation, whereas the fractured 
caudal devices remained in the vessel.  
Histology  
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After 2 and 3½ weeks the struts were closely apposed to the lumen surface and were covered by neointima with a 
thickness of 20-100µm and 100-300µm, respectively (Fig. 5). The neointima was composed of loosely-arranged 
spindle-shaped cells and fibrovascular tissue with some fibrin. At 2 weeks some struts were covered with a single cell 
layer of endothelium, and after 3½ weeks most struts were covered with neointima and endothelium. At both time 
points, inflammation was minimal and composed of a few macrophages immediately adjacent the struts and few 
lymphocytes in the adjacent neointima. At the attachment sites between struts, vein wall smooth muscle cells were 
minimally vacuolated, suggesting mild focal pressure change. 
Confocal imaging  
Confocal imaging was used to visualize the newly formed tissue around the connection-points without disrupting the 
tissue. It has the advantages of visualizing both the strut surface facing the lumen and the sides of the strut covered with 
neointima. The images showed cellular ingrowth around and in the connection-points by either neointima nuclei (blue) 
or actin-filament (green) (Fig. 6). Fibrinogen (red) covers both the struts in (Fig. 6a and b) and connection-points (Fig. 
6c).  The neointima around a strut that has fractured at the connection-point measured between 70 µm (top of the strut) 
and 120µm (on the right side) (Fig. 6a). The actin-filaments occur only in the top cell layer (40-66µm) on the sides and 
are aligned along the strut. At the fracture tip of the strut, the actin-filaments are randomly oriented.  
Discussion 
One of the major concerns regarding a bioabsorbable polymeric IVC filter is the risk of migration, which has been 
detected previously [5].  It was hypothesized that a stent-base for an IVC filter can be made from PLLA tubing, which 
has undergone an SEQ process above glass transition. It would exhibit enough strength to prevent migration, yet 
flexible enough to withstand continuous cyclic compression from the vein. The stent-base was successfully crimped and 
delivered to vena cava with no migration upon implantation. Over the course of 3½ weeks, the RF was found adequate 
to prevent device migration. In vitro test findings predicted that the stent-base would become soft in vivo due to cyclic 
compression at the physiological conditions and become permanently deformed. Due to lack of device integrity, it was 
not confirmed if the stent-base was elliptical in vivo instead of circular.  
The overall inflammation response to the PLLA stent was minimal. Both H&E and confocal imaging showed fewer 
smooth muscle cells in the vein wall under the stent suggesting a mild focal fibrosis due to the oversized stent and 
resultant focal compression. Confocal imaging made it possible to visualize the tissue coverage around and in the 
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connection-points, which was not possible to determine by H&E. The vessel diameter ranged at implantation from 14-
19mm and therefore some stents were stressed more than others. However, the number of fractures within a stent did 
not correlate to the vessel diameter pre-implantation and post-implantation. Caudal devices were best more intact in the 
smaller vessel than the cranial devices.  
Though in vitro tests did not reveal any fracture of the stent-base, MRI and light microscopy confirmed that multiple 
fractures occurred at those sites where FEA predicted to be critical. Without the device being intact, it would not be as 
stressed in the same nature as the FEA prediction and no additional fractures were expected. Additionally, the device 
continued to fracture circumferentially at every connection-point. The fractures of the caudal device likely occurred 
after tissue coverage adequately covered the stent. 
PLLA is a brittle polymer and this particular stent-base is not flexible enough to move with the vena when the 
connection-points are covered in tissue, leading to multiple device fractures. For a stent to successfully survive cyclic 
compression it would have to be made more flexible, but still induce enough radial force to avoid migration.  
Conclusion 
A bioabsorbable self-expandable stent-base made from PLLA tube was successfully delivered in an ovine vena cava. 
The tissue response and radial force were found adequate to prevent device migration. However after two weeks, the 
explants had multiple circumferential fractures in the specific locations predicted by the FEA. The tissue response did 
not cause vessel narrowing and was sufficient to lock the stent in place. This particular PLLA stent-base did not have 
the flexibility to move with the vessel after tissue coverage. The locked circumferential stent cells fractured resulting in 
stent failure.  
Ethical approval: All applicable international, national, and/or institutional guidelines for the care and use of animals 
were followed. 
Conflict of interest: Studied sponsored by William Cook Europe as a part of the Industrial PhD Program. 
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Fig. 1 Lasercut PLLA stent 
  
Fig. 2 Fatigue safety factor contour plot during a flat-plate compression of diamond shape stent design based on 
FEA. Red is the most stressed areas of the stent  
Fig. 3 RF testing at 37°C dry. Crimped from 30mm to 6 mm at of 0.5s/mm. n=1 is the number of stent-bases 
tested.  
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a b 
 
Fig 4. Representative light microscopy (0.75x) of explanted caudal stent-bases and vein after 2 weeks and 3½ 
weeks. The box on the outside is zoomed in (3.2x) 
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Fig. 5 Representative images of H&E stain of PLLA stent-base (S is the PLLA strut) in vena cava after 2 weeks.  
Struts are surrounded by loosely arranged fibrovascular tissue (neointima ↔) that contained small amounts  of 
fibrin and a few inflammatory cells (macrophages and lymphocytes). Furthermore the struts are partially 
covered by endothelium. Smooth muscle cells in the adjacent vena cava wall are minimally vascoulated.  
 
Fig. 6 Representative confocal images of optically cleared specimens after 3½ weeks, where the normal vector to 
the plan (longitudinal-circumferential) is luminal. (a) and (b) show surface of a fractured strut. (c) show a 
connection-point covered in nuclei and fibrinogen (10x). Nuclei are represented by blue, actin-filaments by green 
and fibrinogen by red. The single headed arrows show sides with fewer nucleuses at the corners of the strut. The 
double headed arrow show the neointema. The box show the muscle/adventitial layer.  
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Animal Device Pre-diameter 
RAO/LAO (mm) 
Post-diameter 
RAO/LAO (mm) 
2 week Cranial 15.9/13.8 17.3/18.0 
 Caudal 18.3/19.2 15.8/16.6 
3½ week (1st) Cranial 16.8/12.5 16.3/15.7 
 Caudal 19.3/18.2 17.9/18.3 
3½ week (2nd) Cranial 14.6/15.4 14.4/16.3 
 Caudal 16.0/16.5 16.1/19.1 
Table 1 Placement and position, diameter pre- and post-implantation from right anterior (RAO) and left 
anterior (LAO) position  
 
Compression  
method 
 OD(mm) before  Upon release 
ODtop (mm) 
Upon release 
ODside (mm) 
Shape after 
1. Circumferential 
crimping 
Delivery sheath n=2 28.1±0.6 24.6±0.4 24.6±0.4 Circular 
2. Flat-plate  
compression 
Wet at 37°C n=1 24.2 20.4 27.2 Elliptical 
Table 2 Diameter before loading into delivery sheath and after release from loading (1). Additionally diameter 
before stent base was delivered into a silicon tube and after cyclic flat-plate compression under physiological 
conditions at 37°C (2). n is the number stent-bases tested. ODtop is the distance from top to bottom which was in 
contact with the flat-plate, and ODside is the distance from one side to another not in contact with the flat-plate 
 
9.2 Article: Evaluation of a bioabsorbable self-expandable vein stent-basemade of
Poly(L-lactide) in vitro and in vivo
Table 9.1: Animal ID, prototypes number, placement in animal, the IVC diameter before and
after placement fromRAO and LAO view and the average thickness tav of the prototypes at each
end used in animal study
Animal
no.
Prototype
no.
Placement
IVC dia.
LAO (mm)
IVC dia.
RAO (mm)
Post IVC
dia. LAO
(mm)
Post IVC
dia. RAO
(mm)
tav.
(top / bottom )
(mm)
0089 07_8#7 CR (T11/12) 15.9 13.8 17.3 18.0 79±4/46±7
0089 07_8#6 CA (L4/5) 18.3 19.2 15.8 16.6 75±2/54±5
0122 07_8#5 CR (L5) 16.8 12.5 16.3 15.7 74±5/51±2
0122 07_8#4 CA (T12/L1) 19.3 18.2 17.9 18.3 75±8/47±7
0350 07_8#2 CR (L5) 14.6 15.4 14.4 16.3 72±5/50±8
0350 07_8#3 CA (L1/L2) 16.9 16.5 16.1 19.1 69±5/52±9
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9.2.1 Interim: Devicemigration and venography
From Figure 9.2 it is seen that one animal (ID 0089) showed displacement of the cranial de-
vice is within 4-5 mm after 1 and 2 weeks and the caudal device showed a displacement of
10 mm, none of which are considered as an actual migration of the device. Displacements
are often due to the fact that identical positioning of the implant is difficult at two different
time points. The second animal (ID 0122) did not show any displacement for either cranial
or caudal device. It is therefore concluded that for the duration of 2 weeks, the radial force
was adequate and risk ofmigration limited. Whenplacing a device in the veins, there is a risk
of narrowing of the vessel wall, due to an excessive inflammatory response and tissue cov-
erage of the device. Venography confirms vein patency after 2 weeks, and it was concluded
that tissue covering did not cause narrowing on the vessel wall. The distance between the
gold markers varied over time because they were able to slide along the strut, where they
were attached. The radial force was adequate until sufficient tissue coverage occurred in
the sense that no device migration was detected within the 31/2 weeks.
(a) Implant cranial (b) Follow-up cranial
Figure 9.2: Radiograph of cranial device at implant, interim and follow-up in AP-view after 2
weeks (9.2(a)) and (9.2(b)), respectively
9.2.2 Follow-up
One animal was euthanized after 2 weeks and due to a loss in device integrity, the remaining
two animals were terminated after 31/2 week. Figure 9.3 shows the IVC before harvesting.
Before harvesting the vena cava was perfusion fixated using buffered 10% formalin solution
for 15min to avoid contraction of the vein, once removed from the animal as seen during the
proof of concept. After harvesting the stent was kept in buffered 10% formalin solution. The
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Poly(L-lactide) in vitro and in vivo
explanted veinwith the stent was collapsed after harvesting and nearly flat as seen on Figure
9.4(a). After 24 hours the explants were imaged withMRI (Figure9.5) to estimate integrity of
the device.
Figure 9.3: Stented IVC before harvesting
(a) Explanted cranial (top) and
caudal (bottom) device
(b) Explant of cranial device
Figure 9.4: Explants after 2 weeks
MRI showedmultiple fractures of the stent (Figure 9.5(a)) and an uneven distribution of
struts from a cross-sectional point of view (Figure 9.5(b)).
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(a) (b)
Figure 9.5:MRI scan of the caudal explanted device after 2 weeks implantation
9.3 Histology
9.3.1 Hematoxylin and eosin straining
After 48 hours the explants was embedded in paraffin for sectioning after which they were
stained with H&E. After 2 weeks most of the struts of the caudal device adhered to a sur-
face and was covered in neointima (20-100µm) ($ in Figure 9.6(a)) and was composed
of loosely-arranged spindle-shaped cells representing fibrovascular tissue with some fibrin
present. Some of the neointima over the strut (S) is covered with a single cell layer endothe-
lium (!) (Figure 9.6(b)).
Mature connective tissue was seen at attachment site (A) between the strut (S) and vena
cava (Figure 9.6(a)). Minimal inflammationwas detected as only a fewmacrophages around
the struts and few lymphocytes in the adjacent neointima were present (Figure 9.6(d)). At
sites of attachment between struts and vein wall, low numbers of smooth muscle cells in
the vena cava were vascoulated, suggesting mild focal pressure change. After 31/2 weeks still
most of the struts were adhered to the surface andwere covered by a thicker neointima (100-
300µm). It was composed ofmature neointima and fibrovascular tissue (9.6(c)), but disrup-
tion of the tissue occurred due to a processing artifact. At 31/2 weeks, most struts were now
fully covered with endothelium, and the presence of fibrin was still rare. Inflammation after
31/2 weeks was also minimal and composed of a few multinucleated macrophages around
the struts and a few lymphocytes in the neointima. As for 2 weeks, the attachment site be-
tween struts and vein wall consisted of smoothmuscle cells (low in number) andminimally
vascuolated.
160
9.3 Histology
(a) Cranial device 2 weeks 100x (b) Cranial device 2 weeks 200x
(c) Cranial device 3 1/2 weeks 100x (d) Cranial device 3 1/2 weeks 200x
Figure 9.6: Cross-sections fromH&E stained IVC with PLLA struts from 2 weeks and 312 .
9.3.2 Clearing and confocal imaging
Goal The overall goalswas to stain the vein tissuewith antibodies to visualize tissue growth
and inflammatory response. The attempt was to identify the suitable antibodies for this. It
was done as an alternative way to examine the tissue without disruption of the tissue and
device as seen for the paraffin slicing of cross-sections. With slicing, it was seen that the
struts were mechanically pulled from the tissue during slicing. The clearing was evaluated
as a method to enhance the visibility of the tissue.
As seen in Figure 9.7, clearing gives a much better visibility of the PLLA stent-base and
the tissue through light microscopy. It was possible to visualize the fractures of the stent-
base more clearly.
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(a) (b)
Figure 9.7: Explants after 31/2 weeks, where 9.7(b) was optically cleared.
9.3.2.1 Evaluation of antibody selection
At each time point, two different staining protocols were used. One tissue sample was
stainedwithDAPI, phalloidin, CD31 antibody (IgG2a) and anti-fibrinogen gamma chain an-
tibody (IgG2b). Another piece of tissue was stained with DAPI, WGA and anti-macrophage
antibody (IgG1). In Figure 9.8(e) a small residual of the antibodies are seen when taken im-
ages for all channels separately. Also, CD-31 antibody appears to stain in the same way as
the fibrinogen and the signal for each are overlapping. For this reason, CD-31 antibody was
not suitable for this particular tissue and study.
The reference tissuewhichhadnot been exposed to PLLA, showednopresence ofmacrophages
(Figure 9.9(c)) and the antibody appeared to stain equally with antibody for WGA (Fig-
ure9.9(b)). DAPI staining showed a little degree of residuals in the left corner (Figure 9.9(a)),
whereas antibody for macrophages, showed a large degree of residuals. Due to the nature
of the fluorescent signal, it is unlikely that Figure 9.9(c) represent macrophages, and the an-
tibody is not a plausible way to evaluate the presence of an inflammatory response. From
theH&E stainingmacrophages were few and the overall inflammatory response to the PLLA
was non-existent. It was concluded that the antibody for macrophages was not necessary
for this evaluation. For the remaining tissue samples staining with macrophage antibody,
the channel for red fluorescent light was not used in the images.
From Figure 9.10 it is seen that visibility is not good without clearing. It was not possible
to focus on the tissue in depth. The image showedpoor depth resolution and only an outline
of the PLLA struts were visible. It is difficult to get close enough to the tissue due to the
162
9.3 Histology
(a) (b) (c) (d)
(e) (f)
Figure 9.8: Explants after 2 weeks were optically cleared and stained for nuclei9.8(a), actin-
filaments9.8(b), CD31 9.8(c) and fibrinogen 9.8(d) were stained. All channels together are por-
trayed in 9.8(e). 9.8(f) show where on the stent-base the image is taken.
(a) (b) (c)
Figure 9.9: Un-stented reference tissue after 2 weeks were optically cleared and stained for nu-
clei9.9(a), cell membrane surface9.9(b), and macrophages 9.9(c)
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thickness of the PLLA struts. Clearing the samples would induce much greater focus and
resolution at 300 µm depth (Figure 9.11). Figure 9.12 shows when the slices at each depth
are compiled into a 3D structure and visualization of the connection point is far better than
for the paraffin cross-sections. From Figure 9.11 the actin-filament and their direction is
very clear. Fibrinogen covers the outer most of the tissue. It shows how the tissue is growing
on top of the stent-base connections points and going further into the tissue it also grows
along the sides of the connections points.
Figure 9.10: Uncleared samples after 31/2 weeks from top of the tissue and 288µminto the tissue.
Each slide is 35 µm into the tissue.
The images in Figure 9.13 confirm tissue coverage around and in the connection points
by either nuclei (blue) and actin-filament found in the extracellular matrix (green) (Figure
9.13a). Additionally, deposits of what was meant to be fibrinogen, the precursor for fibrin
appears red and covers the both struts and connection points on top of the cell layer as
seen on Figure 9.13(b). Fibrinogen was also deposited in the connection points in Figure
9.13c and without being part of the cell layer. Fibrinogen is also detected at most peripheral
on neointima as Figure 9.13(b) and seems to align with fibrous connective tissue typically
represented at the peripheral edges of the stretched vessel. Figure 9.13(a) shows a neointima
between 70 (end of the strut) and 120 µm (on the right side of a strut) that has fractured at
the connection point. The neointima after two weeks was enough to lock the stent cells as
it covers the connections points and as a result, the stent-base is unable to ’move’ with the
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Figure 9.11: Cleared samples after 31/2 weeks from top of the tissue and 300 µm into the tissue.
Each slide is 27 µm into the tissue.
vessel during compression and release resulting in the multiple fractures. Confocal images
showed the presence of smooth muscle cells in low number suggesting a mild focal change
in relation to the radial force by the oversized stent.
The actin-filaments (Figure 9.13(a)) occur only in the top cell layer (40-66 µm) on the
sides and are aligned along the strut. At the tip of the strut, the actin-filaments are randomly
deposited. Moving away from the connection points showed less tissue covering. The box in
Figure 9.13a show the muscle layer and their fibers in the smooth muscle cells. The thicker
green fibers in this area resemble elastin or, more likely, smooth muscle cells with actin. At
the corners of the strut, the tissue appears thinner (single-headed arrow) and represents a
compressed vessel. Also, the decreased number of nuclei in this area suggests compression
resulting in tissue atrophy and, likely, fibrosis. The increased red at the arrow shows the
neointima.
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Figure 9.12: Cleared samples after 31/2 weeks compiled
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Figure 9.13: Cleared samples after 31/2 weeks. (a) Shows a fractured strut for all channels show-
ing actin-filament (green), fibrinogen (red) and nuclei (blue), whereas (b) shows only the red
and blue channel for fibrinogen and nuclei, respectively. The double headed arrow in (a) show
the neointima, the side headed arrow shows sites with fewer nuclei and the boxes show the
muscle/adventitial layer and with fibers. The single headed arrow also represents the tissue at
the corners of the strut. (c) shows tissue coverage in a connection point and (d) shows where
the strut and connection point are positioned on the explant
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Discussion in summary
This chapter includes an overall critical assessment of the work is this project and how to
proceed.
10.1 Hypothesis
Within the field of PE preventive treatment, a ’true’ temporary filter is of great interest. State
of the art hypothesized that the ’true’ temporary filter could consist of one or more bioab-
sorbable materials. The filter must withhold its filtering capability until the risk of PE has
passed. Furthermore, it was hypothesized that the ’true’ temporary filter can be achieved by
a convertible filter platform and that it must be fully absorbed with no risk of fragmentation
or migration.
The literature review showed that several polymeric bioabsorbable materials exist, and
some have been used in carrying out a convertible filter (including PLLA, PLGA, and PCL).
There are different ways to interpret the profile of a filter after conversion of it and no longer
is capable of filtration. None of the convertible filters with one or more bioabsorbable com-
ponents address the risk of fragments from the filtration part of the filter. The braided bioab-
sorbable filter by Eggers et al. [37] was not based on such convertible concept and fragments
occur. There is a risk of fragments traveling in the bloodstream as the filter degrades. It
would be a difficult process to ensure that no fragment do so and that the fragments which
did travel, are of no harm to the patient. The remaining two attempts by Zhang et al. [39] and
Thor and Muck [38] were based on the convertible filter. Both filtration parts were made of
Vicryl (3-0, Ethicon Inc, Somerville, New Jersey), a PLGA suture, which undergo hydrolytic
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bulk degradation and fragment during degradation. The key to avoiding this is either by
using a polymer with a controlled surface degradation of struts with narrowing width from
wall to center. The filtration struts become thinner and shortens starting at the tip (center
of the cone) and more towards the caval wall. That way the fragmentation does not occur.
As previously shown the choices of surface hydrolytic polymers are limited. PHA has the
disadvantage of being too weak for the application and PCA has a too fast degradation for
this application. Polycarbonate is used in the bioabsorbable REVA coronary stent, which
exhibits good tensile strength [107], but embrittlement focal mechanical failure occurs as it
degrades[108][109]. An alternative is to create the filter, as described in the patent applica-
tion (US 20110213404 A1) by C. Binkert, based on a convertible filter. It opens up after the
risk of PE has passed and the filtration struts move towards the caval wall after which they
are embedded in tissue over time. When embedded the risk of fragments traveling to the
blood stream is eliminated. The fragmentation will most likely still occur, but the fragments
are secured by the tissue.
Monofilament and braided stent-bases In this study, it was possible to create a braided
stent-base. A braided stent-base made from oriented PLLA and thereby mechanically im-
proved PLLA. It showed a similar radial force, but lower than stent-bases laser cut from
strained PLLA tubing. Despite oriented PLLA having far superior properties to the strained
tubing, the radial force is not superior. It was proven that certain processing parameters
lead to improved stiffness and strength. The improved stiffness and strength correlate with
an increase in radial force during crimping. In retrospect, PLLA tubing appeared to have to
appropriate radial force to avoid migration. Unfortunately, the design suffered from poor
fatigue properties. If the polymer had been more flexible, it might not have fractured to the
same degree in vivo. Other studies used PDS and PCL, which did not fracture when im-
planted in vivo [37][39]. Both exhibit much better ≤b than PLLA. The drawback of PCL is the
low stiffness and thereby also a low radial force, while PDS has a better radial force, but the
strength of lost too quickly in vivo.
10.2 Overall discussion on strain PLLA tubing
To reduce the risk of migration, processing was used to optimize themechanical properties.
The overall findings are discussed in the following section.
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Degree of strain Biaxially straining of extruded PLLA tubes alters the mechanical proper-
ties of the polymer. Overall the stiffness, æy , UTS and ≤b of biaxially strained tubes, increase
with the degree of strain (e.g. total area expansion (Aexp )). It was seen that regardless of
(≤a ;≤r ), the higher the Aexp , the greater stiffness, and strength. An interesting observation
was that the material could exhibit different behavior in the axial and radial direction. This
was regardless of the simultaneous or sequential biaxial strain, and themechanical changes
are due to modification of the amorphous domain. For biaxially strained PLLA tubes the
crystallinity remains constant, though the stiffness and strength will increase with increas-
ing strain. The properties are therefore not related to the crystalline domain of the polymer.
Strain-induced crystallinity is only achieved, when several requirements are fulfilled
such as the adequate degree of strain the processing strain rate and temperature[110][111].
This study showed that axial processing strains (≤a) between 80-90% the amorphous chains
are stretched enough that the relatively low crystallization temperature of 65±C, just a few
degrees above Tg , induces crystals. Axial processing strains between 90-100% cause the
crystallization to grow as the final degree of crystallinity (Xc ) increased from 8-36%. The
greater the strain, the lower the cold crystallization temperature is (Tcc ). Once the ≤a=100%,
no further crystallization seems possible and the cold crystallization peak is diminished.
The behavior is interesting regarding further processing of the filter after the straining pro-
cess. A crystallinity of 36% is far frommaximum achievable crystallinity for PLLA. The same
is seen for sequential biaxially strained tubes, where the crystallization peak is diminished
(1.0;3.2) (Tp=73±C) with a Xc=30%. It was able to crystallize significantly at a temperature
above 110±C, regardless of indications from the DSC scan.
Processing strain rate and temperature Biaxially strained tubes belowTg turnmilky-white
on the inner part of the tube, compared to the transparent nature seen when raising the
temperature. If strain occurs below Tg there is a risk of plastic deformation of the amor-
phous PLLA, and there is a risk of craze formation. This was not possible to quantify for
the strained tubes by SAXS. In instances where a tube was processed under the same con-
dition, one could be white and another transparent. It was confirmed that the crystallinity
and orientation between the two were the same. Further more the displacement between
crystals was identical, and their size was the same (58Å circumferentially and 142 Å). The
light refractive index is different when the tube appears white. It is possibly due to clustering
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of crystals of the same size. Individual crystals of the same size distributed evenly through-
out the tube would possibly create a transparent material. The tubes were processed at the
same temperature and subsequently cooled in the same manner. Despite this, some tubes
were more white. Small inhomogeneities in the extruded tube might cause the difference
in refractive index. Whether it is crystal clusters or not, their mechanical behavior was the
same and no difference in ≤b was observed. Successful strain temperature (Tp ) was iden-
tified as low as 60±C. At Tp above 73±C crystallinity was not induced during the axial strain
possibly due to an increase in chain mobility, which prevents sufficient alignment for crys-
tal formation. Despite this, the mechanical properties both circumferentially and axially
improve with Tp .
The influence of axial strain and radial stent force It was hypothesized that the larger the
circumferential and axial stiffness and strength of a tube, the larger the radial force of the
stent made from such tube will be. Overall the design of the stent-bases used in this project
was diamond shaped cell stents. It is expected that the radial force lies in the resistance
to compress these cells and due to the design of the diamond shaped cells, not dominated
by the circumferential properties, but the properties at a 40± angle. It was seen that these
diagonal properties are dependent on the degree of axial strain before the radial strain is
applied. The axial stiffness and strength, as well as the ’diagonal’ (40± to the axial direction)
properties, improve if the initial axial strain is high. As a result, the larger the axial strain,
the more alignment in that direction is achieved, and the subsequential alignment during
the radial strain is thereby smaller and as well the circumferential properties. It is possi-
ble to use sequential biaxial straining at large strains and create a material, which exhibits
isotropicmechanical properties. It would be beneficial to take advantage of this when using
the diamond shape stent design, and potentially better radial force is achieved. In practice,
the degree of strain in each direction is a compromise between the best possible mechani-
cal properties and the thickness of the strained tube. In this project, the aim was to create a
tube with a wall thickness below 0.4 mm. This fact limits the axial strain to be below 30%.
Orientation of PLLA During straining or stretching the chains in the amorphous domain
are stretched and ultimately the amorphous fraction is reduced with increasing degree of
strain. While the crystalline fraction remains constant with increasing degree of strain, the
reduction in the amorphous domain is taken over by a transitional domain between the two,
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before transitioning into the crystalline domain. Axial strain alone is expected to induce less
amorphous scattering and result in higher crystallinity. Once the sequential radial strain
is applied some of the alignment achieved during the axial strain is lost. The larger the
axial strain, the less orientation of the crystals are achieved. During simultaneous biaxial
strain, the chains would be stretched in the 2D plan in which they are stretched, creating
in-plane isotropy [92]. Orientation, therefore, would be low as a result of randomly oriented
chains, at low strains. It appears in this project that the crystal orientation is independent of
the axial strain as the crystal orientation remains constant as a function of Aexp and radial
strain. A sequential biaxial strain will eliminate the crystal orientation in the axial direction
and create new crystals in the transverse direction. The efficiency of the transverse strain
is dependent on the degree of strain in the axial direction and if the crystalline domain is
fully formed (strong crystalline domain). For this reason, there is a difference in crystal
orientation between (0.2;2.3) and (1.0;3.3). The former has a weak crystalline domain, and
the latter has a strong crystalline domain before the transverse strain is applied leading to a
crystal orientation of 0.5 and 0.3, respectively. It was concluded that to achieve a high order
of crystalline orientation, the initial axial strain must be low.
Themechanical properties appear to be indifferent of crystal orientation during sequen-
tial biaxial strain, but upon annealing the crystal orientation factor is reduced to 0.1 and the
mechanical properties are compromised upon annealing. This is the only time, where the
change in orientation factor corresponds to a change in directional mechanical properties,
regardless of simultaneous or sequential biaxial strain. As for oriented PLLA monofilament
from Zeus, the orientation factor before annealing was similar to the axially strained PLLA
tubes (0.7), only higher (0.8). The orientation of biaxially strained tubes was reduced to less
than half upon annealing below crystallization temperature. It appears that themechanical
properties are compromised upon annealing. It is unknown if it is due to the relaxation of
the amorphous domain or due to the lack of oriented crystals. Raman spectroscopy had
been investigated to see if there was a difference between the amorphous and crystalline
domains. Either the method was not sufficient to establish such, or the difference in ori-
entation between sequential and simultaneous biaxial strain was not enough. The method
would need further investigation.
It appears that orientation and Xc are not the main contributors to the mechanical per-
formance of PLLA. The increase in crystallinity will result in an increase in stiffness and æy .
It is not preferable to create amaterial that is high in crystallinity and thereby brittle and not
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very flexible. Flexibility is needed if the device is to withstand compression repeatedly and
move with the vessel during implantation. Biaxially strained tubes with a moderate crys-
tallinity, should be beneficial in this matter. If the tubes are merely extruded into the appro-
priate size, the stiffness, æy and ≤b are much less than for the strained tubes. As expected
the major strength and stiffness lies in the axial direction, the extrusion direction, where
the chains are aligned. The elongation is greater for the direction transverse to extrusion.
The extruded tube has been cooled at a rate that prevents the material from crystallizing.
It should be noted that the axial properties are in accordance with values reported by the
vendor.
The BVS stent from Abbott Vascular, which is composed of most likely a laser-cut PLLA
tubing was investigated in this study. It showed a low degree of crystal orientation but ex-
hibits a high crystallinity compared to the sequential biaxially strained PLLA tubes. At the
same time, oriented tubing from Zeus exhibited an orientation factor similar to the simul-
taneous biaxially strained PLLA tubes and a high degree of crystallinity. As simultaneous
and sequential biaxial straining evokes mechanical properties in the same range, but not
the same degree of crystal orientation, the improved mechanical properties are not related
to the crystal orientation itself. It should be noted that despite the higher orientation de-
gree in PLLA tubing from Zeus, the mechanical properties are inferior. It is unknown if the
raw material differs slightly. It cannot be ruled out that one of the materials have a nar-
rower molecular weight (Mw ) distribution and therefore better stiffness and strength. The
tube from Zeus exhibit higher stiffness and æy and ≤b in the circumferential direction as op-
pose to their axial direction, indicates it has been biaxially strained as opposed to simple
extrusion of the tube. If the straining is sequential, the orientation factor would have been
lower, but similar if a simultaneous method used. It is more likely that whenmanufacturers
claim the existence of an oriented tubing and improved mechanical properties thereof, it is
important to identify where these properties originate from. It is more likely the degree of
crystallinity which caused the improvement of properties. The oriented PLLA tubing from
Zeus and the BVS stent from Abbott have a crystallinity close to the maximum crystallinity
of PLLA, which is not preferable for the IVC application.
Crystal size Post-annealing reduces the axial crystal size slightly, but it enlarges the radial
crystal size significantly. It is expected that during annealing the crystals grow in size either
in the plan or depth or both. Crystal sizes in each direction are indifferent to simultaneous
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or sequential biaxial strain. It could be expected that the crystals grow in the direction of
strain and their sizes likewise. The crystals formed during the axial strain are elliptical and
largest in the circumferential direction. Once annealed above crystallization temperature,
they become more circular in shape, where the circumferential size is reduced the axial di-
rection is elongated. Perhaps this is a perfect crystal and a natural shape for the crystal to
be in. The biaxial strain, regardless of simultaneous or sequential, also shows elliptically
shaped crystals, that are largest in the axial direction. Annealing does not change the shape
of the crystal below crystallization temperature, which is not very surprising as the crys-
tallinity does not increase. In fact, it was reduced and possibly due to the melting of smaller
imperfect crystals.
Crystal structure In all cases of the biaxially stained tubes and axially strained tubes, the
Æ’-crystal occurs, as they were not strained at high strain ratio or above 95±C. With this in
mind creating Æ-crystals by strain-inducing seems challenging, as 95±C is very close to the
Tcc temperature of these PLLA tubes. Supposedly the Æ’-crystal has a looser chain pack-
aging, and the disordered structure will result in a lower modulus and higher ≤b[89]. None
of the tubes, in this project, were produced at a temperature which could give rise to Æ-
crystals. The impact of theÆ0-crystal could not be confirmed, as straining above Tcc was not
possible, and the tubes contain only Æ’-crystal.
Annealing, heat treatment, and sterilization There are many ways to improve the prop-
erties of PLLA. Thematerial must remain free of additives and particles and consists only of
material, which is commercially available and approved in combination by the regulatory
authorities, and thereby limits the material options. Annealing is one way to overcome this
and improve the mechanical properties. Annealing was done to investigate the possibility
and influence of heat treatment on already crystalline tubes. The effect of annealing was
different for the amorphous extruded tubes compared to the sequential biaxially strained.
As expected the closer the annealing was to Tcc the faster the crystallization rate. Already
highly crystalline tubes, whether just axially strained or biaxially strained tubes, showed no
crystallization peak during heating in a DSC scan. It indicates that further crystallization
is not possible. It was possible to anneal the biaxially strained tubes at 110±C and above
for 30 min and thereby increase the crystallinity further. Such annealing leads to improved
stiffness and strength, and a lowering in ≤b as described in the literature. It is likely due to
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a reduction in the orientation of chains in both the crystal and amorphous domains. This
occurs even if further crystallization is not happening during annealing. The rate of crystal-
lization is not indifferent to the previous crystallization within the material. It was possible
to establish a linearity in crystallinity growth as a function of temperature for the sequential
biaxially strained tubes. The crystallinity growth rate for the extruded tubes was non-linear
as a function of time and faster. It means that it takes more energy to overcome the mobil-
ity barrier for PLLA which has previously been subjected to strain-induced crystallization.
Either the crystals do not grow, or the amorphous chains are aligned and cannot rearrange
and create more crystals.
Because a low to moderate crystallinity is preferable, annealing was not considered a
viable way to improve themechanical properties further. The heat treatment is essentially a
short form of isothermal annealing. From the annealing experiment, it was safe to use heat
treatment at 93±C without further increasing the crystallinity. Annealing at 90±C compro-
mise both the crystal orientation as well as the amorphous orientation and thereby also the
mechanical properties. Unfortunately, this also occurs during heat treatment even at short
periods of time. During EO sterilization, it was expected that mechanical properties would
be compromised due to the presence of both water and temperatures close to Tg . When
heat treated first, the amorphous chains relax and due to rapid cooling after heat treatment
at 93±C the crystallinity is reduced to 27%. It means that some of the imperfect crystals have
melted at that point, which could explain the lower modulus. In retrospect, it was seen that
rapid cooling using freeze spray reduces the stiffness and strength, more than slow cooling
at room temperature, and rapid cooling is not suggested after heat treatment.
When sterilizing the polymer with EO, the standard sterilization process usually takes
7-8 hours, in which the material is subjected to both heat and moisture. The closer the
temperature is to Tg the more aligned the chains become, which is seen by an increase in
stiffness and strength, while crystallinity remains constant. The presence of moisture has
no impact on the stiffness or strength, and it is expected that the heat close to Tg softens
the material, but no changes in mechanical properties or thermal properties are detected.
Cold sterilization limits the chain mobility, and they do not align after heat treatment. The
mechanical properties do not improve from the sterilization as seen at higher temperatures.
Therefore the standard EO sterilization at 53±C is preferred.
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Processing concerns In general, the process of biaxially strained tubes was at a point un-
predictable and create tubes with larger thickness variations along the tube. The extruded
did not seem to have a difference in wall thickness along the tube. At times the supplied
extruded tubes were not straight and possibly adding to an uneven distribution of material
along the tube. The tube will expand where least resistance is found, which leaves more
material on one side of the mold than the other. As the air is injected through the distal
end, the end is likely to expand slightly before the proximal end. The material would have
to move from the distal to proximal end as the expansion propagates along the tube, leav-
ing the proximal end thicker. The higher the processing temperature, the more difficult it is
to evenly distribute the material along the tube. At the highest possible straining tempera-
ture (Tp=93±C ) tubes with the same strain parameter as tubes processing at lower temper-
atures, proved to be very thin (0.1 mm) compared to the former (0.2 mm). It was previously
seen that despite thickness differences along the tube, there was no difference in Tg , Tm or
Xc [13]. It is believed that the biaxial straining is successfully happening all along the tube.
The thickness variation was indeed apparent for the tubes with an initial large wall thick-
ness. It appeared that a larger initial axial strain, the less variation was detected along the
length of the tube. The expansion process is easier to control for the smaller length (50mm)
rather than, the longer length (100 mm) as used for prototypes in the animal study.
In vivo The size of the vena cava just above the hepatic vein ranged from 13.8 mm to 27.4
mm for 95% of the patients in a study of cava sizes[112]. The animals used in the animal
study in this project were in that range of those diameters, but on average in the lower
range of the spectra. Despite the failure of the device integrity after 2 weeks implantation,
the stent-base showed a positive outcome with no migration and limited inflammatory re-
sponse to PLLA in the vein. Overall it did no harm to any of the animals. One of the major
concerns of an IVC filter is the risk of migration[39]. The stent-base exerted a radial force
of approximately 2.3 N on the vessel (15 mm). It is significantly higher than for the Cook
Celect filter, which has a radial force of 0.3 N when compressed to 14 mm [113]. The radial
force of the PLLA stent-base was considered adequate, as nomigration was detected within
2 weeks. During a simple ex vivo test, the stent-base was delivered in an explanted swine
IVC but did not give sufficient information on whether or not the stent would migrate. It
gave an indication of the friction between the device and the caval wall. It was seen from
in vitro testing that over time the PLLA stent-base becomes permanently deformed during
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cyclic flat-plate compression. This is partly due to the degree of deformation as well as the
physiological environment which weakens the polymer. As it becomes soft, the radial force
of stent-base is reduced. In vivo the vein most likely collapses over the stent-base and as a
result the individual cells fracture. The animal study was unable to confirm or validate if the
stent-base underwent permanent deformation before fracturing.
The FEA showed where the stent was most likely to fracture, and it did fracture in those
places. It was not expected that the stent-basewould fracture inmultiple places, as the stent
lost its device integrity and strength after the first few fractures. It cannot be explained why
additional fractures were seen. It is possible that the tissue coverage is extensive, and the
cells of the stent-base are unable to be compressed. They are held in place by the tissue and
as the vein collapses the stent fractures. This is a plausible explanation because the main
part of the fractured pieces are still held in place by the tissue despite the fractures. Less
tissue was present on the fractured ends compared to along the sides. This indicates that
tissue coverage happened after and not necessarily just as the stent-base fractured. There-
fore fractures must have occurred after the tissue covered the stent-bases.
The traditional histology paraffin embedding proved not to be suitable for the stented
vein. As slices were made, the PLLA was pulled from the tissue, which was damaged in the
process. By clearing the explanted tissue in stead, it was possible to visualize the fractures
and the underlying tissue better. Additionally, the fluorescent antibody has the great ad-
vantage over standard slicing of paraffin-embedded explants by leaving the explant (tissue
and implant) intact, while getting the histology information needed. It is possible that the
slicing of paraffin could be optimized so that the tissue and PLLA struts were not disrupted
upon slicing.
In vitro Testing the device under physiological conditions could not predict the outcome
of a device implanted in vivo. The radial force surprisingly showed that a braided stent from
oriented PLLA would exhibit a radial force half of the stent-base from stained tubing used
in the in vivo study. When braiding it is possible to align the filament in the circumferential
direction giving it radial strength. The diamond shape stent design does not benefit from a
circumferential strength and stiffness. It is possible that the braided stent would have been
able to withstand the cyclic compression in vivo, but it is unknown if the radial force would
be adequate. Another bioabsorbable polymer might have performed better. PDS has lower
mechanical properties than the oriented PLLA, and the radial force would be less for a PDS
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stent. Based on the results presented by Eggers et al. [37] the PDS stent, with presumably
less radial force, did not migrate. The oriented braided PLLA stent might have had enough
radial force to withstand migration.
Regarding design considerations, it was seen that a wider stent cell from a laser cut tube
results in the greatest compression force. A high ≤˙p was previously seen to optimize both
the circumferential stiffness and strength of the biaxially strained tubes and the radial force
of an equivalent stent. The optimized stiffness and strength were also portrayed by a larger
compressional force of a single stent cell. The single stent cells fractured in the same place
as the stent did. An interesting observation was that water appears to have a larger effect
on the single stent cells compared to biaxially strained tubes during aging. In a static load
compression setup, the single stent cells, deform if kept under ambient conditions, but only
fractured when kept in water. It was expected that the polymer softened, and relaxed over
time due to penetration of water molecules, but in stead of relaxing fractures are observed.
This is a very good indication of why the stent-base fractured to a large extend in vivo.
Previously it was discussed that a stent-base processed with a low degree of axial strain,
benefits from a high Tp . This is true to the extend where the higher Tp and thereby the
greatest stiffness and strength circumferentially, also results in the largest force needed to
crimp the stent. It did not exert the largest force on the 15 mm vein. From an integrity
perspective, the stent-bases with a high axial strain during processing coiled up upon heat
treatment, and released the tension of the aligned chains axially. The stents processed at
high Tp are permanently deformed to a larger degree under cyclic compression test in vitro.
This is despite the larger radial force and circumferential tube stiffness and strength when
processed at high Tp than seen for lower Tp . The parameters were therefore not used for
stent processing.
As seen from in vitro testing, the PLLA tubing cut into a diamond shaped stent design,
was able to be crimped down to 6 mm, multiple times, without fractures. Permanent defor-
mation at this crimping occurred. It reached a plateau, in which the force to crimp as well
as the change in stent diameter remained constant. The flexibility of the stent-base was also
detected as the stent survived 150.000 cycles when compressed to 30% in a flat-plate design,
under physiological conditions. However, the model was inadequate for prediction of the
failure mode in vivo.
Aging of the tubes in serum for two weeks (37 ±C) did not increase the crystallinity of the
tubes. However, an increase in stiffness and strength was observed, while ≤b was reduced.
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The tube ultimately became more brittle over time at elevated temperature, and not due
to degradation of the amorphous domain. The brittleness mean that the polymer is more
likely to fracture and a possible explanation for the failure in vivo. In retrospect, a cyclic
compression test after 2 weeks at 37 ±C, would possibly clarify this issue.
10.2.1 What can be taken from all of this
It will take some tryouts before a ’true’ temporary filter made from bioabsorbable materials
will reach the market. This study only investigated the presence of a stent-base in the vena
cava. Once successful with no device migration, fracture or loss of integrity, no significant
inflammatory response to the material or narrowing of the wall, the next step is to test the
functionality of the filter. If moving forward with the idea of a fully bioabsorbable convert-
ible filter, further investigation of the filtration struts and the filtration mechanismmust be
done to ensure that the filter can trap clots. Such test setupwas previously done by Eggers et
al. [37], where they induced clots in vivo to the vascular system, and their filter was able to
trapmultiple clots. This could be a way, if found ethical, to test the functionality of the filter.
Furthermore, after an appropriate indication period, the filtration struts must open up and
move towards the caval wall, without fracturing. The animal study in this project lacked
these and had the result from the study been positive, and device integrity remained, the
next animal study would include a fully functional filter. It is very important to investigate if
the filtration struts indeed can move towards to caval wall after 2-3 months of indication. It
is possible that neointima covers the end of the filtration struts connected to the stent-base,
and simple flipability of the struts is not possible. Also PLLA (Xc=27%) is known to relax over
time[14]. When the struts are pinned together is the center, the polymer might relax and
have the limited elasticity to move towards the caval wall.
10.3 Future
10.3.1 An alternativematerial: bioabsorbablemetals
An interesting alternative to bioabsorbable polymers are the less known bioabsorbablemet-
als. Within the last two decades, these material have been of increasing interest[114], with
the first patent in 2002[115]. The focus has mainly been on the magnesium stent for vascu-
lar use or orthopedic implants They are becoming more and more used in academia, and
180
10.3 Future
several manufacturers can now supply commercial alloys on a large scale. Biotronik (WE-
43-Biotronik, Berlin, Germany) developed a bioabsorbable magnesium stent and the first
to be clinically testing in 2007[116]. The drawback is the rapid degradation and can within
2-3 month create significant amounts of hydrogen between the tissue and implant[116]. It
is therefore not without issues to corrode metals in bulk in the vascular system. The iron-
based alloys seem more appropriate for application with high load (vascular stents and or-
thopedic implants). They have a significantly slower degradation rate compared to themag-
nesium alloys[117].
What about thedegradationproduct - the ions Cytotoxicity of iron in high concentrations
have been a concern, but overall the concentration have proved to be acceptable in vivo.
Pure iron has certain drawbacks. It has an insufficient degradation rate for a bioabsorbable
implant and it is ferromagnetic, which can be an issue for patients in need of an MRI scan
for diagnostic purposes[114]. To overcome this issue alloying to a significant degree with
nickel or manganese has been done. Nickel has the drawback of being a strong allergen, but
manganese is not and is essential to the body[117][114]. The Fe-Mn becomes antiferromag-
netic, and can enhance mechanical properties so that it matched the ones of stainless steel
(316L) the referencematerial for coronary stents[117]. The incorporation ofMn reduces the
corrosion potential and the material becomes less noble and increase the degradation rate
[114]. An additional increase in degradation rate can be achieved by alloying with palla-
dium or silicon, which also benefits the mechanical properties. It should be noted that an
overdose of manganese can toxic[117] and lead to intoxication and neurotoxicity[118].
Several studies have been done on the alloy Fe-Mn with different Mn content [119][114]
[117][120][121][122][123][124][125] behavior in vitro, but limited reporting on in vivo studies
exists[116]. Anything over 20 wt% does not lower the ferromagnetic properties further. With
increased amounts of Mn the æy and UTS decrease, while the ≤b increase[117]. FeMn20 has
an æy of 420MPa, UTS of 700MPa, ≤b of 8%, whereas Fe35Mn has a æy of 230MPa, UTS of
430MPa and ≤b of 30%. The latter composition has properties close to stainless steel 316L
with a æy of 190MPa, UTS of 430MPa and ≤b of 40%. Fe35Mn would therefore be a good
candidate for a bioabsorbable metal filter.
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10.3.1.1 Challenges with bioabsorbablemetal
As described above the mechanical properties are superior to the bioabsorbable polymers.
They can exhibit a good radial force while exhibiting good fatigue properties, which the
brittle polymers lack. The challenge faced upfront, is the limited knowledge of these mate-
rials compared to the bioabsorbable polymers, which have been used inmedical devices for
decades. The journey of bioabsorbable metals is just beginning. One challenge lies in the
degradation of the metals. Without going into the specifics, the degradation profile in vitro
can be difficult to match the in vivo degradation. The degradation is corrosion through an
electrochemical reaction with electrolyte and produces oxides, hydroxides, and hydrogen
gas[126]. As the metal degrades the mechanical integrity of the material is gradually lost.
Mechanical loads often speed up the degradation due to a phenomenon is known as stress
corrosion. The process includes both stress corrosion cracks and fatigue and makes the in
vivo degradation difficult to predict.
During corrosion, metal ions are produced (for example Fe* Fe2++2e° andMn*Mn2+
+2e°) and the electrons are used in reduction of oxygen dissolved as hydroxide, which then
react with the metals ions and creates a hydroxide layer. The hydroxide layer is not uni-
formly distributed over the surface of the metal and chloride can access the metal to com-
pensate for the increasedmetal ions is these spots. The reaction by the two become ametal
chloride and when it is hydrolyzed become hydroxide, metal ions, and free acid. The pH
level in those particular pits decreases, while the bulk is neutral. This autocatalytic reaction
leads to wider and deeper pits[117]. The pitting corrosion is a concern as it is not controlled
and it is. Therefore, it is difficult to predict the in vivo degradation from in vitro studies.
As their degradation is not dependent on hydrolysis, shelf-life and sterilization are easier.
On the positive side, their mechanical properties are superior to polymers, less material is
required, and the filter profile is much smaller. The latter is a good selling point amongst
the physicians. The shape memory of bioabsorbable metals is excellent and eliminates the
risk of a permanent set and can be loaded into the delivery system by the manufacturer
and not the physician. Furthermore, metals aremuch less sensitive to temperature than the
polymers.
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10.3.2 Future investigation of bioabsorbable polymers
Both the bioabsorbable polymer and metals have their strength and drawbacks. At this
point, the bioabsorbable polymers are more understood than the metals and should not
be discarded due to the failure of the strained PLLA as a bioabsorbable filter. The design
and thematerial used in this project lacked the flexibility. For the polymer to work in a filter,
it needs to either be more flexible and have better fatigue properties. Alternatively, it would
need to be stiffer and exhibit a great radial force to prevent the vein from collapsing. The
latter would not be advisable as disturbances within the blood flow could cause additional
DVTs. It is possible that a braided filter would exhibit the appropriate flexibility while still
using PLLA. A different loading procedure would have to be investigated to ensure that it
expands fully towards the wall. The most important lesson learned from this study is that
PLLA fails too easily under cyclic compression both in vitro and in vivo. Also, it proved to be
highly sensitive to temperature and handling during the procedure is difficult. In retrospect,
a more expensive investigation of the fatigue properties should have been done rather than
optimizing the radial force of the stent-base. PLLA might not be as useful in an IVC filter as
it is for an arterial stent, where fatigue requirements are different. The ingrowth or degree
of tissue coverage over the PLLA stent-base was faster than anticipated and prevented suc-
cessful compression of the stent-base. Regarding design, the diamond shaped stent design
is not ideal. Fatigue testing will occur near the connection points, which is also seen forma-
terials such as nitinol when incorporated in a diamond shape design and undergone cyclic
fatigue testing[127]. The fatigue failure is either due to the poor fatigue properties of PLLA
or due to the nature of the design. Regardless of material, it is expected that the design will
fracture over time near the connection points. At which point in time this occurs depends
on the material.
It is unlikely at this stage that it would be possible to process PLLA in a way which would
improve the fatigue properties greatly, and that it would undergo continuous cyclic com-
pression without fatigue failure. This might only be achievable with an elastomer, such as
PCL. The tissue growth might be different for PCL, as it exhibits less radial force, and does
not stimulate the cells to grow in the same way as PLLA did. This could potentially be an
issue as incorporation into the wall diminishes the risk of migration. The answer might lie
within a composite, where the initial stent-base skeleton is made from amaterial with great
stiffness and thereby radial force with an underlying elastomeric layer. An adequate radial
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force would then be achieved initially, and sufficient tissue coverage occurs. As the stiff
polymer fractures, the stent-base is kept together by the underlying elastomer.
The main focus of the project became to optimize the radial force of PLLA to avoid the
risk of migration. The focus might have been wrong as it was not determined if the radial
force of the PLLA stent-base with too high, only that it was adequate. PCL was previously
investigated by others[39] and proved not to have enough radial force. The material of in-
terest might have properties which lie between the strained PLLA and PCL as a copolymer
or as a composite.
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Conclusion
Bioabsorbable polymers are today well known as an alternative to permanent implants. De-
pending on the different applications different requirements are needed to fulfill the in-
tended function. The overall aim of this project was to investigate the possible material
candidates for a bioabsorbable vascular implant, the inferior vena cava (IVC) filter. The
overall requirement of a bioabsorbable IVC filter was the need to function as a filter for 2-
3 months. Furthermore, no fragments of the filter should cause harm to the patient until
complete absorption of the filter has occurred. Additionally, the IVC filter must not migrate
upstream to the heart, and the radial force should be adequate until the IVC filter is suffi-
ciently embedded into the caval wall. A challenge with the vena cava is that the blood pres-
sure is low and the vein therefore easily collapses during respiratorymovements. The device
must, therefore, be able to either withstand the continuous cyclic compressions of the vein
(good fatigue properties are required) and have enough radial force to prevent migration. It
was found that no polymer seemed to fulfill the requirements of both having adequate flex-
ibility while maintaining a high radial force. It was learned that amonofilament with a great
stiffness but low flexibility would provide a braided stent-base for an IVC filter with higher
radial force than obtained for monofilament with a lower stiffness. With that in mind, the
goal became to improve the stiffness and radial force of a stent-base. This was done by an
orientation of chains and crystals through strain-induced crystallization of extruded poly(L-
lactide) (PLLA) tubes in a biaxial straining process. It was seen that braiding a filter with the
same dimension from highly crystal orientedmonofilament would provide only half the ra-
dial force of a stent-base from biaxially strained PLLA tubing when placed in a 15 mm vein.
Whether or not the radial force is enough to prevent migration was not confirmed in this
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study.
Strainingof PLLA tubes Biaxial strain of PLLA tubes, induced the tubewith improved stiff-
ness and strength in both axial and circumferential direction in correlationwith the increase
in total area expansion (Aexp ), despite a constant degree of crystallinity (Xc ). The elongation
at break (≤b) was also dependent on the degree of Aexp . The biaxial strain was done either
simultaneously in each direction, or in two steps (sequential) with the axial strain applied
first. It was found that certain processing parameters need to be fulfilled to obtain strain-
induced crystallization. During the axial processing strain (≤a) the degree of strain must
be close to 100% before crystallization occurs. Below this strain the extruded tube remains
amorphous. Processing temperatures (Tp ) ∏85±C will not induce crystals in the axial di-
rection during strain due to an increase inmobility of thematerial that prevents permanent
alignment ofmolecular chains and thereby crystal formation. The degree of strainwas inad-
equate at elevated temperature. Unfortunately, the mechanical properties after axial strain
were not measured. Applying a transverse strain to the axially strained sample will induce
crystals, which in most instances were much larger than the axial strain degree. It is, there-
fore, possible to induce crystals at elevated temperature, but the degree of strain must be
higher than 100%. The crystal orientation is poorer when transverse strain (≤˙p ) is imposed
at elevated temperatures and the increase in stiffness and strength are dependent on the
alignment and elongation of amorphous chains. The strain processing rate also determines
if crystals are formed during the axial strain. If the rate is too slow, the chains tend to relax,
and crystals are not formed regardless of Tp .
Heat treatment or annealing of the strained tubes reduces the amorphous chain align-
ment or cause the chains to relax to their initial state before being biaxially strained. Thus
heat treatment deteriorates the mechanical properties. The crystal orientation is also re-
duced, but thought not to be of interest as the improved mechanical properties of the tube
did not seem to correlate with the orientation factor previously. The heat treatment was
used to expand a laser cut strained tube to a larger diameter (27 mm). It was seen that rapid
cooling with freeze spray reduced the mechanical properties even further and cooling in
air at room temperature was preferable. The sterilization of the strained tubes proved to
be beneficial if sterilized close to the Tg . The improved stiffness and strength were not re-
lated to the presence of ethylene oxide (EO) during sterilization, but rather the temperature.
During sterilization, it was possible to regain some of the improved stiffness and strength
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from the biaxial strain but not to the same level as before heat treatment. Overall the strain-
inducing crystallization process was beneficial for improving certainmechanical properties
of PLLA, but the process appeared to be reversible through heating.
Evaluation of ≤˙p , Tp and sterilization was done on different prototypes and showed the
same tendencies as for the biaxially strained tubes. It was concluded that the circumferen-
tial properties of the tubes could be correlated to the radial force of a stent-base. Stent-bases
processed with a high degree of axial strain or at high Tp were proven not to be ideal and
were not chosen for the in vivo study. A braided filter from an oriented PLLAmonofilament
exhibit about half of the radial force of the biaxially strained laser cut stent-bases in a 15mm
vein. The filter was less prone to permanent deformation and appeared more flexible. Due
to the lower radial force, the braided filter was not be considered for an in vivo study. Dur-
ing cyclic compression (120,000) of the laser cut stent-bases under physiological conditions,
permanent deformation was seen, but fractures were not detected.
In vivo The biaxially strained PLLA tubes were processed to their optimal abilities and
laser-cut into a diamond shape stent cell design. Based on the in vitro findings, the best
prototype and processing parameters were chosen. The chosen prototype was implanted
in an ovine animal model in vivo. The results were not as promising as anticipated, and
the study was terminated after just 3 1/2 weeks due to multiple fractures. Despite prediction
from the in vitro testing, it was seen that the PLLA stent-base would fracture much sooner
than anticipated. It appeared that the caudal stent-base had adequate tissue coverage to
prevent to fragmented PLLA pieces frommigrating, whereas few pieces of the cranial stent-
base remained. It was concluded that the stent-base had shown adequate radial force until
fragmentation occurred and prevented migration of the whole stent. The limitation of the
stent-base design and material was attributed to poor fatigue properties during compres-
sion. The cyclic compression station in vitro, which tested the whole stent-base was not
a good model for predicting fractures in vivo. It compressed to the stent-base about 30%
which was based on the degree of collapse of the vena cava clinically but was not enough
to detect fractures in vitro. PLLA showed poor fatigue properties when used in a diamond
shaped stent-base. Therefore it might be better to choose amaterial with a greater flexibility
and better fatigue properties. To ensure both flexibility and appropriate radial force a com-
posite material could be the solution. One layer could contain a stiffer polymer to ensure
great radial force until tissue coverage occurred and fragments would stay in the wall. The
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second layer could consist of a more flexible polymer with better fatigue properties, and
would be able to withstand the compression and hold the stent-base together despite the
stiff fragmented layer.
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Appendix A
Bioabsorbablematerials
A.1 Bioabsorbable stents
Table A.1: Table over bioabsorbable polymeric stents
Name Company Application Configuration OD(mm) Material Study time
Igaki-Tamai
Igaki Medical
Planning Com-
pany
Coronary Artery
Disease
Self-expanding[20]. Zig-
zag with straight bridges
with gold marker[19]
3 PLLA
10 year clinical,
stopped[19]
BVS Abbott Vascular
Coronary Artery
Disease
Out of phase zig zag with
straight bridges with plat-
inummarkers[19]
3
PLLA back bone
with PDLLA
coating[128]
Several clinical
trials. Upcoming
clinical trial for
US approval[20]
ReZolve 2
(REVA)
REVAMedical
Coronary Artery
Disease
Slide and lock. Iodine
impregnated for radio-
opacity
2.7-4.0
Tyrosine-derived
polycarbonate[20]
Clinical followup
expected in
2016[19]
Ideal
Bioabsorbable
Therapeutics
Coronary artery
disease[128]
Drug eluting
poly(anhydride ester)
salicylic acid
PLLA, anhydride
and saliccyclic
acid
Under
development[19]
[20]
AMS Biotronik
Coronary artery
disease
[19]
Sinusoidal in-phase
hoops linked by straight
bridges
3.0-
3.5[129]
Magnesium
based
Ongoing clinical
trials[19]
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Appendix B
Characterizationmethods
B.1 Mechanical properties definitions
Figure B.1: Stress-strain curve with its mechanical properties defined
B.2 Matlab Scripts
B.2.1 Tensile testing script
%% Specify the samples names by sample number. Tube 254, sample 1-3
specimens={'254.1','254.2','254.3'};
%% Import dimensions
run('Importdimension.m')
%Find index for specimens
for i=1:length(specimens);
for j=1:length(ID)
if strcmp(ID{j},specimens{i}) == 1
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index(i)=j;
end
end
end
% Find length (L0) and cross-sectional area (A0) for specimens
for k=1:length(index)
L0(k)=Lmm(index(k));
A0(k)=A0mm(index(k));
end
%% Import data for each specimen
for i=1:length(specimens)
% insert correct path
fid = fopen(['Specimen_RawData_' num2str(i) '.csv']);
out = textscan(fid,'%q%q%q%q','delimiter',';');
fclose(fid);
%replace , with .
for u=1:4
for j=1:length(out{1,1})
out{u}{j}=str2double(strrep(out{u}{j},',','.'));
end
out{u}=cell2mat(out{u});
end
% Define deflection and load
defl=out{1,3}(5:end);
load=out{1,4}(5:end);
% Calculate stress and strain values
strain254=defl/L0(i);
stress254=load/A0(i);
% Calculate an intersection to move curve to the left going through 0 on the
% x-axis
[Test.flyout,func1]=CalcLinFit(strain254,stress254,2,[5 40]);
Test.a1(i)=func1.p1;Test.b1(i)=func1.p2;
% x-values for which y=0
Xx(i)=func1.p2/func1.p1
h=(ones(1,50)*Xx(i))';
strain254{i}=strain254{i}+h(i)
Test.strain254{i}=strain254;
Test.stress254{i}=stress254;
% Cut off curve after max stress is reaced and stress is dropped to 80% of
% max stress
maxadd=0.8;
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[imax(i),imaxclip(i)]=CalcMax(Test.stress254{i},maxadd);
Test.strain254{i}=strain254(1:imaxclip(i));
Test.stress254{i}=stress254(1:imaxclip(i));
% Find yield stressat the first local maximum in stran interval [0.02;0.1]
[pks(i),locs(i)]=max(Test.stress254{i}(Test.strain254{i}>=0.02&Test.strain254{i}<=0.1))
Test.stressyield254(i)=pks(i);
% Calculate modulus in a specific stress interval
[Test.Emod254(i),Test.linfitEmod{i}]=
CalcLinFit(Test.strain254{i},Test.stress254{i},2,[20 40]) ;
%find max stress and max elongation
sigmamax254(i)=max(Test.stress254{i});
elongmax254(i)=max(Test.strain254{i});
end
%% Following functions are written by L. P. Mikkelsen (2009)
% CalcMax
% CalcLinFit
B.2.1.1 Import data
%% Import dimensions from spreadsheet
[~, ~, raw] = xlsread('dimensions.xls','Ark1');
raw(cellfun(@(x) ~isempty(x) && isnumeric(x) && isnan(x),raw)) = {''};
cellVectors = raw(:,[1,11,12,13,14,15,16,18]);
raw = raw(:,[2,3,4,5,6,7,8,9,10,17,19,20]);
%% Replace non-numeric cells with NaN
R = cellfun(@(x) ~isnumeric(x) && ~islogical(x),raw); % Find non-numeric cells
raw(R) = {NaN}; % Replace non-numeric cells
%% Create output variable
data = reshape([raw{:}],size(raw));
%% Allocate imported array to column variable names
ID = cellVectors(:,1);
A0mm = data(:,6); % Cross-sectional area
Lmm = data(:,7) % Length
B.2.1.2 CalcLinFit
The CalcLinFit function was used to calculate a slope of a linear line
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function [slope,linfit]=CalcLinFit(x1,x2,xn,xnrange,imax)
%% [slope,linfit]=CalcLinFit(x1,x2,xn,xnrange)
% Find a linear fit in the xnrange
%% Inddata:
% x1: x-vector
% x2: y-vector
% xn: =1 or 2 depending on what xnrange is for x or y values
% =0 istart and iend given in xnrange instead
% =3 full range, xnrange is not taken into acount
% xnrange: the range for the fit (x or y values depending on xn)
% imax(opt.): include large range in CalcRange
%% Outdata:
% slope: the slope of the linear fit in the plot (e.g. Emod or strainrate)
% linfit: fit information used in PlotLinFitAdd function
%% Author: L.P. Mikkelsen, AFM-KOM, Risoe-DTU, 2009.
%%
if xn==1
if nargin>4
[istart,iend,ierr]=CalcRange(x1,xnrange,imax);
else
[istart,iend,ierr]=CalcRange(x1,xnrange);
end
elseif xn==2
if nargin>4
[istart,iend,ierr]=CalcRange(x2,xnrange,imax);
else
[istart,iend,ierr]=CalcRange(x2,xnrange);
end
elseif xn==0
istart=xnrange(1);iend=xnrange(2);
ierr=0;
elseif xn==3
istart=1;iend=length(x1);
ierr=0;
end
if ierr > 0; % in the case of an error in the range
disp(['ERROR CalcLinFit range,',num2str(xn),' ',num2str(xnrange)])
slope=0.0;
linfit.p1=0.0;
linfit.p2=0.0;
linfit.istart=1;
linfit.iend=length(x1);
return;
else
%% Calculate slope for x1range(1)<x1<x1range(2)
194
B.2Matlab Scripts
p=polyfit(x1(istart:iend),x2(istart:iend),1);
slope=p(1);
linfit.p1=p(1);
linfit.p2=p(2);
linfit.istart=istart;
linfit.iend=iend;
end
B.2.1.3 CalcMax
CalcMax was used to cut the stress curve after UTS.
function [imax,imaxclip]=CalcMax(load,maxadd)
%% [imax,imaxclip]=CalcMax(load,maxadd)
% Find the array element with the max value and maybe a later point as well
%% Inddata:
% load: the vector from where the max value is found
% maxadd(opt.): a factor < 1 which add some additonal curves to the range and
% save that array element in imaxclip (used if some part of the curve
% after the max is wanted in the plots or during the following data
% analysis
%% Outdata:
% imax: array element for max value
% imaxclip: array element for max value or after maxvalue*maxadd
%% Author: L.P. Mikkelsen, AFM-KOM, Risoe-DTU, 2009.
%%
iall=length(load);
maxload=-1.0e99;
for i=1:iall
if abs(load(i))>maxload
maxload=abs(load(i));
imax=i;
end
end
if nargin>1
i=imax;
if maxadd >= 1.0; imaxclip=imax; return; end;
if maxadd == 0; imaxclip=iall; return; end;
while i<iall && abs(load(i))>maxload*maxadd
imaxclip=i;
i=i+1;
end
else
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imaxclip=imax;
end
B.3 WAXS package
Figure B.2:WAXS package used for analysis for XRD patterns
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Materials
C.1 Stereometry
Figure C.1: Stereochemical possibilities observed with polylactide synthesis either through ring
opening polymerization (ROP) or polycondensation. Used from [78]
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C.2 Specifics onmonofilaments from vendors
Table C.1: Composition of the monofilament purchased from Corbion and Zeus
Manufacturer number Polymer Processing
Purac Purasorb
PL24
PLLA
As extruded
Oriented
Purac Purasorb
PD24-PL24
PDLA-PLLA blend
As extruded
Oriented
Purac Purasorb
PLC7015B
70:30 PLLA-PCL blocky
Elongated
As extruded
Zeus Absorv
85L/15G PLGA
85:15 PLGA Oriented
Purac Purasorb
PLC8516B
85:15 PLGA As extruded
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Appendix D
Additional results
D.1 Radial force of braided stents during the 1st cycle
Figure D.1: Radial force of braided stent after 1 compression cycle from 10mm to 2.1mm
199
D. ADDITIONAL RESULTS
D.2 Analysis of tubes from Zeus and BVS from Abbott Vascular
D.2.1 Mechanical properties
Table D.1:Mechanical properties of Zeus extruded and oriented PLLA tube
Eaxial
(MPa)
æmax,ax
(MPa)
æy,ax
(MPa)
≤ f ,ax
(%)
Eci r c
(MPa)
æy,ci r c
(MPa)
æmax,ci r c
(MPa)
≤ f ,ci r c
(%)
PLLA ext. 1076±56 532± 47±2 368±100 585±107 39±2 44±2 73±23
PLLA 1196 700±24 66±1 71±3 341±41 922±156 78±0 112±1 124±5
0 0.2 0.4 0.6 0.8 1
ϵ
0
100
200
300
400
500
σ
 (M
Pa
)
E=2635±245MPa
σy=74±7MPa
ϵy=5±1%
E=5805±349MPa
σy=374±35MPa
ϵy=32±2%
(a)
0 0.2 0.4 0.6 0.8
Strain
0
100
200
300
400
500
σ
 (M
Pa
)
50C 1 min
60C 1 min
70C 1 min
80C 1 min
90C 1 min
110C 1 min
Plla Ori
(b)
Figure D.2: Stress-strain curves for PLLA non-oriented and oriented monofilament before and
after annealing
D.2.2 Thermal properties andWAXS analysis
Table D.2: Thermal properties and scattering data of Zeus oriented PLLA tube (1196) and PLLA
BVS from Abbott
Tg (±C) Tm (±C) Xc% F2 Dax Dci r c
PLLA 1196 63 179 47 0.6 176 74
Abbott BVS 68 178 52 0.02 148 50
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D.3 Differential scanning calorimetry scans
(a) (b)
Figure D.3:WAXS images of BVS from Abbott Vascular and the oriented PLLA tube from Zeus
D.3 Differential scanning calorimetry scans
Figure D.4: DSC scan for isothermal annealing of sequential biaxially strained for 30 min at
temperatures between 100 and 130±
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Figure D.5: DSC scan for isothermal annealing of sequential biaxially strained for 30 min at
temperatures between 100 and 130±
Figure D.6: DSC scan for isothermal annealing of sequential biaxially strained for 30 min at
temperatures between 100 and 130±
Figure D.7: DSC scan for sequential biaxially strained tubes, which have undergone aging for 2
weeks in air, 37±C serum and water and at ambient conditions
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D.4 Gel permeation chromatographymeasurement
D.4 Gel permeation chromatographymeasurement
Table D.3: Molecular weight (Mn , Mw ), polydispercity index (Pd) and refractive (RI) index area
for extruded and sequential biaxially strained tubes under different treatment
Type Fr size Lot# Mass /mg Mn (kg/mol) Mw (kg/mol) Pd RI area
Concept 0706, heat
treated, rapid cool
16.5 17 94.9 193.6 2.04 65.5
85.9 195.4 2.28 65.5
Concept 0706, heat
treated, rapid cool
16.5 18.3 100.1 188.3 1.88 65.8
94.5 192.7 2.04 67.10
Sequential (1.2;3.2)
(2x25kGy)
10.2 21.6 31.9 67.7 2.12 63.7
35 67.60 1.93 62.1
Concept0608 16.5 26.9 93.3 187.9 2.10 66.5
97.3 192.1 1.97 66.5
Extruded tube 13.2 JP237396 24.1 94.3 186 1.97 70.00
106.8 190 1.78 68.50
Extruded tube 10.2 JP253453 25 102.9 195.9 1.90 66.33
112.7 195 1.73 64.14
Extruded tube 16.5 JP241546 24.9 107.9 194.6 1.804 65.19
113.3 198.2 1.75 65.10
Extruded tube 16.5 JP241546 25.2 97.8 192.3 1.966 66.72
115 199.5 1.74 65.95
Extruded tube 10.2 JP246909 23.7 105.9 197.4 1.86 65.67
102.5 194.8 1.9 65.60
Sequential (1.2;3.2)
60min at 90C
10.2 25.3 98.9 191.7 1.94 68.40
102.6 190.6 1.86 67.83
D.5 Thickness after sterilization
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Figure D.8: Thickness of sequential biaixally strained tubes before and heat treatment and ster-
ilization at 53±C from one end to another
D.6 Cylic testing
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D.6 Cylic testing
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Figure D.9: Load-extension curve for a single stent cell tested under cyclic compression. The
cell was strained at Tp=73±C and cut into cells based on the Concept0708 design. It was further
heat treated 93±C for 5 min. During testing the cell was crimped to 50% of its initial height.
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Tube parameter for in vivo study
Table E.1: Processing parameters for tubes used in the animal study
Process parameters
Tube size
(Fr)
Axial elonga-
tion (mm)
Radial ex-
pansion
(mm)
Form diame-
ter (mm)
Form length
(mm)
T(±C) time(s)Pressure
(bar)
16.5Fr 28 5 10.5 120 73 150 20
Tube parameters
≤ax (mm) ≤r (mm) Aexp Thickness
(mm)
128% 52% 216% 0.46-0.79
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